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SUMMARY 
 
Trypanosoma brucei, the causative agent of Human African Trypanosomiasis 
(HAT), is a major health and economic burden in sub-saharian Africa and treatment 
against its infection relies on a few drugs that present serious limitations. The cell 
surface and lysosomal/endosomal compartments of T. brucei are rich in glycoconjugates 
that are essential for its survival and infectivity. Consequently, the study of T. brucei 
glycobiology might lead to the identification of novel therapeutic targets. 
The present work started after the discovery that the de novo biosynthesis of 
GDP-Fucose is essential for T. brucei cell growth. The aim was to characterize the 
enzyme(s) involved in the transfer of fucose from the sugar nucleotide donor to its 
acceptor(s) and to search for T. brucei fucose-containing glycoconjugates.  
Only one putative fucosyltransferase (TbFT) was identified in the T. brucei 
genome. TbFT was recombinantly expressed and its activity as a fucosyltransferase 
demonstrated. The enzyme showed its best activity with Galβ1,3GlcNAc or its β-methyl 
glycoside as substrates. Furthermore, the reaction product was structurally characterized 
to demonstrate the anomeric and stereochemical specificity of TbFT. From these 
analyses, we concluded that TbFT was a GDP-Fuc: β-D-Gal α-1,2-fucosyltransferase, 
with a preference for Galβ1,3GlcNAc-containing structures. 
To try to elucidate the role of fucose in T. brucei, we attempted to generate 
TbFT conditional null mutants. In procyclic form, deletion of TbFT resulted in a 
reduction of cell growth that eventually led to cell death. These cells displayed a slightly 
abnormal morphology and an apparent reduction in the surface high molecular weight 
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glycoconjugate complex. In bloodstream form, attempts to generate a TbFT conditional 
null mutant were unsuccessful. 
The identification of T. brucei fucosylated glycoconjugates was attempted using 
various biochemical techniques, e.g. purification with fucose-specific lectins or ESI-MS 
analysis of the total N-glycan and O-glycan fractions. The results seemed to suggest that 
in procyclic form parasites fucose is present only in the high molecular weight 
glycoconjugate complex. However, this hypothesis needs further testing and alternative 
approaches are needed to finally identify the fucosylated component(s) of this complex. 
We also biochemically characterized T. brucei phosphomannomutase (TbPMM), 
an enzyme involved in the biosynthesis of GDP-Mannose, the starting metabolite for the 
biosynthesis of GDP-Fuc in this parasite.  TbPMM showed activity not only towards its 
natural substrates, mannose-phosphates, but also towards glucose-phosphates and the 
significance of this is discussed. 
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1.   INTRODUCTION 
 
 
1.1   Human African Trypanosomiasis 
Trypanosoma brucei is the causative agent of African sleeping sickness or 
Human Afican Trypanosomiasis (HAT) and the cattle disease n’gana. It is an 
extracellular vector-borne protozoan parasite that belongs to the kinetoplastida order, 
family trypanosomatidae, together with Trypanosoma cruzi and the Leishmania species 
and these parasites impose an enormous burden on the health and economy of the 
developing world (Simarro et al., 2008).  T. brucei is transmitted by the blood meal 
of a tsetse fly (Glossina genus). Both male and female flies can transmit the parasite, 
although usually only a small percentage of the tsetse population is actually infected, 
even in areas where the disease is endemic 
(http://www.cdc.gov/parasites/sleepingsickness) 
HAT is transmitted to humans by two parasite sub-species: Trypanosoma brucei 
rhodesiense and Trypanosoma brucei gambiense. T. b. rhodesiense causes an acute 
syndrome, is endemic of eastern and southern Africa and is defined as a zoonotic 
disease, i.e. domestic and wild animals, acting as reservoirs, are involved in the parasite 
transmission cycle. On the other hand, T. b. gambiense induces a chronic infection, is 
found in the west and central areas of the African continent and is responsible for the 
majority of the reported HAT cases (Simarro et al., 2008; Simarro et al., 2011; Fevre et 
al., 2008; http://www.cdc.gov/parasites/sleepingsickness). Both forms of the disease 
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display an early stage characterized by malaria-like symptoms, where the parasites are 
confined to the bloodstream and the lymphatic system, followed by an advanced stage 
in which the trypanosomes have crossed the blood-brain barrier and thus infected the 
central nervous system. This later stage is responsible for the severe neurological 
disorder and the disturbances in the sleep pattern. African human trypanosomiasis 
(HAT), in both its forms, is lethal if left untreated (Simarro et al., 2008; Fairlamb, 
2003). 
In 2009, the number of new cases reported was just below 10,000 (Simarro et 
al., 2011). The standard for serological diagnosis of HAT in the field is the card 
agglutination trypanosomiasis test (CATT). However, this test has limited sensitivity 
and cannot always discriminate between infected and cured individuals. Staging of the 
disease is performed by lumbar puncture and cerebrospinal fluid examination (Lejon et 
al., 2010). In the laboratory, a test based on loop-mediated isothermal amplification 
(LAMP) is also available for T. b. rhodesiense (Njiru et al., 2008). 
The currently available therapeutic agents are very old and have major 
limitations. Firstly, they are not effective in both stages of the disease. Suramin is used 
in the first stage of T. b. rhodesiense infection, while pentamidine is the drug of choice 
for the early stage of HAT caused by T. b. gambiense. Eflornithine is effective in the 
late stage of T. b. gambiense and melasoprol can be used in the treatment of the late 
stage of HAT caused by either of the parasite sub-species (Simarro et al., 2008; 
Fairlamb, 2003). Also, since 2009, nifurtimox/eflornithine combination treatment 
(NECT) has been included in the WHO list of HAT treatments as a second stage 
therapeutic agent in T. b. gambiense infections (Simarro et al., 2011). Secondly, some 
of the drugs present severe side-effects. For example, melasoprol causes 
encephalopathy in 5-10% of cases and can often be fatal (Fairlamb, 2003; Renslo and 
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McKerrow, 2006). Thirdly, all these treatments are costly and not orally available, 
requiring parenteral administration. This causes practical problems; sterile instruments 
and trained staff are necessary and patients show poor compliance, especially in the 
case of eflornithine, which has a very laborious administration regimen (Simarro et al., 
2008; Fairlamb, 2003). Lastly, there is the issue of drug resistance, which has been 
observed in the case of melasoprol (Fairlamb, 2003). In conclusion, there is a strong 
need for new, more effective and easy to administer drugs to treat the infection caused 
by this parasite. 
 
1.2 Trypanosoma brucei life cycle 
Trypanosoma brucei has a complex life cycle that allows it to proliferate in both the 
insect vector and the mammalian host (Figure 1.1). The different developmental forms 
present varied morphologies, e.g. nucleus, kinetoplast and flagellum positioning, 
changes in metabolism and in the surface coat expressed. When an infected tsetse fly 
takes its blood meal, the metacyclic trypomastigotes are injected in the bloodstream of 
the mammalian host. Here they differentiate into proliferative bloodstream 
trypomastigotes and start to divide and infect other sites. This cell population is 
pleomorphic: at the beginning of the infection the cells are defined as long slender, but 
as the parasitemia increases, more and more cells develop into stumpy form. These cells 
are arrested in G1/G0 phase, making them non-proliferative, and are ready to be taken 
by the insect vector (McKean, 2003; Fenn and Matthews, 2007). Parasite development 
in the flies requires 20-30 days. This maturation process starts in the tsetse midgut, 
where in the first 24 h, T. brucei differentiates into the proliferative procyclic form, 
which expresses procyclin as a surface coat. Procyclics colonize the midgut and move 
to the proventrinculus where an asymmetric division takes place, giving rise to the long 
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and short epimastigote forms. These cells migrate to the salivary glands where only the 
short epimastigote form is believed to be able to attach and proliferate. 
  
 
Figure 1.1: Life cycle of Trypanosoma brucei. Infection of the mammalian host starts with the 
trasmission of metacyclic forms by the tsetse bite. These cells differentiate to slender 
bloodstream form and, as the parasetimia increases, to stumpy form. At this stage, they can be 
taken up by the insect vector, where they differentiate to procyclic form in the fly midgut. 
Asymmetric division gives origin to the short epimastigote form that migrates and attaches to 
the salivary gland. Here the cells proliferate and mature to the infectious metacyclic form. 
Image taken from McKean, 2003. 
 
The proliferative epimastigote form expresses a surface coat protein called BARP for 
brucei alanine rich protein (Fenn and Matthews, 2007; Sharma et al., 2009). These cells 
are able to attach to the midgut epithelium through flagellar outgrowths that intercalate 
with the epithelial cell microvilli (Tetley and Vickermann, 1985; Ralston et al., 2009). 
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Here T. brucei differentiates to metacyclic trypomastigotes, expressing a variant surface 
glycoprotein (VSG) surface coat, that detaches from the epithelium and are ready for 
mammalian infection (Sharma et al., 2009). It should be noted that the cultured 427 
strain bloodstream form cells are the slender stage and are monomorphic, therefore 
unable to differentiate to stumpy form (Fenn and Matthews, 2007). 
 
1.3 The cell biology of Trypanosoma brucei 
T. brucei is a flagellated eukaryotic organism. The cell shape of this parasite is 
defined by a cytoskeletal sub-pellicular microtubules corset that underlies the plasma 
membrane (Figure 1.2, panel B).  The orientation of the cell is defined by the direction 
in which the parasite is propelled by the flagellum (panel A); following this definition, 
the flagellum exits the cell at the flagellar pocket near the posterior end and follows a 
left-handed helical path towards the anterior pole of the cell (McKean, 2003; Matthews, 
2005; Vaughan et al., 2008). 
As shown in panel B of Figure 1.2, the flagellum is composed of a classical 9+2 
microtubule axoneme, attached to which there is the paraflagellar rod (PFR). The PFR 
is a paracrystalline structure that has been shown to be essential for the parasite motility 
even though its precise function has not been elucidated (Bastin et al., 1998; Ralston et 
al., 2009; Vaughan, 2010). One of the characteristic features of Trypanosoma brucei is 
that the flagellum is attached to the cell body through a complex structure called 
flagellum attachment zone (FAZ). The FAZ is composed of the microtubule quartet, 
which is nucleated in the vicinity of the basal body, and the FAZ filament. This last 
structure is localized along the cell body in a gap between two of the sub-pellicular 
microtubules, where the plasma membrane and the flagellum are in contact (Vaughan et 
al., 2008). The main function of the flagellum is of course motility. T. brucei is a highly 
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motile organism and flagellar motility has been shown to be essential for bloodstream 
form viability in vitro (Broadhead et al., 2006). Furthermore, the T. brucei flagellum 
has been implicated in host-cell attachment (Tetley and Vickermann, 1985) and normal 
flagellar beating has been shown to be required for clearance of VSG-immunoglobulin 
G protein complexes from the parasite surface by endocytosis (Engstler et al., 2007). 
Lastly, the flagellum and the FAZ have very important roles in cytokinesis, structural 
inheritance and organelle segregation, as will be discussed later (Vaughan, 2010). 
At the point at which the flagellum exits the cell, the plasma membrane forms a 
deep invagination known as the flagellar pocket (Figure 1.2, panel A). This area 
represents less than 5% of the cell surface and is the only known site where endocytosis 
and exocytosis occur (Landfear and Ignatushchenko, 2001). Mammalian stages present 
high endocytotic and recycling activities, while these processes are less active in the 
vector stages. The flagellar pocket lumenal volume and membrane are asymmetric with 
the secretory pathway always associated with the larger section of the flagellar pocket 
(Field and Carrington, 2009). The membrane of the flagellar pocket presents a distinct 
protein composition, being the only cell localization of many important receptors, e.g. 
transferrin receptor (Tf) and low density lipoprotein (LDL) receptor. The flagellar 
pocket lumen has a carbohydrate rich-matrix of unknown function (Brickman and 
Balber, 1990; Landfear and Ignatushchenko, 2001; Field and Carrington, 2009). At least 
part of these carbohydrates can be purified with ricin as N-glycosylated glycoproteins 
and their N-glycans can be divided in two families: a low molecular weight mannose-
rich fraction and a high molecular weight fraction containing giant poly-N-
acetyllactosamine chains (Nolan et al., 1999; Atrih et al., 2005).  With the exception of 
the endoplasmic reticulum (ER), which is distributed through out the cytoplasm, the 
endocytic and exocytic systems of T. brucei are polarized to the posterior end of the cell 
 
1. INTRODUCTION   9 
(Field and Carrington, 2004; Field and Carrington, 2009).  Apart from this polarization, 
the parasite presents a quite conventional endomembrane system: endocytosis proceeds 
through early to recycling and late endosomes to reach the lysosome, while the 
secretory cargo is synthesized in the ER and delivered to the Golgi via a COPII-
dependent machinery before reaching the flagellar pocket via exocytic carriers (Field 
and Carrington, 2009; Sevova and Bangs, 2009; McConville et al., 2002). Endocytosis 
has been shown to be essential for cell growth in T. brucei (Allen et al., 2003; Hall et 
al., 2004).  
In kinetoplastids, like the trypanosomatids T. brucei, T. cruzi and Leishmania 
spp., mitochondrial DNA is organized in a complex network in a disc-shaped structure, 
the kinetoplast, localized in the matrix of the cell only mitochondrion and connected to 
the flagellar basal bodies. The kinetoplast DNA (kDNA) network is made of 
maxicircles and minicircles and displays an S phase discrete from the nuclear one 
(McKean, 2003; Liu et al., 2005). As in the mitochondrial DNA of higher eukaryotes, 
kDNA maxicircles encode for components of the respiratory complexes. In 
trypanosomatids, the mRNAs transcribed from these genes are subjected to editing and 
the guide RNAs that ensure editing fidelity are encoded by the minicircles, indicating 
that mitochondrial gene expression requires a complex coordination of maxicircles and 
minicircles transcription (Liu et al., 2005; Stuart et al., 2005). RNA editing was first 
described in trypanosomes and in these organisms it involves modification of precursor 
mRNA sequences by insertion or deletion of uridine nucleotides (Stuart et al., 2005; 
Field and Carrington, 2009). 
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Figure 1.2: Trypanosoma brucei cellular architecture. A. Schematic representation of 
Trypanosoma brucei cell. Although there are some discrepancies in the morphologies of the 
parasite different life stages, this illustration is still valid to show the general organization. 
Image taken from Matthews, 2005. B. T. brucei flagellum and flagellar attachment zone (FAZ). 
Top Left: scanning electron microscopy (EM) micrograph of a cell; Top right: Transmission EM 
section of the flagellum viewed from the posterior end; Bottom: schematic representation of the 
flagellum and FAZ structures visible in the EM section. PFR: paraflagellar rod; IFT: 
intraflagellar transport; MT: microtubule; DRC: dynein regulatory complex. Image taken from 
Ralston et al., 2009. 
 
The single mitochondrion of T. brucei runs along the whole cell length from 
posterior to anterior end (Figure 1.2, panel A). The organelle activity is repressed in 
bloodstream form, as in this stage energy production is completely dependent on 
metabolization of glucose to pyruvate by glycolysis (Matthews, 2005; van Hellemond et 
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al., 2005). Instead, in the procyclic form, the mitochondrion is very active and presents 
the expected respiratory complexes. Glucose is still the preferred energy source for 
these cells in culture, however sugars are thought to be very limited in the tsetse midgut 
and under glucose starvation in culture, proline and threonine are used for ATP 
production. Futhermore, in procyclics, pyruvate is further metabolized to acetate via 
acetate:succinate CoA transferase and the succinyl-CoA synthetase cycle, generating an 
additional ATP molecule (van Hellemond et al., 2005; Ginger et al., 2007).  
In Trypanosoma brucei, the first seven steps of glycolysis take place in the 
glycosomes. It has been postulated that compartmentation could be an alternative to 
allosteric regulation of these enzymes in preventing accumulation of lethal 
intermediates (Haanstra et al., 2008). Glycosomes are peroxisome-like organelles found 
in the cytosol of kinetoplastids. In addition to glycolysis, they are involved in the 
pentose-phosphate pathway, purine salvage and pyrimidine biosynthesis, β-oxidation of 
fatty acids, ether-lipids and squalene synthesis (Michels et al., 2006). Recent data 
suggest that in Trypanosoma brucei all or most of sugar nucleotide biosynthesis 
localizes to these organelles (Roper et al., 2005; Turnock et al., 2007; Stokes et al., 
2008; Marino et al., 2010; Marino et al., 2011). 
The parasite cell cycle starts with the maturation of the pro-basal body and the 
nucleation of the new flagellum. Replication of the Golgi apparatus follows 
immediately.  At this point the cell enters the kinetoplast S phase. Duplication of the 
kDNA commences just before the start of the nuclear S phase and it is shorter, meaning 
that the replicated kinetoplasts have already segregated by the time the cell enters 
mitosis. Both kinetoplast and Golgi segregation are dependent on basal body 
segregation (McKean, 2003; Hammerton et al., 2007). Once mitosis is complete, the 
cell can enter cytokinesis. In Trypanosoma brucei a cleavage furrow splits the cell from 
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anterior to posterior pole, cleaving between the old and the new flagella. Evidence 
suggests that FAZ plays an important role in the positioning of the cleavage furrow 
(McKean, 2003; LaCount et al., 2002). Furthermore, procyclic and bloodstream 
flagellar mutants with motility defects but correct flagellar attachment also present 
defects in cytokinesis (Broadhead et al., 2006; Branche et al., 2006; Ralston and Hill, 
2006). In procyclics another structure, the flagellar connector (FC), has been implicated 
in this process. The FC keeps the distal tip of the new flagellum attached to the side of 
the old one, probably to ensure that the newly synthesized flagellum is correctly 
positioned. Evidence of the presence of the FC in bloodstream form trypanosomes has 
not been found (McKean, 2003). 
 
1.3.1 The glycoprotein repertoire of Trypanosoma brucei 
The cell surface, flagellar pocket and lysosomal/ endosomal compartments of T. 
brucei are rich in glycoconjugates and these molecules play a very important role in the 
virulence, infectivity and also survival of this parasite (Turnock and Ferguson, 2007). 
The most abundant cell surface molecule in bloodstream form T. brucei is VSG. 
About 5 million copies of VSG homodimers are expressed by a single cell, covering the 
surface of bloodstream form trypanosomes in a dense coat that acts as a diffusion 
barrier (Figure 1.3, panel A): it allows small molecules to diffuse to the plasma 
membrane, but prevents macromolecules from reaching it, e.g. the components of the 
alternative complement pathway (Mehlert et al., 1998; Pays and Nolan, 1998). The 
parasite genome encodes for more than 1000 VSG genes and pseudogenes and every 
surface coat is composed of a single, immunologically distinct VSG variant. To escape 
the host immune response, the parasite switches the expression to different VSG genes 
in a very efficient example of antigenic variation (Swede and Carrington, 2010). 
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Bloodstream form T. brucei contains about 20 telomeric VSG expression site 
transcription units. Each unit comprises a distinct telomeric VSG and expression site 
associated genes (ESAGs). The cell can switch to a different variant by activating 
another VSG expression site or by modifying the active site by exchanging the VSG 
gene for one of the silent genes (Taylor and Rudenko, 2006; Horn and McCulloch, 
2010). Each VSG monomer has a molecular weight of approximately 50-55 kDa, is 
attached to the plasma membrane through a GPI anchor (see Section 1.4) and has at 
least one occupied N-glycosylation site. The structures of these N-linked glycans have 
been determined (Zamze et al., 1990; Zamze et al., 1991; Mehlert et al., 2002; Mehlert 
et al., 2010) and they vary (Figure 1.4), depending on the VSG variant, from 
oligomannose structures to biantennary complex glycans, to larger poly-N-
acetyllactosamine structures (Mehlert et al., 1998). Various invariant surface 
glycoproteins (ISG) are also present on the surface of bloodstream form T. brucei cells, 
e.g. ISG65 and ISG75 (Ziegelbauer and Overath, 1992; 1993). These are 
transmembrane proteins about 100-200 times less abundant than VSG and their function 
is unknown (Pays and Nolan, 1998). The ESAG6/ESAG7 heterodimeric transferrin 
receptor (TfR) is also localized on the cell surface of bloodstream form T. brucei, but 
exclusively in the flagellar pocket. The TfR is bound to the membrane through a GPI 
anchor to the ESAG6 subunit (Mehlert and Ferguson, 2007) and presents oligomannose 
and paucimannose N-glycan structures on both subunits (Mehlert et al., manuscript 
submitted). Fla-1 is a glycoprotein localized to the FAZ and it has been suggested to 
contain both N-linked and phosphodiester-linked glycans (Nozaki et al., 1996). 
Other glycoproteins can be found in the endosomal/lysosomal system: the 
endosomal membrane-bound histidine acid phosphatase (TbMBAP1) (Engstler et al., 
2005), the ER-localized GPI-deacylase (Guther et al., 2003), the Golgi and lysosomal 
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tGLP-1 (Lingnau et al., 1999) and p67 (Kelley et al., 1999). The lysosomal p67 
glycoprotein has been shown to contain large poly-LacNAc glycans, possibly capped 
with α-galactose, and experimental evidence also suggested the presence of small 
complex type N-glycans and oligomannose type structures (Turnock, 2006; Kelley et 
al., 1999). 
 
 
Figure 1.3: Cell surface architecture of bloodstream form and procyclic form T. brucei. A. VSG 
homodimers cover the surface of bloodstream form trypanosomes in a dense coat that acts as a 
diffusion barrier and helps evade the host immune system. B. The most abundant components of 
the procyclic cell surface are GPI anchored proteins called procyclins. A high molecular weight 
glycoconjugate complex is also present and it has been estimated to be half as abundant as 
procyclin. Image adapted from Ferguson, 2000. 
 
Of all these glycoproteins, Fla 1, p67 and tGLP-1 are also found in procyclic 
form T. brucei, although the glycan structures present on these proteins might be 
different between the two life stages (Alexander et al., 2002; Nozaki et al., 1996).  
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The surface of the procyclic form trypanosomes is less dense and its best 
characterized components are GPI anchored proteins called procyclins (Figure 1.3, 
panel B) and the free glycoinositolphospholipids (Richardson et al., 1988; Vassella et 
al., 2003; Roper et al., 2005; Nagamune et al., 2004). There are about 3x106 copies of 
procyclin per each cell (Treumann et al., 1997). Procyclins are classified in two families 
based on their sequence repeats: EP isoforms are made of glutamate-proline repeats, 
while GPEET procyclins display glycine-proline-glutamate-glutamate-threonine 
repeats.  
In procyclic form T. brucei 427 strain, procyclins are encoded by four genes: 
EP1-3 and GPEET (Acosta-Serrano et al., 1999). The GPI anchors of these proteins are 
modified with carbohydrate chains composed of branched poly-N-acetyllactosamine 
and Lacto-N-biose repeats and EP procyclins can present an N-glycosylation site on 
their N-terminal domain (Figure 1.4; Mehlert et al., 1998). The N-glycans on procyclin 
are exclusively oligomannose structures of Man5GlcNAc2 (Treumann et al., 1997). 
Recently a high molecular weight glycoconjugate complex has been identified on the 
surface of procyclics. Proteomic analysis revealed the presence of many polytopic 
transmembrane proteins, e.g. P-type ATPase. This structure is quite abundant with one 
complex every two molecules of procyclin (Güther et al., 2009). 
 
1.4 The glycobiology of Trypanosoma brucei 
Glycolipids can be used to anchor proteins to membranes via covalent linking of 
the protein through ethanolamine phosphate in structures known as 
glycosylphosphaditylinositol (GPI) anchors. This class of glycoconjugates plays an 
important role in the life of Trypanosoma brucei, because they are responsible for 
anchoring important components of the surface coat to the plasma membrane in both 
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procyclics (procyclin) and bloodstream form (VSG and the parasite transferrin receptor) 
(Ferguson, 1999). Structure and biosynthesis of GPI anchors were first described in T. 
brucei and are well characterized in this organism (Ferguson et al., 1988; Doering et al., 
1989; Masterson et al., 1989, 1990; Hong and Kinoshita, 2009; Fujita and Kinoshita, 
2010). Furthermore, GPI biosynthesis is essential in bloodstream form T. brucei and has 
been validated as a drug target against HAT (Nagamune et al., 2000; Chang et al., 2002; 
Smith at al., 2004). All T. brucei protein-linked GPI glycans have a common core 
structure: Manα1,2Manα1,6Manα1,4GlcNα1,6. In bloodstream form, this structure is 
further decorated with α- and β-Gal residues, while in procyclic form it presents poly-N-
acetyllactosamine and Lacto-N-biose side chains capped with sialic acid (Treumann et 
al., 1997; Mehlert and Ferguson, 2007). 
 
Figure 1.4: Trypanosoma brucei known glycan structures. The characterized structures from 
bloodstream form and procyclic form N-glycans and GPI anchors and the distinct glycosidic 
linkages required to synthesize them are shown. The glycosidic linkages required for the 
biosythesis of base J and Dol-P-Man are shown as well. Taken from Izquierdo et al., 2009a. 
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Glycan chains can be directly attached to proteins, most commonly through 
nitrogen (N-linked) or oxygen (O-linked) atoms (Varki et al., 2009). Oligosaccharides 
attached through a phosphate to serine or threonine have also been described, e.g. in 
gp72 and NETNES in T. cruzi (Haynes et al., 1996; MacRae et al., 2005), GARP in T. 
congolense (Thomson et al., 2002) and the proteophosphoglycans of the Leishmania 
(Ilg et al., 1994, 1996, 1998). N-linked glycosylation is the most common and the best 
studied pathway for protein glycosylation. In most eukaryotic organisms, an 
oligosaccharide precursor of Glc3Man9GlcNAc2 is synthesized linked to a dolichol 
pyrophosphate (Dol-PP) carrier (Varki et al., 2009). In T. brucei the mature precursor 
can be Man5GlcNAc2-PP-Dol or Man9GlcNAc2-PP-Dol (Löw et al., 1991; Jones et al., 
2005; Acosta-Serrano et al., 2004; Manthri et al., 2008). The first steps of the precursor 
biosynthesis (up to Man5GlcNAc2-PP-Dol) occur in the cytosolic face of the ER. The 
Dol-PP-oligosaccharide is flipped to the ER lumen, where it can be further modified 
before the enzyme oligosaccharyltransferase (OST) catalyzes the transfer of the whole 
oligosaccharide portion of the precursor to an asparagine residue, within the Asn-X-
Thr/Ser sequon, of the nascent polypeptide (Varki et al., 2009). Recent data have shown 
that bloodstream form and procyclic form T. brucei express two single-subunit OSTs 
with distinct but overlapping peptide acceptor specificity. TbSTT3A transfers 
Man5GlcNAc2 preferentially to N-glycosylation sequons flanked by acidic residues. 
Processing of only this precursor oligosaccharide leads to complex glycans in this 
parasite (Manthri et al., 2008; Izquierdo et al., 2009b). On the other hand, TbSTT3B 
transfers Man9GlcNAc2 to any of the remaining N-glycosylation sequons and 
modification of this triantennary glycan is the route to oligomannose structures 
(Izquierdo et al., 2009b). The final glycan structures, oligomannose or complex, are 
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obtained by processing of the precursor via the actions of glycosyltransferases (GTs) 
and glycosidases in the ER or in the Golgi apparatus (Varki et al., 2009).   Analysis of 
T. brucei GPI glycans, N-glycan structures and of other known glycoconjugates, e.g. 
Dol-P-Man and trypanosomatid-specific base J (β-glucosyl-5-hydromethyluracil) 
indicates that this parasite makes at least 38 different glycosidic linkages (Figure 1.4). 
Some of these glycosidic linkages are common to other eukaryotes and T. brucei 
homologues can be identified for some, but not all, of these GTs (Izquierdo et al., 
2009a). Furthermore, three of the α-mannosyltransferases involved in the biosynthesis 
of Dol-PP-oligosaccharide precursor have been characterized (DPMS: Mazhari-Tabrizi 
et al., 1996; ALG12: Leal et al., 2004; ALG3: Manthri et al., 2008).  For the linkages 
unique to T. brucei, a list of 21 putative UDP-Gal or UDP-GlcNAc GTs has been 
obtained by homology searches and secondary structure prediction. Of these, GT8 has 
been identified as a UDP-GlcNAc:β-Gal-GPI β1,3GlcNAc transferase involved in the 
biosynthesis of the poly-LacNAc side chains of procyclic GPI anchors (Izquierdo et al., 
2009a). 
In addition to the N-glycans found on VSG (Section 1.3.1), bloodstream form T. 
brucei contains also a fraction of high-molecular weight ricin-binding glycoproteins 
localized in the flagellar pocket and the endosomal/ lysosomal system (Nolan et al., 
1999; Atrih et al., 2005). The N-glycans in this fraction present a 
Manα1,3(Manα1,6)Manβ1,4GlcNAcβ1,4GlcNAc core structure decorated with very 
large branched poly-N-LacNAc side chains. They contain an average of 54 repeats with 
predominantly GlcNAcβ1,6Gal interrepeat linkages (Atrih et al., 2005). 
O-glycans are most commonly attached to the hydroxyl group on the side chains 
of serine or threonine residues (Varki et al., 2009). O-glycosylation on hydroxylated 
proline residues has been described in plants, algae and Dictyostelium discoideum 
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(Teng-umnuay et al., 1998; Fincher et al., 1974), while collagens present short O-
glycans on hydroxy-lysine residues (Spiro, 1969). Moreover, extensively O-
glycosylated mucin-like glycoproteins are present on the surface of T. cruzi (Previato et 
al., 1995; Almeida et al., 1994). O-glycans have not been described in T. brucei so far, 
although a putative T. brucei UDP-GlcNAc:polypeptide α-N-
acetylglucosaminyltransferase  (GntB) has been identified by sequence homology 
searches using the gene encoding a UDP-GlcNAc:polypeptide α-GlcNAc transferase of 
T. cruzi (Heise et al., 2009) and a GFP-tagged ectopic copy of GntB has been shown to 
localize to the Golgi apparatus in T. b. rhodesiense procyclic form (He et al., 2004).  
 
1.4.1 Sugar nucleotides in T. brucei: focus on GDP-sugars biosynthesis 
Sugar nucleotides are activated forms of sugars required for glycoconjugate 
biosynthesis. They can be synthesized via two alternative routes: the salvage pathway 
involves phosphorylation of the sugar followed by condensation with the appropriate 
nucleotide, while de novo synthesis requires the conversion of an existing sugar or sugar 
nucleotide. Generally, sugar nucleotides are synthesized in the cytoplasm and then 
transported into the ER or the Golgi, where they act as substrates for glycosylation 
reactions (Varki et al., 2009). Analysis of the sugar nucleotide pools of T. brucei, T. 
cruzi and L. major, by liquid chromatography-electrospray ionization-tandem mass 
spectrometry (LC-ESI-MS/MS), identified UDP-glucose (UDP-Glc), UDP-
galactopyranose (UDP-Galp), UDP-N-acetylglucosamine (UDP-GlcNAc), GDP-
mannose (GDP-Man) and GDP-fucose (GDP-Fuc) in T. brucei bloodstream and 
procyclic forms (Turnock and Ferguson, 2007). In the last years, the study of T. brucei 
sugar nucleotide metabolism has shown that several steps in the biosynthesis of UDP-
GlcNAc (Stokes et al., 2008; Mariño et al., 2011), UDP-Gal (Roper et al., 2002, 2005; 
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Urbaniak et al., 2006a,b), GDP-Man (Denton et al., 2010) and GDP-Fuc (Turnock et 
al., 2007) are essential for the parasite growth. Interestingly, while the enzymes 
responsible for the first and last step in the UDP-Glc biosynthesis have been 
characterized in this organism (Marino et al., 2010; Nwagwu and Opperdoes, 1982), no 
putative T. brucei phosphoglucomutase (PGM) gene can be identified. This result is 
even more perplexing given that T. cruzi and Leishmania have easily identifiable PGM 
genes (Penha et al., 2005; Penha et al., 2009).   
 GDP-Man is synthethized de novo from fructose-6-phosphate by the action of 
three different enzymes. Phosphomannoisomerase (PMI) catalyses the reversible 
isomerization of Fru-6-P to mannose-6-phosphate. The second step is the transfer of the 
phosphate group from C6 to C1, obtaining Man-1-P, a reaction catalyzed by 
phosphomannomutase (PMM). Lastly, GDP-mannose pyrophosphorylase is responsible 
for the condensation of Man-1-P and GTP to yield GDP-Man and pyrophosphate (PPi) 
(Figure 1.5). Canditate genes for all these three activities have been identified in T. 
brucei (Turnock and Ferguson, 2007) and MPGT has been biochemically characterized 
in this parasite (Denton et al., 2010). Experimental evidence has shown that T. brucei 
glycoconjugates can be metabolically labelled with [3H]Man, indicating the presence of 
a salvage pathway (Strickler and Patton, 1980). In the salvage pathway, exogenous Man 
is uptaken by the parasite through its glucose transporters (THT1/THT2; Azema et al., 
2004; Barrett et al., 1995) and phosphorylated to Man-6-P probably by the action of the 
hexokinase, HK (Figure 1.5). The remaining two steps leading to the biosynthesis of 
GDP-Man are again catalysed by PMM and MPGT. Interestingly, mutations in 
phosphomannomutase 2 in humans are responsible for the congenital disorder of 
glycosylation type 1a (CDG-1a), which is characterized by developmental defects, 
especially in the nervous system (Silvaggi et al., 2006).  
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Figure 1.5: Biosynthesis of GDP-mannose and GDP-fucose in T. brucei. GDP-Man is 
synthesized de novo from Fru-6-P by the action of three enzymes: phosphomannoisomerase 
(PMI), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (MPGT), marked 
in orange above. GDP-Fuc is synthesized from GDP-Man in a three step process catalyzed by 
two enzyme: GDP-mannose-4,6-dehydratase (GMD) and GDP-4-keto-6-deoxymannose 
epimerase/reductase (GMER), shown in green. The sugar nucleotide biosynthetic enzymes in T. 
brucei that are not involved in the synthesis of GDP-Man or GDP-Fuc are shown in gray. The 
UDPGlc/UDPGal pathway is maeked by a black box. PGI: phophoglucoisomerase; PGM: 
phosphoglucomutase; PAGM: phospho-N-acetylglucosamine mutase; UGP: UDP-glucose 
pyrophosphorylase; HK: hexokinase. 
 
In T. brucei, GDP-Fuc is synthesized via a classical de novo pathway from 
GDP-mannose (Turnock et al., 2007). This is a three-step process, carried out by two 
enzymes (Figure 1.5): GDP-mannose-4, 6-dehydratase (GMD) catalyses the extraction 
of hydride from GDP-mannose to form GDP-4-keto-6-deoxymannose, while GDP-4-
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dehydro-6-deoxy-D-mannose epimerase/reductase (GMER) first performs the 
epimerization in positions 3 and 6 of the intermediate to GDP-4-keto-6-fucose, then the 
reduction of the ketonic group to hydroxyl, resulting in the formation of GDP-fucose 
(Becker and Lowe, 2003; Ma et al., 2006). No candidate genes for the salvage pathway 
of this sugar nucleotide could be identified in T. brucei. 
 
1.5  Fucosylation in eukaryotic and prokaryotic glycoconjugates 
 L-Fucose is a deoxyhexose commonly found in many glycoconjugates (Becker 
and Lowe, 2003). In eukaryotes, it has been involved in both biological and 
pathological processes. Fucose is also found on the carbohydrate chains of prokaryotic 
organisms, but it is a less common modification (Ma et al., 2006).  
In humans, the ABO blood groups antigens contain fucose in α1,2 linkage to 
terminal galactose. No further modifications are required to obtain the H antigen 
expressed by type O individuals, while transfer to the terminal galactose of a GlcNAc or 
a second Gal residue generates antigens A and B, respectively (Becker and Lowe, 
2003). The structurally related Lewis blood antigens carry α1,3/α1,4-fucose residues 
(Figure 1.6, panel A) and have been implicated in many processes. Sialyl-Lewisa and 
sialyl-Lewisx antigens are expressed on mucins on the leukocyte surface and are 
involved in selectin-dependent leukocyte adhesion. The expression of these structures 
by epithelial cancers has been correlated with poor prognosis in humans and metastatic 
potential in mice (Varki et al., 2009). In addition, Helycobacter pylori uses the host 
Lewisb antigens to attached itself to the gastric epithelium, but it also synthesize its own 
Lewis-related structures in a case of molecular mimicry that may induce autoimmune 
responses or facilitate bacterial colonization (Becker and Lowe, 2003).  
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In mammals, more recently, carbohydrates containing Fucα1,2Gal have been 
implicated in neuronal growth connected to long-term memory storage by regulation of 
synapsin Ia/Ib expression (Murrey et al., 2006). 
 
 
Figure 1.6: Examples of fucosylated glycoconjugates. A. Type-1 and 2 Lewis 
determinants. R can be either a N- or O-glycan or a glycolipid. Taken from Varki et al., 2009. 
B. Some of the fucose-containing N-glycans of C. elegans. Taken from Paschinger et al., 2007. 
C. O-fucose glycans on the EGF repeats of mouse Notch receptors. Taken from Stanley, 2007. 
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From a structural point of view, fucose is generally found as a terminal sugar in 
N-glycans (Becker and Lowe, 2003). However, in recent years different structures have 
been described where fucose is further substituted by other sugars.  In the N-glycans on 
squid rhodopsin, the α1,6Fuc residue, linked to the innermost GlcNAc, can be further 
substituted by βGal (Takahashi et al., 2003). This modification has been described also 
in the N-glycans of C. elegans (Figure 1.6, panel B; Paschinger et al., 2007) and in 
keyhole limpet haemocyanin (Wuhrer et al., 2004).  
In higher eukaryotes, fucose can also be found directly linked to Ser/Thr 
residues. This modification is probably best characterized in Notch receptors (Figure 
1.6, panel C). When the O-Fuc modification is missing from these receptors, they are 
unable to bind their ligands suggesting a role in ligand recognition and implicating 
fucose in development. On Notch receptors, fucose can be further modified by 
sequential addition of GlcNAc, Gal and sialic acid residues (Stanley, 2007). 
Fucose-containing O-glycans have been described also in D. discoideum and 
Schistosoma mansoni. The social amoeba D. discoideum presents an O-linked 
pentasaccharide on a hydroxy-proline of the cytoplasmatic protein Skp1 with the 
following structure: Galα(?)Galα1,3Fucα1,2Galβ1,3GlcNAcα1-O (West et al., 2003; 
West et al., 2010). The human stage of the parasite S. mansoni presents a glycocalyx 
composed mainly of fucose-rich O-glycans with the following repeat unit:  
-3GalNAcβ1,4(Fucα1,2Fucα1,2Fucα1,3)GlcNAcβ1,3Galα1- (Khoo et al., 1995).  
 
1.5.1 Fucosylation in trypanosomatids 
GDP-fucose, the sugar nucleotide donor for fucose, has been found not only in 
T. brucei but also in T. cruzi and L. major. The presence of this sugar nucleotide in L. 
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major and T. brucei was unexpected, because there was no prior knowledge of any 
glycoconjugates containing fucose in these two parasites (Turnock and Ferguson, 2007).  
In T. brucei and probably in T. cruzi, GDP-Fuc is synthesized via the previously 
described de novo pathway from GDP-mannose (Figure 1.5). Alternatively, GDP-
Fucose can be synthesized via salvage pathway. L. major expresses a bifunctional 
arabinose/fucose kinase and pyrophosphorylase (AFKP80) that catalyzes the 
biosynthesis of both GDP-Fuc and GDP-Ara and a closely related gene able to 
synthesize only GDP-Fuc (Guo et al., 2009). Bifunctional fucokinase/ GDP-Fuc 
pyrophophorylases have been described also in Arabidopsis (Kotake et al., 2008) and 
Bacteroides fragilis (Coyne et al., 2005). 
As mentioned in Section 1.4, GDP-Fuc biosynthesis is essential in T. brucei. 
Conditional null mutants for GDP-mannose dehydratase (GMD) were engineered in 
both bloodstream and procyclic forms. The cell line deficient in GMD presents loss of 
GDP-Fuc from the intracellular pool, followed by reduction of the growth rate and cell 
death. After 12 days of growth in non-permissive conditions, procyclic form 
trypanosomes die and analysis of the cell morphology by scanning electron microscopy 
(SEM) showed flagellar detachment (Figure 1.7, panel A). Instead, bloodstream form 
GMD null mutants die after 6 days of growth in non-permissive conditions (panel B). 
The cells lyse and no clear effect on flagellar attachment can be observed (Turnock et 
al., 2007). 
Recently fucose has been identified in a high molecular weight glycoconjugate 
complex on the surface of procyclic form T. brucei by neutral monosaccharide 
compositional analysis (Güther et al., 2009). However, it has not been possible so far to 
identify the component(s) of this complex containing the fucosylated glycans or to 
determine the structure of the fucose-containing glycan(s). 
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Figure 1.7: Phenotype of T. brucei GMD conditional null mutants. Procyclic (A) and 
bloodstream form (B) GMD cKO were grown in permissive (plus tetracycline) or non-
permissive (no tetracycline) conditions and analyzed by scanning electron microscopy as 
described in Turnock et al., 2007.   
 
Figure 1.8: Complex P-glycans on T. cruzi gp72. The unit represented may repeat via 
phosphodiester bonds between one of the Galp residues from the Galp-(Galp)Xyl-Xyl core and 
the GlcNAc residue. Rha: rhamnose; Xyl: xylose: Galf: galactofuranose; Galp:galactopyranose; 
Fuc: fucose; GlcNAc: N-acetylglucosamine; Ser: serine. Taken from Allen, 2001. 
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The only known fucose-containing structure in the trypanosomatids is the low-
abundance Ser/Thr-phosphodiester-linked glycan (P-glycan) of T. cruzi gp72. These P-
glycans are extremely complex, containing αFuc, αRha, βXyl, βGalf as well as Galp and 
GlcNAc as shown in Figure 1.8 (Haynes et al., 1996; Allen, 2001). 
 
1.6 Fucosyltransferases 
 Fucosyltransferases (FTs) transfer fucose from GDP-fucose to oligosaccharide 
or peptide acceptors with an inversion of the anomeric configuration (Breton et al., 
1998). The mechanism of inverting gycosyltransferases (GTs) has been described as a 
direct displacement SN2-like reaction (Figure 1.9): in the active site, the side chain of 
one of the amino acid residues works as a base catalyst by deprotonating the 
nucleophile on the acceptor and facilitating the direct displacement of the activated 
phosphate leaving group (Lairson et al., 2008).  
Different classes of fucosyltransferases catalyze the addition of fucose to distinct 
sites and with different linkages. Like other GTs, these transferases can be classified on 
the basis of sequence homology into different families (CAZy database, Cantarel et al., 
2009; Coutinho et al., 2003; Rosen et al., 2004). FTs can be classified in two 
superfamilies, one composed of all α1,3/α1,4-FTs (GT10) and the other made of α1,2-, 
α1,6- and O-fucosyltransferases  (GT11, GT23, GT37, GT65 and GT68; Martinez-
Dunker et al., 2003; Both et al., 2011). Recently an α1,3-FT belonging to the GT11 
family has been characterized (Zhang et al., 2010), suggesting there might be 
exceptions to this classification.  
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Figure 1.9: Proposed mechanism for inverting glycosyltranferases. It should be noted that 
fucosyltranferases structures to date suggest a divalent cation independent mechanism (M2+) and 
the role of Asp/Glu residues as base catalysts to stabilize the departure of the NDP leaving 
group (Lairson et al., 2008). R’OH: acceptor; R: nucleoside monophosphate. 
 
In the majority of cases, α1,2-FTs (EC 2.4.1.69) transfer fucose to terminal Gal 
on poly-N-acetyllactosamine chains. Instead, α1,3/α1,4 and α1,6-fucosyltransferases 
recognize N-acetylglucosamine as their acceptor, although on different sites: α1,6-FTs 
(EC 2.4.1.68) link fucose to the peptide-linked N-acetylglucosamine on the chitobiose 
unit, while α1,3/1,4 (EC 2.4.1.65) enzymes transfer it to LacNAc repeats. A class of 
α1,3-FTs (EC 2.4.214), present in plants and invertebrates, can catalyze the transfer of 
fucose to the reducing GlcNAc in the chitobiose core of N-glycans (Both et al., 2011; 
Martinez-Dunker et al., 2003; Oriol et al., 1999). In eukaryotic organisms, all these 
fucosyltransferases are type II transmembrane Golgi proteins (Breton et al., 1998). 
O-fucosyltransferases catalyze the linkage of fucose to the hydroxyl group on 
the side chains of Ser/Thr residues on epidermal growth factor-like (EGF) repeats, like 
in the Notch receptor, or thrombospondin type (TSR) repeats (Ma et al., 2006). In 
humans, POFUT1 is responsible for the transfer to the EGF-like repeats. Interestingly, 
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this protein has been shown to be soluble and to localize to the lumen of the 
endoplasmic reticulum (Luo and Haltiwanger, 2005).  
A bifunctional β1,3-galactosyltransferase/ α1,2-FT (PgtA, GT74 family) has 
been described in D. discoideum. PgtA is a soluble, cytoplasmic protein that presents 
two GT domains. The N-terminal domain is associated with the transfer of β1,3-Gal to 
GlcNAcα-O-HyPro on Skp1, while the C-terminal GT domain is responsible for the 
transfer of fucose to the just added Gal residue (West et al., 2010).  
All crystal structures of sugar nucleotide-dependent GTs reported so far fall in 
two general folds, called GT-A and GT-B (Lairson et al., 2008; Bourne and Henrissat, 
2001). Crystal structures have been determined for a H. pylori α1,3-FT (Sun et al., 
2007) and two α1,6-FTs, human FUT8 (Ihara et al., 2007) and Bradyrhizobium NodZ 
(Brzezinski et al., 2007). All three enzymes adopt a GT-B fold and appear to use a 
metal ion-independent mechanism to stabilize the GDP leaving group (Lairson et al., 
2008; Brzezinski et al., 2007). Most of the known GT families have been predicted to 
have GT-A or GT-B structures by iterative sequence searches and motif extraction (Liu 
and Mushegian, 2003; Lairson et al., 2008). A third fold, GT-C, has been recently 
described for the soluble C-terminal domain of Pyrococcus furiosius OST-STT3 (Igura 
et al., 2007). This enzyme uses lipid phosphate activated donor sugars as substrates. 
These same substrates are used by 10 out of 12 of the GT families predicted to adopt the 
GT-C fold by iterative sequence searches (Lairson et al., 2008). The α1,2- and O-
fucosyltransferase families (GT11, GT37, GT65, GT68 and GT74) are not predicted to 
adopt any of these three folds (Lairson et al., 2008). 
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2. AIMS 
 
The aim of this thesis was to learn more about fucosylation in Trypanosoma brucei. 
Different approaches were taken to better understand the role of fucosylation in this 
parasite, producing the following experimental targets: (a) to discover and characterise 
the specificity and function of T. brucei fucosyltransferase(s), (b) to search for T. brucei 
fucosylated glycoconjugates and (c) to analyse TbPMM, a key enzyme in the 
biosynthetic pathway leading to GDP-mannose and GDP-fucose. 
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3.1 Reagents 
All general chemicals were purchased from Sigma or VWR BDH unless otherwise 
indicated. HPLC grade solvents were obtained from VWR BDH with the exceptions of 
acetonitrile (Merck) and methanol (Sigma). 
 
 
3.2 Trypanosoma brucei cell cultures 
 
3.2.1 T. brucei cell lines and media 
3.2.1.1 Bloodstream form 
 T. brucei bloodstream form cells (strain 427, variant MIT-aT 1.2) were grown in 
HMI-9t medium, at 37°C with 5% CO2 in tissue culture flasks with filter lids (Greiner) 
and cultured to a maximum density of 3x106 cells/ml. HMI-9t is a variant of the HMI-9 
medium described in Hirumi & Hirumi, 1994 where the more stable thioglycerol is used 
instead of β-mercaptoethanol. The concentration of thiol is 0.2 mM in both cases. The 
cell line used in all experiments was the single marker (sm) cell line, which expresses a 
T7 polymerase and a tetracycline repressor protein (TetR) (Wirtz et al., 1999). These 
modifications are under neomycin (G418) selection. Table 3.1 lists the concentration of 
antibiotics used to maintain selection. 
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3.2.1.2 Procyclic form 
 T. brucei procyclic form parasites were cultured in SDM-79 medium (Brun and 
Schonenberger, 1979) containing 10-15% fetal bovine serum (PAA Labs) and 1x 
GlutaMAX™  (Gibco) at 28°C in Becton Dickinson culture flasks. Cells were grown to 
a maximum density of 5x107 cells/ml. The transgenic cell line 29.13.6, known also as 
double marker (dm) cell line, was used for all experimental work. This cell line was 
modified to contain a T7 polymerase and a tetracycline repressor protein (TetR) under 
G418 and hygromycin selection (Wirtz et al., 1999). Table 3.1 lists the concentration of 
antibiotics used to maintain selection. 
 
Table 3.1:Antibiotics used in the cell culture and genetic manipulation of T. brucei 
 
 
Blasticidin was prepared at a stock concentration of 10 mg/ml, stored at -20°C 
for 2 months and added to the medium every 14 days to maintain the selection. 
Tetracycline was freshly prepared every 7 days in 70% ethanol at 10 mg/ml and added 
to the cells every 48 h to the final concentration indicated in Table 3.1. Tetracycline was 
removed from the culture by washing the cells three times in medium without this 
antibiotic. 
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3.2.2 General T. brucei cell culture protocols 
3.2.2.1 Cell density and cell volume determination 
 T. brucei bloodstream form cells were counted in an haemocytometer either 
directly or diluted 1:10 in 1x trypanosome dilution buffer (TDB) (Table 3.2).   
 T. brucei procyclic form cells were counted in an haemocytometer after being 
diluted from 1:20 to 1:40 in 1x phosphate buffer saline (PBS) (Table 3.3) or in SDS-79 
medium when viability was assessed. Alternatively, the cells were counted using a 
CASY® Cell Counter + Analyser system. Procyclic form were diluted 1:10 in PBS 
before being diluted in the CASY-ton solution for measurements.  The system provides 
a measurement of the average cell volume in the culture together with the cell density.  
 
Table 3.2: 5x Trypanosome Dilution Buffer (TDB) 
 
The pH of the 5xTDB should be 7.45 and after dilution to 1xTDB the pH raises to 7.8. 
Table 3.3: 1x Phosphate Buffered Saline (PBS) 
 
The pH should be 7.4 
 
3.2.2.2 Generation of stabilates 
  T. brucei bloodstream form were grown to mid log phase (1-2x106 cells/ml), 
centrifuged (800 g, 10 min, 4°C on 4K15 Sigma centrifuge) and resuspended in 1 ml 
HMI-9t medium, containing 10% glycerol but no antibiotics, per every 10 ml of culture. 
Aliquots of 1 ml were transferred to 2 ml Cryovials (Nalgene). T. brucei procyclic form 
were grown to mid-log phase (2x107 cells/ml), centrifuged (600 g, 10 min 4°C) and 
Chemical substance Amount per 1L (g)
KCl 0.2
NaCl 8
Na2HPO4 1.42
KH2PO4 0.24
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resuspended in SDS-79 containing 10% glycerol to be a third of the initial volume. 
Aliquots of 0.5 ml were transferred to Cryovials. In both cases the Cryovials were 
frozen overnight in a freezing chamber containing isopropanol (Nalgene) and then 
stored in a K-series cryostorage unit (Jencons). 
 
3.2.2.3 Sedimentation assay 
 About 5x106 T. brucei procyclic form cells were resuspended in 1 ml of SDM-
79 medium and transferred into a 2 ml polystyrene cuvette (Sarstedt). The cuvettes were 
incubated at 28°C (CPS-controller, Shimadzu) in a UV-1601 Spectrophotometer 
(Shimadzu) and the optical density at 600 nm measured every 30 min. SDM-79 medium 
was used as a blank.  
 
3.2.2.4 T. brucei crude cell lysate 
 T. brucei cells were grown to log phase density and 5x106-2x107 cells were 
harvested by centrifugation (4K15 Sigma Centrifuge) and washed in 1x PBS (procyclic 
form) or 1 x TDB (bloodstream form) at 4°C. Cells were washed twice if the protein 
lysate was needed for western blotting or 5 times if required for lectin blots. After the 
last wash, cells were transferred to a 1.5 ml tube and pelleted for 10s at 16000xg 
(Centrifuge 5417R, Eppendorf). The cells were then resuspended in buffer to be 2x109 
cells equivalent/ ml and lysed by addition of an equal volume of 2% SDS sample buffer 
(Invitrogen). The cell lysate was heated at 50°C for 20 min before loading on a gradient 
SDS-PAGE gel (Invitrogen). For peptide:N-glycosidase F digestion, cells were lysed in 
2 % SDS, 0.15 M NaCl, 0.1 M DTT, 40 mM sodium phosphate pH 6.8, vortexed and 
heated 20 min at 50°C. After extraction (30 min, room temperature) the samples were 
diluted to 0.5 % SDS, 1 % TX-100, 0.4 M DTT, 0.15 M NaCl, 20 mM sodium 
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phosphate pH 7.3 in the presence of 1/10 of a Mini EDTA-free Complete Protease 
Inhibitors Tablet (Roche) and treated or mock treated with 0.35 U PNGaseF (Roche) at 
37°C for 16 h. The samples were then heated at 50°C for 20 min before loading on a 
gradient SDS-PAGE gel (Invitrogen). 
 
3.2.3 T. brucei procyclic form electroporation 
Procyclic form cells were grown to a density of 9x106-1x107 cells/ml, 
centrifuged (600xg, 10 min, 20°C on a 4K15 Sigma centrifuge) and washed once in 
cytomix buffer (van der Hoff et al., 1992). The cells are then resuspended to be 3-4x107 
/ml and 450 µl were transferred to each of 2-5 cuvettes (4 mm gap, 800 µl, VWR) 
containing 10 µg of plasmid DNA each and 1 cuvette with no DNA as a negative 
control. The plasmid DNA had been previously digested with NotI (Promega) at 37°C 
for 16 h. At the end of the incubation, the restriction enzyme was inhibited (65°C, 30 
min) and an aliquot of the reaction was used to confirm the correct digestion had taken 
place by agarose gel elctrophoresis (Section 3.4.5). The remaining DNA was ethanol 
precipitated (Section 3.4.15) and redissolved in sterile H2O at 1µg/µl just before the 
electroporation. The cells were electroporated using a BTX-830 Electro Square Porator 
(ECM83) with a 630B shock chamber set up as follows: voltage 1760 V, pulse length 
100 µs, pulse interval 200 µs for a total of 3 pulses. After electroporation, the cells from 
each cuvette were transferred in a flask with 10 ml of SDM-79 media containing 15% 
fetal bovine serum, GlutaMAX™ and antibiotics but without the selection antibiotic for 
the electroporated construct. The cells were left to recover overnight at 28°C and then 
plated out in 24-well plates (Becton Dickinson) so that 0.5 ml of culture plus 0.5 ml of 
medium containing double the concentration of selection antibiotic were added to each 
well. The plates were left incubating at least two weeks adding if necessary 1 µl/well 
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every 48 h of a 1:200 dilution of tetracycline in medium. At this point, the cells from the 
negative control should have all been dead and resistant clones were fed slowly until a 
culture could be established. Stabilates were generated from the resistant cultures and 
their genotypes were verified by Southern blot analysis (Section 3.4.17). 
 
3.2.4 T. brucei bloodstream form electroporation 
 Bloodstream form cells were grown to mid log phase density (1x106 cells/ml), 
centrifuged (800xg, 10 min, 20°C) and resuspended in Amaxa® Human T-Cell 
Nucleofector solution containing supplement (Lonza) so that the final concentration was 
1-2x108 cells/ml. A volume of 100 µl was transferred to each of 2-5 cuvettes (Amaxa 
certified, included in the Nucleofector kit) containing 1 µg of plasmid DNA each and 1 
cuvette with no DNA as a negative control. The plasmid DNA for the electroporation 
was prepared as described in Section 3.2.3, but resuspended in sterile water to be 0.2 
µg/µl. The cells were electroporated using an Amaxa Nucleofector® II, program X-001 
(Burkard et al., 2007). After the electroporation, the cells from each cuvette were 
transferred in a flask with 24 ml of HMI-9t containing antibiotics but without the 
selection antibiotic for the electroporated construct and immediately plated out in 12-
well plates (TPP). The cells were left to recover for 6-8 h at 37°C before 1 ml of 
medium containing double the concentration of selection antibiotic was added to each 
well. Alternatively, each cuvette was transferred to 30 ml of media and then diluted 
1:10 or 1:100 always in flasks containing 30 ml. The selection antibiotic was added 
directly to the flask after 6-8 h of recovery. When the pLew100 construct was 
electroporated, 5 cuvettes were transfected with the construct and transferred to 100 ml 
of HMI-9t containing G418. Phleomycin was added to the flask after the usual recovery 
time at 37°C. Once the cells electroporated with no DNA were dead, resistant clones 
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were established in culture, stabilated and their genotype analysed by Southern blot 
(Section 3.4.17).  
 
 
3.3 T. brucei cell labelling 
3.3.1 Galactose oxidase/NaB[3H]4 labelling of surface glycoconjugates 
 Procyclic form wild type (dm) and TbFT conditional null mutant (cKO) cells, 
grown in permissive or non permissive conditions, were labelled as described in Guther 
et al., 2009. The cells were grown to a density of ~107/ml and a starting material of 
6x107 cells was used for each culture. The cells were washed 3 times with SDM-79 
medium without fetal bovine serum (600xg, 10 min, at room temperature on a 4K15 
Sigma centrifuge) to remove the serum sialylated glycoconjugates and resuspended in 
the same medium containing 1 mM non-radioactive NaBH4 (freshly prepared) to block 
any reducible sites. Each culture was incubated with 20 mU (5 mU/ml) of Clostridium 
perfringens neuraminidase (Sigma) for 30 min at 28°C. At the end of the incubation, the 
cells were washed twice with 1x PBS (same settings as above) and resuspended in the 
same buffer.  Half of the cells from each culture was incubated with 1.5 U of Dactylium 
dendroides galactose oxidase (Sigma) for 30 min at 37°C, while the remaining cells 
were incubated in the same conditions but without enzyme. Before incubation, the 
galactose oxidase had been heated at 50°C for 30 min to inhibit any contaminant 
protease activity. After galactose oxidase treatment, the cells were washed 3 times at 
0°C with ice cold 1xPBS (10 s at 16000xg, Centrifuge 5417R Eppendorf) and then each 
culture (treated or non treated) was resuspended in 1x PBS in the presence of 0.8 mCi 
NaB[3H]4 (Perkin Elmer) dissolved in 0.1 M NaOH to be labelled for 30 min at 28°C. 
Cells were then washed once with 1x PBS, resuspended in 1 mM non-radioactive 
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NaBH4 in 1x PBS, washed three more times with 1x PBS and lysed in 2% SDS, 8 M 
urea, 0.2 M NaCl, 0.1 M DTT, 20 mM TrisHCl pH 6.8 to be 107 cell equivalents/10 µl. 
The lysates were then heated at 50°C for 20 min and left to extract at room temperature 
for 30 min. An aliquot (1 µl) of each sample was put to count on a scintillation counter 
(LS 6500, Beckmann) for 5 min to determine the counts per minute (cpm) in the 
samples. About 20% of the material from each sample was run on a 4-12% Bis-Tris 
Nupage gel (Section 3.5.1) in MOPS buffer (Invitrogen) and used for protein 
quantitation on gel (Section 3.5.6) before being processed for fluorography (Section 
3.5.5). The remaining material was used for lectin purification: galactose oxidase 
treated and non-treated samples were diluted to 0.03% SDS, 0.8% NOG, 0.2 M NaCl, 
10 mM DTT, 20 mM TrisHCl pH 6.8 (Buffer PD) in the presence of 1 µg/ml leupeptin, 
1 µg/ml aproteinin, 1 mM tosyl-L-phenylalanine chloromethyl ketone (TLCK) and 1 
mM phenylmethylsulfonyl fluoride (PMSF) (all from Sigma), equal protein amounts 
from each sample were incubated with either 2.5 µg biotinylated Aleuria aurentia 
(AAL) or 1.25 µg biotinylated ricin (Vector Labs) for 2 h at 4°C before adding 
Dynabeads™ MyOne C1 Streptavidin (Invitrogen) and incubating for a further 45 min 
in the cold. The material bound to the beads was washed 4 times with Buffer PD and 
then eluted 3 times in 0.2 M methyl-α-L-fucopyranoside (Carbosynth) in buffer PD 
containing 0.05% NaN3 in the case of AAL or 30 mg/ml galactose and lactose (Sigma) 
in Buffer PD in the case of ricin.  The first elution was carried out 16 h at room 
temperature on a shaking plate at 1000 rpm (IKA-VIBRAX-VXR, Janke & Kunken 
GmbH), while the following two elutions were carried out with the same set-up but only 
for 3 h. The cpms in each elution were determined by measuring 1 µl at the scintillation 
counter. Elutions 1 and 2 were combined and loaded on a 4-12% Bis-Tris Nupage gel 
run in MOPS and processed for fluorography. 
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3.3.2 Labelling of procyclic form cell surface with GST-TbFT and GDP-[3H]Fuc 
 The GPI12 null mutant cell line (Güther et al., 2009) was grown to log phase 
density (2-3x107 cells/ml) and 4x107 cells were centrifuged 10 s at 16000xg on a 5417R 
centrifuge (Eppendorf). The cells were then washed 5 times with SDM-79 containing no 
fetal bovine serum, GlutaMAX™ or antibiotics and resuspended in the same medium to 
be 107 cells/ 100 µl. The cells were then incubated 30 min at 28°C with 50 U of 
Xanthomonas manihotis α-1,2-fucosidase (New England Biolabs). At the end of the 
incubation, the cells were washed (as above) 3 times with 1x PBS to remove the 
fucosidase and resuspended in 1x PBS containing 2 µCi GDP-[3H]Fuc. Half of the cells 
were treated by adding 4 µg of freshly purified GST-TbFT (Section 3.5.7) or mock 
treated by adding 1x PBS. Both the treated and mock treated cells were further 
aliquoted so that half of the material was labelled in the presence of 1 mM ATP or in 
the absence of any ATP. The labelling was carried out for 30 min at 28°C and the cells 
were then washed with 1x PBS to remove the free label. After resuspension in 1x PBS, 
cells were lysed in SDS sample buffer containing 8 M urea and 0.1 M DTT, heated at 
50°C for 20 min and half of the material was loaded on a 4-12% Bis Tris Nupage gel 
run in MOPS buffer. The gel was then processed for fluorography (Section 3.5.5). 
 
 
 
3.4 Molecular biology protocols 
3.4.1 In silico analyses and searches of DNA and protein sequences 
 The T. brucei, T. cruzi and L. major genomes (from the GeneDB database, 
http://www.genedb.org)  were searched for putative fucosyltransferases using the 
BLASTp search algorithm (Altschul et al., 1997). The query input sequences are listed 
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in Table 4.1. Protein sequence multiple alignments were assembled using ClustalW 
(Chenna et al., 2003) and Jalview (Waterhouse et al., 2009). TbFT untranslated regions 
were identified on GeneDB. In silico plasmid constructs sequence for expression and 
gene replacement were assembled using GCK (Texcto BioSoftware) or CLC Main 
Benchwork (CLC Bio). 
 
3.4.2 Primers 
The primers used are listed in Table 3.4. When possible, primers were designed 
to contain ~20 bp of complementary sequence, have a guanine (G) or cytosine (C) at 
their 3’ end and a melting temperature (Tm) around 60°C. The Tm was calculated 
according to the following formula: Tm= (G+C)x 4°C + (A+T)x 2°C, where only the 
nucleotides in the complementary sequence of the primer were considered in the 
calculations.  However, in the case of MUTF and MUTR the Tm was calculated using 
the formula given in the QuickChange® Site-Directed Mutagenesis Kit (Stratagene). 
 
Table 3.4: List of primers 
 
*Tm calculated using formula given in the QuickChange® Site-Directed Mutagenesis protocol  
 
 
The primers were all synthesized by the Oligonucleotide Synthesis Service, University 
of Dundee (http://www.lifesci.dundee.ac.uk/services/oligo/index.html). 
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3.4.3 List of plasmid vectors 
Table 3.5: List of plasmids used in this project 
 
 
3.4.4 PCR 
 All polymerase chain reactions (PCRs) were performed with the high fidelity 
Platinum® Taq DNA Polymerase (Invitrogen) in a 50 µl volume using a PTC-225 
Peltier Thermal Cycler (MJ Research). The conditions and programs used are listed in 
Table 3.6. 
 
Table 3.6: PCR reactions 
 
a The annealing temperature depends on the primers Tm. Generally, an annealing temperature of 
Tm – 5°C was chosen. 
b The elongation time was modified depending on the product length (1 kb/min) 
 
The reactions were analyzed by agarose gel electrophoresis, bands containing a product 
of the correct size were excised and the DNA purified as detailed in Section 3.4.6. 
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3.4.5 Agarose gel electrophoresis 
 Agarose gel eletrophoresis was used for DNA separation. For plasmid DNA 
analysis 1 % w/v agarose (Electran agarose, VWR) gels in 1x TAE (40 mM Tris-
acetate, 1 mM EDTA) buffer containing 0.4 µg/ml ethidium bromide were used, while 
1.5 % and 0.8% gels were used for RT-PCR and Southern blotting respectively. DNA 
samples were run in the presence of 1x Blue/Orange Load Dye (Promega) and 1 Kb or 
100 bp DNA ladders (Promega) were used to estimate DNA fragment size. The gels 
were run at 80 V in 1x TAE using BioRad Mini-Sub Cell GT tanks connected to Power 
Pac 300 power packs, with the exception of agarose gels for Southern blotting that were 
run at 40 V. The gels were imaged with a GelVue UV Transilluminator on a UGenius 
gel documentation system (Syngene). 
 
3.4.6 Gel Extraction of DNA fragments and plasmid DNA 
 Plasmid vectors or DNA fragments obtained from PCR or endonuclease 
digestions were purified, after separation on agarose gel, using the QIAquick® Gel 
Extraction Kit (Qiagen). The protocol for a microcentrifuge was followed, but the final 
purified DNA was eluted in 2 mM TrisHCl pH 8.5. DNA concentration was estimated 
by A260 at the spectrophotometer (Bio Photometer, Eppendorf) using UVettes 
(Eppendorf) with a 1 cm path length. 
 
3.4.7 Restriction endonuclease digestion 
 Endonucleases were purchased either from Promega or NEB. The DNA to be 
digested was incubated with the restriction enzyme and the required digestion buffer at 
the optimal temperature (generally 37°C). Analytical digestions were carried out for 1-2 
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h, while preparative digestions were performed overnight. The digestion mix or an 
aliquot of it where then analyzed by agarose gel electrophoresis (Section 3.4.5). 
  
3.4.8 E. coli strains and cultures 
 E. coli cells were grown in LB medium (Table 3.7) containing 50 µg/ml 
ampicillin and other antibiotics when required (see Table 3.8) at 37°C, 200 rpm in 
Infors HT incubators. After transformation, colonies were selected on LB + agar plates 
grown at 37°C for 16 h. The strain used and the selection antibiotics required in each 
case are listed in Table 3.8. High-efficiency TOP10 cells were used for transformation 
after ligation, DH5α strain was used for sub-cloning and BL21 (DE3), BL21 Tuner™ 
(DE3) and BL21 CodonPlus (DE3) RiPL strains were used for recombinant protein 
expression. For bacterial stabilates, 100 µl of 80% glycerol (AnalaR, VWR) were added 
to 400 µl of log phase cells (grown for 6 h at 37°C, 200 rpm) and freezed on dry-ice 
before storage at -80°C. All media were obtained from the Media Kitchen service in the 
College of Life Sciences, University of Dundee. 
 
Table 3.7: LB medium 
 
 
Adjusted pH to 7  
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Table 3.8: E. coli strains 
 
3.4.9 Transformation 
 An aliquot of competent E. coli cells (50 µl) was mixed with ~10 ng of purified 
plasmid DNA or 1/3 of a ligation reaction and incubated 30 min on ice. The cells were 
heat shocked at 42°C for 25-35 s depending on the strain and then cooled on ice for 2 
min. After addition of SOC medium the cells were grown 1 h at 37°C, 200 rpm (infors 
HT incubator) before being plated on LB + agar plates containing ampicillin and any 
other required antibiotics. Colonies were selected after overnight growth at 37°C. 
  
3.4.10 Purification of plasmid DNA 
 Plasmid DNA transformed in DH5α or TOP10 E. coli strains, was purified and 
prepared from 5 ml cell cultures (miniprep) grown at 37°C, 210 rpm for 16 h using the 
QIAprep® Spin Miniprep Kit (Qiagen). When a large scale preparation was necessary, 
100 ml of bacterial cells were grown as above, aliquoted to have 5 ml/tube in 14 ml 
Falcon® round-bottom tubes (Becton Dickinson) and sent for robot (Qiagen Biorobot 
9600s) Miniprep purification to the Sequencing Service, University of Dundee 
(http://www.dnaseq.co.uk/home.html). DNA concentration was estimated by A280 at a 
spectrophotometer (Bio Photometer, Eppendorf). 
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3.4.11 Dephosphorylation 
 After endonuclease digestion, plasmids were dephosphorylated once or even 
twice when necessary to reduced the re-ligation background. The plasmids were 
incubated at 37°C for 30 min with Shrimp Alkaline Phosphatase (Promega) and at the 
end of the reaction the phosphatase was inhibited by heating at 65°C for 20 min. 
  
3.4.12 Ligation 
The concentrations of purified and digested plasmid vector and insert were 
estimated at the spectrophotometer (A260). Different molar ratios of vector to insert were 
tried in each ligation, most commonly 1:1, 1:3 and 3:1 (vector:insert). Also a reaction 
without insert was run as a control for the vector re-ligation background. The legation 
reactions were set up in 10 µl volume using the Rapid DNA Ligation kit (Roche) as 
described in Table 3.9. The reactions were then incubated at room temperature for 20 
min, before 1/3 of the volume of each was transformed in TOP10 competent cells 
(Invitrogen) as described in Section 3.4.9. Once colonies were selected, the plasmid 
DNA was purified and its sequence verified by endonuclease digestion and sequencing 
(Section 3.4.7 and 3.4.13).  
 
Table 3.9: Ligation reaction 
 
a H2O was added to a final volume of 10 µl if necessary 
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3.4.13 DNA sequencing 
 DNA sequencing was performed by the Sequencing Service, University of 
Dundee using Applied Biosystems 3730 DNA analyzers. The regions of interest in the 
plasmid DNA were sequenced twice in each direction. The consensus sequence was 
built using SeqMan (DNAstar Analysis) or CLC Main Workbench (CLCbio). 
Comparison between the consensus and the in silico sequences were performed using 
CLC Main Workbench or Clustal W (Chenna et al., 2003). 
 
3.4.14 Site-Directed Mutagenesis 
After ligation of the joint UTRs in the pGEM5Zf plasmid, the BamHI site 
contained in the 5’-UTR region was mutated from ggatcc to ggctcc using the 
QuickChange® Site-Directed Mutagenesis Kit (Stratagene) according to manufacturer’s 
instructions. The primers used are listed in Table 3.4.  
 
3.4.15 Ethanol precipitation of DNA 
 This protocol was used to concentrate or store plasmid and genomic DNA. For 
each volume of solubilized DNA, 1/10 of the volume of 3 M sodium acetate pH 5 was 
added, followed by 3 times the volume of DNA plus sodium acetate of cold absolute 
ethanol. The mix was incubated at -20°C for at least 16 h or alternatively 30 min on dry 
ice. To resuspend the precipitated DNA, the mix was centrifuged at 4°C for 10 min at 
16000xg in a 5415 R centrifuge (Eppendorf). The supernatant was decanted and the 
pellet washed with cold 70% ethanol. After decanting the wash, the ethanol was left to 
air-dry and then the pellet was resuspended in buffer or sterile water. 
 
 
3. MATERIALS AND METHODS  
 
47 
3.4.16 Genomic DNA isolation 
 Bloodstream form or procyclic form T. brucei were grown to log phase density 
and 4x107-1x108 cells were harvested by centrifugation (4K15 Sigma Laboratory 
Centrifuge) for 10 min at 4°C, 800 or 600xg respectively. The cells were then lysed in 1 
ml DNAzol™ (Helena Biosciences) and incubated at least 30 min at room temperature. 
After addition of 0.5 ml of absolute ethanol, the cell lysate was centrifuged for 10 min 
at 16000xg (5415 R microcentrifuge, Eppendorf). The supernatant was decanted and the 
pellet washed with 70% ethanol (2 min, 16000xg). After decanting the wash, the 
pelleted genomic DNA was left to air-dry before being redissolved in 50-100 µl of 2 
mM TrisHCl pH 8.5. The DNA was further purified by treatment with 10 µg RNase at 
37°C for 16 h. The quality and the concentration of the purified genomic DNA were 
estimated by agarose gel electrophoresis (Section 3.4.5).  
 
3.4.17 Southern blotting 
 Approximately 5 µg of genomic DNA were digested at 16 h with restriction 
endonucleases and run on a 0.8% agarose gel without ethidium bromide (Sigma) as 
described in Section 3.4.5. The gel was then stained for 20 min in 1x TAE containing 
0.2 µg/ml ethidium bromide and imaged as previously described. The excess ethidium 
bromide was removed by washing 5 min in 1x TAE before preparing the gel for transfer 
by washing it 10 min in 0.2 M HCl, 15 min in 0.5 M NaOH, 1.5 M NaCl and twice for 
20 min in 1 M TrisHCl, 1.5 M NaCl pH 7.5. All washes were performed at room 
temperature under shaking (Mini gyro-rocker SSM3, Stuart). The DNA was then 
transferred on a positively charged nylon membrane (Roche) by capillary action as 
described in Figure 3.1. The transfer was performed overnight in 10x sodium chloride, 
sodium citrate buffer (SSC, Table 3.10). At the end of the transfer the membrane was 
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rinsed 3 times in 2x SCC and air-dried between two pieces of 3 MM paper (Whatman). 
DNA was crosslinked to the membrane using 1200 UV counts on a CL-1000 (UVP) UV 
crosslinker.   
 
Table 3.10: 20x SSC Buffer 
 
The pH was adjusted to 7.4 
 
 
Figure 3.1: Set up for the transfer of DNA from the agarose gel to the nylon membrane.  
 
3.4.17.1 32P-labelled probe detection 
 The DNA probe was generated by PCR as described in Section 3.4.4 and then 
diluted in TE buffer (10 mM TrisHCl, 1 mM EDTA pH 7.5) so to have 20 ng of DNA 
in 45 µl. The probe was denatured at 100°C for 5 min, quickly cooled on ice and 
RediPrime II (Amersham) previously reconstituted in 10 mM TrisHCl pH 7.5 was 
added to it. The radioactive isotope [α32P]-dCTP (5 µl) was then added to the DNA mix 
and the reaction was incubated at 37°C for 10 min before the probe was denatured again 
as above. The membrane was placed in a roller bottle and pre-hybridized in Ultrahyb 
(Albion) at 42°C for 30 min in a HybAid oven. The previously prepared 32P-labelled 
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DNA probe was added to fresh Ultrahyb and the membrane hybridized overnight at 
42°C. After hybridization, the membrane was washed twice for 5 min in 2x SSC, 0.1% 
SDS at 42°C and twice for 5 min in 0.1x SSC, 0.1% SDS at the same temperature. The 
membrane was sealed in a plastic bag, placed in an appropriate exposure cassette and 
bands were visualized by exposing film (Biomax XAR film, Kodak) for 6 h to 2 days 
and developing them on a Compact X4 developer (X-ograph Imaging Systems). During 
exposure the cassette were stored at -80°C. 
 
3.4.17.2 DIG-labelled probe detection 
 The DNA probe was generated using the PCR DIG Probe Synthesis Kit (Roche). 
A negative control in which the DIG labeling reagent was not added was also run. 
Aliquots of the reactions (10 µl) were then analyzed by agarose gel electrophoresis to 
check the size increase in the labelled probe and estimate the amount. When a bright 
band was observed, 15 µl of probe /25 ml of hybridization buffer were used. The 
membrane was placed in a roller bottle (Techne) and pre-hybridized in EasyHyb 
solution (Roche) at 42°C for 30 min in a Hybridized HB-1D oven (Techne). The probe 
was denatured by heating for 100°C for 5 min and quickly cooled on ice, before being 
added to a fresh aliquot of EasyHyb solution. The membrane was then hybridized 
overnight in the EasyHyb solution containing the probe, always at 42°C. After 
hybridization, the membrane was washed twice for 5 min in 1x SSC, 0.1% SDS at 42°C 
and twice for 15 min in pre-warmed 0.5x SSC, 0.1% SDS at 65°C. The membrane was 
then equilibrated for 5 min at room temperature in 1x wash buffer before being blocked 
for 30 min in blocking solution (DIG wash and block buffer set, Roche). The membrane 
was then incubated for 30 min with a 1:10000 dilution in blocking buffer of Anti-DIG 
AP-conjugate antibody (Roche), followed by two 15 min washing steps in 1x wash 
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buffer and a 5 min equilibration step in 1x detection buffer. The membrane was placed 
in a plastic folder and CSPD detection reagent (Roche) was applied drop by drop. The 
membrane was then incubated 5 min at room temperature in the dark and 10 min at 
37°C. Films (Hyperfilm™ ECL, Amersham) were exposed from 30 sec to 5 min and 
developed with a Compact X4 developer. 
 
3.4.18 RNA isolation 
Total RNA was extracted from T. brucei procyclic or bloodstream form using 
the RNeasy Mini Extraction Kit (Qiagen) according to manufacturer’s instructions. 
Briefly, cells were centrifuged for 10 min, at room temperature at 600xg (procyclic 
form) or 800xg (bloodstream form) in a 4K15 Sigma centrifuge and carefully 
resuspended in buffer RLT. After addition of one volume of 70% ethanol the material 
was transferred to the provided column and centrifuge 15 s, 10000xg. The column was 
then washed with Buffer RWI and the DNA was digested on the column as follow: 70 
µl Buffer RDD plus 10 µl DNase I RNase-free were used and each column was 
incubated at room temperature for 15 min. The columns were then washed again with 
Buffer RWI and twice with Buffer RPE. After transferring the column to a sterile 
Eppendorf tub, the RNA was eluted in 50 µl RNase-free. RNA concentration was 
estimated by A260 at the spectrophotometer (Bio Photometer, Eppendorf) using UVettes 
(Eppendorf) with a 1 cm path length. 
 
3.4.19 Semi quantitative RT-PCR 
Semi quantitative RT-PCR analysis was carried out using the Access Quick RT-
PCR kit (Promega). A series of reactions with a range of RNA amounts (4-40 ng) were 
run. The primers amplyfing the TbFT ORF (ORFN and ORFC) were used in the 
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reactions. A negative control, where no retrotranscriptase was added to the reaction and 
a positive control, using primers for Dolichol-P-Mannose synthase (DPMS), were run as 
well. The PCR cycler (PTC-225 Peltier Thermal Cycler, MJ Research) was 
programmed as described in Table 3.11. The reactions were run on a 1.5 % agarose gel 
as described in Section 3.4.5. 
 
Table 3.11: RT-PCR programme 
 
 
 
 
3.5 Protein biochemistry 
3.5.1 SDS-PAGE 
 SDS-PAGE was performed using pre-cast Novex 4-12% Bis-Tris gels with 
MOPS running buffer (Invitrogen) in n XCELL-II mini tank (Novex) at 200 V using a 
BioRad Power Pac Junior. Alternatively, gels were cast by hand using the recipe in 
Table 3.12. The gels were assembled and run in Tris-Glycine buffer (25 mM Tris base, 
250 mM glycine, 0.1% SDS) in a MiniPROTEAN Tetra cell (BioRad) at 180 V using a 
Power Pac 300 (BioRad). Samples were prepared using 4x SDS Sample buffer 
(Invitrogen) and a final concentration of 0.1 M DTT as reducing agent. Before loading, 
the samples were boiled at 100°C for 10 min or heated at 50°C for 20 min. 
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Table 3.12: Recipe for hand cast SDS-PAGE gels 
 
 
3.5.2 Coomassie and Silver staining 
 Proteins present on SDS-PAGE gels were stained by incubating for 1 h with 
0.1% Coomassie brilliant blue stain in 40% methanol, 10% acetic acid. The excess stain 
was removed washing the gel in 40% methanol, 10% acetic acid (Destain solution) or in 
10% acetic acid only. For peptide mass fingerprinting, the gel was stained for 30 min 
with SimplyBlue™ Safe Stain (Invitrogen) and destained in water. When protein 
amounts were too low to be detected by Coomassie staining, gels were stained with 
silver using the SilverQuest™ kit (Invitrogen) according to manufacturer’s instructions. 
 
3.5.3 Western/lectin blotting 
 After separation by SDS-PAGE, protein were transferred on a ECL 
nitrocellulose membrane (Amersham) using the XCELL-II Blot Module (Novex) and 
Nupage Transfer Buffer (Invitrogen) at 45 V for 75 min or 2 h for one or two SDS-
PAGE gels, respectively (Figure 3.2). Alternatively the protein were transferred on a  
nitrocellulose membrane (iBlot gel transfer stack) using a iBlot system (Invitrogen) 
according to manufacturer’s instructions. The membrane was incubated for 5 min in 
Ponceau S (Sigma) to verify the success of the proteins transfer and then blocked in 50 
mM TrisHCl, 0.15 M NaCl, 0.05 % NP-40, 0.25 % BSA (Blocking buffer) for either 1 h 
or overnight.  
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Figure 3.2: Assembly of XCELL-II Blot module for the transfer of two gels 
 
Primary antibodies or lectins were diluted in Blocking buffer as detailed in Table 3.13 
and incubated with the membrane in a sealed plastic bag for 1 h at room temperature 
rotating (Rotator SB2, Stuart). For controls with the sugar inhibitors, lectins were pre-
incubated at their final dilution with the inhibitory sugars for 30 min, before being 
incubated with the membrane. After incubation with the primary antibody/lectin, the 
membrane was washed 4 times for 10 min in Blocking buffer. HRP-conjugated 
secondary antibodies or ExtraAvidin were appropriately diluted in Blocking buffer  
(Table 3.13) and incubated with the membrane for 1 h at room temperature with 
rotation. The membrane was washed as described above before addition of the ECL 
Plus Western Blotting detection reagent (Amersham). The detection solution was 
prepared as follow: 0.5 ml 1x PBS, 0.5 ml solution A and 25 µl solution B. The 
membrane was incubated with the detection solution in the dark for 5 min before being 
exposed to ECL Hyperfilm (Amersham). The films were developed using a Compact 
X4 developer (X-ograph Imaging Systems). 
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Table 3.13: List of lectins and antibodies 
 
 
3.5.4 Immunoprecipitation and lectin purification 
 For lectin purification, T. brucei procyclic form cells were washed 5 times in 1x 
PBS (600xg, 10 min, 4°C), resuspended to be 2x109/ml and lysed by adding an equal 
volume of 2% SDS, 0.15 M NaCl, 0.1 M DTT, 40 mM TrisHCl pH 6.8. After heating at 
50°C for 20 min, the cell lysate was extracted at room temperature for 30 min and 
finally diluted to 0.03% SDS, 1% TX-100, 0.15 M NaCl, 20 mM TrisHCl pH 6.8 
(Buffer PD). The cell lysate was then incubated for 2 h at 4°C with the biotinylated 
lectin of choice, plus 45-60 min after addition of Neutravidin-agarose beads (Pierce) or 
Dynabeads® MyOne C1 Streptavidin (Invitrogen). The material bound to the beads was 
eluted with specific sugar (Table 3.13) dissolved in Buffer PD, by incubating for 3-16 h 
at room temperature shaking and loaded on a gradient 4-12% SDS-PAGE gel 
(Invitrogen). Alternatively, beads were heated at 50°C for 20 min in SDS sample buffer 
(Invitrogen) and the extracted material analysed by SDS-PAGE.  
For human Galectin-2 immunopurification trials, the recombinant protein was diluted in 
Buffer PD and incubated 2 h at 4°C with biotinylated anti-Galectin-2 plus 45 min after 
addition of Dynabeads® MyOne C1 Streptavidin or Dynabeads® Protein G (Invitrogen). 
A as control, the anti-Galectin-2 antibody alone was incubated with the Dynabeads in 
the same conditions. The beads were heated at 50°C for 20 min in SDS sample buffer 
(Invitrogen) and the extracted material analysed on a 12% SDS-PAGE gel. The 
Reagent Dilution Supplier Inhibition
Ulex europeus I biotinylated 1:2000 Vector Labs. 0.2 M methyl-!-L-fucopyranoside (CarboSynth)
Aleuria Aurantia biotinylated 1:10000 Vector Labs 0.2 M methyl-!-L-fucopyranoside
Ricin biotinylated 1:3000 Vector Labs. 30 mg/ml Lactose, 30 mg/ml Galactose (Sigma)
Human Galectin-2 1:500 R&D Systems 30 mg/ml Lactose, 30 mg/ml Galactose
anti-Galectin-2 biotinylated 1:500 R&D Systems
ExraAvidin-HRP 1:10000 Sigma
rabbit anti-GSTTbFT serum 1:500
goat anti-rabbit HRP-conjuagted 1:10000 Jakson Labs
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composition of the immunoprecipitation buffer was varied by decreasing the 
concentration of NaCl to 0.1 M or exchanging the SDS for 0.01% sodium deoxycholate.   
 
3.5.5 Fluorography 
 After staining with Coomassie and destaining with 10% acetic acid, gels were 
incubated 30 min shaking with En3Hance solution (PerkinElmer). The gel was rinsed 
with water twice and then left to incubate still in water for 10 min, shaking. The gel was 
dried on a 583 gel dryer (BioRad) before being incubated at -80°C to expose with film 
(Biomax XAR film, Kodak) in the presence of an intensifying screen (Kodak). Films 
were developed on a Compact X4 developer. 
 
3.5.6 Protein concentration determination 
 Protein concentration was estimated from a solution by Bradford assay using 
Coomassie Plus protein assay reagent (Thermo) according to manufacturer’s 
instructions. BSA (Thermo) was used as a standard.  Alternatively, protein amounts 
were estimated by 2D densitometry after SDS-PAGE and Coomassie staining. Gels 
were imaged on a FujiFilm LAS-4000 system and evaluated using the AIDA image data 
analysis software (Raytest).  
 
3.5.7 TbFT recombinant expression and purification for activity assay 
 pGEX6P1-GST-PP-TbFT was transformed BL21 (DE3) E. coli strain and a 40 
ml culture was grown at 37°C, 210 rpm for 5 h (Infors HT incubator). The culture was 
enlarged to 1 liter and incubated again at 37°C until OD600 was between 0.6 and 0.8. At 
this point the culture was moved to an incubator pre-cooled at 16°C, IPTG was added to 
100 µM final and the culture incubated for 16 h with rotation. Cells were harvested by 
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centrifugation (4500xg, 20 min 4°C, J6-MC Beckmann centrifuge) and resuspended in 
50 mM TrisHCl, 0.15 M NaCl, 1 mM DTT pH 7.3 (buffer A) containing a EDTA-free 
Complete Protease Inhibitors Tablet (Roche). The cells were then treated with 1 mg/ml 
lysozyme (Sigma) for 30 min on ice before being disrupted with a French Press. The 
soluble fraction was obtained by centrifugation at 17000xg, 4°C for 30 min (J2-21 
Beckmann centrifuge) and incubated 2 h at 4°C with Sepharose Glutathione Fast Flow 
beads (GE Heathcare) that had been pre-washed in Buffer A. At the end of the 
incubation, the material was loaded on a disposable column (BioRad) and the beads 
washed with 10 column volumes of 50 mM TrisHCl, 0.25 M NaCl, 1 mM DTT pH 7.3 
(Buffer B), followed by 10 column volumes of 50 mM TrisHCl, 0.15 M NaCl, 0.1 % 
sodium deoxycholate, 1 mM DTT pH 7.3 (Buffer C) and 10 additional volumes of 
Buffer B. GST-TbFT was eluted 3 times with 1 column volume of 50 mM TrisHCl, 
0.15 M NaCl, 10 mM reduced glutathione pH 8 (Buffer E). The recombinant expression 
yield was estimated by Bradford assay and the degree of purification by SDS-PAGE 
analysis. 
  
3.5.8 Small-scale TbFT recombinant expression trials 
 pGEX6P1-GST-PP-TbFT was transformed in Tuner™ (DE3) and BL21 
CodonPlus (DE3) RiPL E. coli strains as described in Section 3.3.9. Cultures (5 ml) 
from single colonies of these two cell lines and the previously used BL21 (DE3) cell 
line were grown for 5 h at 37°C, 200 rpm (Infors HT incubator) in LB medium 
containing ampicillin and in the case of the RiPL strain also chloramphenicol, before 
being transferred to a larger volume (125 ml). The cultures were grown in the same 
conditions as above, until the optical density at 600 nm was between 0.6 and 0.8 and 
then aliquoted in 24-well blocks (Qiagen) to have 5 ml/well. The blocks were covered 
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with AirPore Tape Sheets (Qiagen) and incubated as follow: one of the BL21 (DE3) 
blocks was incubated at 16°C, together with the Tuner™ strain block, while the RiPL 
block and the remaining BL21 (DE3) block were incubated at 20°C. A range of IPTG 
concentrations and four incubation time points (2, 4, 16 and 24 h) were tested. IPTG 
was added to 100-250-500-750-1000 µM in the Tuner™ (DE3), BL21 CodonPlus 
(DE3) RiPL blocks and in the BL21 (DE3) block incubated at 20°C In addition, IPTG 
concentrations of 50-75-100-150-175 µM were tested for the BL21 (DE3) block 
incubated at 16°C and at each time point the cultures were transferred to 15 ml Falcon 
tubes and centrifuged 30 min at 4°C, 3200xg (Allegra X-12 R Centrifuge, Beckman 
Coulter). The cells were enzymatically lysed in 300 µl 20 mM TrisHCl, 0.3 M NaCl pH 
7.5 containing 0.2 mg/ml lysozyme and benzonase (Sigma). The cell lysates were 
transferred to a 96-well plate with conical wells (GE Healthcare) and centrifuged 15 
min at 3000xg, 4°C. The soluble fractions were moved to a 96-well plate (Nunc) and 12 
µl aliquots transferred to a PCR plate. SDS sample buffer (Invitrogen) was added to 
each well and the plate heated for 15 min at 70°C in a PTC-225 Peltier Thermal Cycler 
(MJ Research). The wells of a 96-well 6 % E-PAGE gel (Invitrogen) were re-hydrated 
with water and the sample loaded. The gel was run on a E-Base system (Invitrogen) for 
14 min (program EP), stained with Coomassie for 4 h and destained in 10% acetic acid.   
 
3.5.9 TbFT recombinant expression and purification for animal immunization 
 pGEX6P1-GST-PP-TbFT was transformed BL21 CodonPlus (DE3) RiPL E. coli 
strain and a 40 ml culture was grown at 37°C, 210 rpm for 5 h. The culture was 
enlarged to 1 liter and incubated again at 37°C until OD600 was between 0.6 and 0.8. At 
this point the culture was moved to an incubator pre-cooled to 20°C, IPTG was added to 
100 µM final and the culture incubated for 16 h with rotation. Cells were harvested by 
3. MATERIALS AND METHODS  
 
58 
centrifugation (4500xg, 20 min 4°C, J6-MC Beckmann centrifuge) and resuspended in 
50 mM TrisHCl, 0.15 M NaCl, 1 mM DTT pH 7.3 (buffer A) containing a EDTA-free 
Complete Protease Inhibitors Tablet (Roche). The cells were treated with 1 mg/ml 
lysozyme (Sigma) for 15 min on ice before being disrupted with a French Press. The 
soluble fraction, obtained by centrifugation at 17000xg, 4°C for 15 min, was filtered on 
a 0.45 µm Minisart single filter unit (Sartorious) and incubated 2 h at 4°C with 
Sepharose Glutathione Fast Flow beads (GE Heathcare) rotating. The beads were pre-
washed in Buffer A. After the incubation, the material was loaded on a disposable 
column (BioRad) and the beads washed with 20 column volumes of 50 mM TrisHCl, 
0.25 M NaCl, 1 mM DTT pH 7.3. GST-TbFT was eluted 3 times with 1 column volume 
of 50 mM TrisHCl, 0.15 M NaCl, 10 mM reduced glutathione pH 8 (Buffer E). The 
elutions were pooled, diluted to have a final concentration of 15 mM NaCl and loaded 
on a 5 ml HiTrap Q HP column (GE Heathcare). After washing for 10 min with 100 % 
Buffer 1 (20 mM TrisHCl, 35 mM NaCl pH 8), the material was eluted on a 20 min 
linear gradient to 100 % Buffer 2 (20 mM TrisHCl, 1 M NaCl pH 8). The flow was 5 
ml/min through out the programme. Fractions 21-23 were pooled and dialyzed at 4°C in 
sterile 1x PBS using a Slide-A-Lyzed dialysis cassette (Thermo) with a 10 kDa 
molecular weight cut-off. After dialysis, the protein amount was estimated by Bradford 
assay and GST-TbFT concentrated to 1 mg/ ml by centrifugation using a Vivaspin20 
concentrator (Sartorius) with a molecular weight cut-off of 30 kDa.  
 
3.5.10 Analysis by size exclusion chromatography of GST-TbFT 
  GST-TbFT was recombinantly expressed in BL21 CodonPlus (DE3) RiPL E. 
coli and affinity purified on Sepharose Glutathione Fast Flow beads (GE Heathcare) as 
detailed above. The material eluted from the beads was concentrated using a Vivaspin20 
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concentrator (Sartorius) with a molecular weight cut-off of 10 kDa to a final volume of 
0.5 ml and loaded on a Superose 12 10/300 GL (GE Healthcare) size exclusion 
chromatography column. The column was eluted with 1.5 column volumes 20 mM 
HEPES, 150 mM NaCl pH 7.2 with a 0.5 m/min flow. Aliquots from the fractions of 
interest were loaded on a 10% SDS-PAGE gel and proteins stained with Coomassie. 
 
3.5.11 Trials for cleavage of the GST-tag 
 GST-TbFT still bound to the Sepharose Glutathione Fast Flow (GE Healthcare) 
beads from BL21 (DE3) expression was incubated with 0.25 mg/ml GST-PreScission 
Protease (a kind gift from Prof. Daan Van Alten, University of Dundee) at 4°C for 16 h. 
Aliquots of the beads and of the supernatant fractions were run on a 10% SDS-PAGE 
gel. Alternatively, 0.1 mg of GST-TbFT expressed in BL21 CodonPlus (DE3) RiPL 
(purified by affinity chromatography and anion exchange chromatography) were 
incubated as described above in the presence of Sepharose Glutathione Fast Flow beads 
for 16, 24 and 40 h. Aliquots of beads and supernatant from each time point were 
analyzed by SDS-PAGE to gauge the cleavage efficiency. 
 
3.5.12 Coupling to CNBr-activated agarose beads 
 About 5 mg of Schistosoma japonicum GST (Sigma) were dialysed in 0.1 M 
sodium bicarbonate, 0.5 M NaCl pH 8.5 (Coupling buffer). CNBr-activated agarose 
beads  (0.1 g dry beads/ mg of protein, Sigma) were re-hydrated in 1 mM HCl at room 
temperature for 30 min, washed 3 times with the same acid solution and equilibrated by 
washing 3 times with Coupling buffer (5 min, 500xg in a 4K15 Sigma Centrifuge). The 
GST protein solution was incubated with the beads for 24 h at 4°C. The supernatant was 
removed and the beads incubated for 2 h at room temperature with 1 M ethanolamine 
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pH 9. The beads were washed three times with acidic buffer (0.1 M sodium acetate, 0.5 
M NaCl pH 4) and then with Coupling buffer (15 min, 500xg, 4°C). Lastly, the beads 
were washed three times in 1x PBS before being resuspended to a 50% slurry in 1x PBS 
containing 0.05% NaN3. A small aliquot of the beads was analyzed on a 10% SDS-
PAGE gel to verify the success of the protein coupling. 
 
3.5.13 Depletion of anti-GST antibodies from rabbit and mouse anti-GSTTbFT sera 
 Aliquots of rabbit serum (1 ml) and mouse serum (0.1 ml) were centrifuged 20 
min at 16000xg, 4°C (Centrifuge 5415 R, Eppendorf) to remove any insoluble material, 
before being incubated with 90% and 10% respectively of GST-agarose beads (Section 
3.5.12) for 2 h at 4°C. The depleted sera were removed by centrifugation (5 min, 
500xg). The anti-GST antibodies were eluted from the beads with 50 mM sodium 
citrate pH 2.8 and the beads re-equilibrated by washing in 1 x PBS containing 0.05% 
NaN3. 
 
 
 
3.6 Immunofluorescence 
3.6.1 List of antibodies 
 The antibodies used in the analysis of flagellar attachment by 
immunofluorescence were kindly donated by Prof. Keith Gull, University of Oxford. 
Table 3.14: Antibodies and dilutions used for immunofluorescence 
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3.6.2 Cell fixing, staining and imaging 
All solutions used in this protocol were filtered on a 0.2 µm Minisart filtering 
unit (Sartorious). About 2x107 T. brucei bloodstream or procyclic form cells at log 
phase density were harvested by centrifugation and washed with cold 1x TDB or 1x 
PBS, respectively. Both bloodstream and procyclic form cells were centrifuged at 
600xg, 10 min at 4˚C (4K15 Sigma Centrifuge) and resuspended very gently to reduce 
cell bursting. Round coverslips (13 mm diameter, VWR) were placed in the wells of a 
12-well plate (TPP) and pre-cooled on ice. After washing, the cells were resuspended to 
be 1-3x10^7/ml and 10 µl of cell suspension were placed on the centre of each coverslip 
and incubateded 15 min on ice. The excess of cell suspension was removed, leaving 
only a very thin film behind, before submerging each coverslip in 1 ml of pre-cooled 
4% PFA/TDB (bloodstream form) or 4% PFA/PBS (procyclic form). The cells were 
fixed for 30 min on ice before the coverslips were washed 3 times with cold 1x PBS. To 
permeabilise the cells, the cover slips were incubated for 10 min in filtered 0.1% TX-
100 in PBS at room temperature, with shaking (Mini gyro-rocker SS-M3, Stuart). After 
washing 3 times with 1x PBS, the coverslips were blocked for 30 min on the plate 
shaker with 1% FSG + 0.05% TX-100 in PBS + 0.05% NaN3. The coverslips were 
moved to a humid chamber and additionally blocked 1 h with 100 µl/ coverslip of 5% 
w/v FSG + 0.05% TX-100 + 10% normal goat serum in PBS containing 0.05% NaN3. 
After washing 3 times with 1% w/v FSG + 0.05% TX-100 in PBS containing 0.05% 
NaN3, the coverslips were incubated with primary antibody solution for 1 h at room 
temperature. The solution was prepared by diluting the antibody stock in 1% w/v FSG + 
0.05% TX-100 in PBS containing 0.05% NaN3. If more than one primary antibody was 
used, they were diluted in the same solution. After the dilution, the antibodies solution 
was centrifuged 10 min at 16000xg, 4˚C (Microcentrifuge 5415 R, eppendorf) and 50 µl 
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added to each coverslip. After washing 3 times with 1% w/v FSG + 0.05% TX-100 in 
PBS containing 0.05% NaN3, the coverslips were incubated with secondary antibody 
solution, which was prepared as described for the primary antibody, 1 h at room 
temperature. The humid chamber was covered with foil during the incubation. The 
coverslips were washed twice with 1% w/v FSG + 0.05% TX-100 in PBS containing 
0.05% NaN3 and twice with 1 x TBS (20 mM TrisHCl, 150 mM NaCl pH 7.2) before 
mounting on frosted glass slides (VWR). ProLong® Gold antifade reagent with DAPI 
(Invitrogen) was spotted on the slide and the coverslip lowered slowly on the drop of 
mounting agent. The slides were left curing overnight in the dark at room temperature 
before being sealed with nail varnish. Microscopy was performed on a Zeiss LSM 700 
confocal microscope. 
  
3.7 Analytical techniques 
3.7.1 TbFT activity assay 
 An aliquot of 2 µg of the affinity purified GST-TbFT was incubated with 1 µCi 
GDP[3H]Fuc (ARC), 1 mM acceptor in 50 mM TrisHCl, 25 mM KCl, 5 mM MgCl2, 5 
mM MnCl2 pH 7.2 to a final volume of 25 µl for 2 h at 37°C. When the dependency on 
divalent cations was studied the buffer was modified to 50 mM TrisHCl, 25 mM KCl 
pH 7.2 or in 50 mM TrisHCl, 25 mM KCl, 10 mM EDTA pH 7.2. A reaction without 
acceptor was run as a negative control. At the end of the incubation, the reactions were 
cooled on ice and water was added to 200 µl final volume. The reactions were desalted 
on a mixed-bed column made of 100 µl each of 100% slurry Chelex100, AG50, AG3 
(BioRad) and QAE-Sepharose A25 (Sigma) from top to bottom. The column was pre-
washed with 10 column volumes of water, the samples loaded and the glycans eluted 
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with 4 times 400 µl of water. The flow through and the elutions were combined: 5% 
was counted at LS 6500 scintillation counter (Beckmann), while the remaining material 
was freeze-dried on a Alpha 1-2 LD plus lyophilizer (Christ). The freeze-dried 
oligosaccharides were redissolved in water, dried in a speedvac concentrator (Savant 
SC110A, Thermo) and redissolved in 20% 1-propanol (HiPerSolv Chromanorm, 
VWR). The radiolabelled reaction products were analyzed by TLC, as described in 
Section 3.7.2, together with cold and radioactive standards. The acceptors tested are 
listed in Table 4.3, they were purchased from Sigma, Dextra Laboratories or Toronto 
Research Chemicals.   
 
3.7.2 TLC analysis  
 Thin layer chromatography was performed on 10 cm high HPTLC SI-60 plates 
(Merck) with 1-propanol: acetone: H20 9:6:4 (v:v:v) as mobile phase (Solvent A).  All 
solvents used were HiPerSolv Chromanorm grade (VWR). To improve resolution the 
plates were run twice before imaging. Non-radioactive sugars were visualized by 
orcinol/ H2SO4 staining as described below. In the case of radiolabelled material, the 
TLC plates were fluorographed by spraying with En3hance® Spray solution (Perkin 
Elmer) and incubated between 24 h and three weeks at -80°C to expose with film 
(Biomax XAR film, Kodak) in the presence of an intensifying screen (Kodak). The 
films were developed on a Compact X4 developer (X-ograph Imaging Systems). 
 
3.7.3 Orcinol/H2SO4 staining 
 To stain non-radiolabelled carbohydrates, the HPTLC plates were sprayed using 
a Aldrich® flask-type sprayer with an orcinol/H2SO4 solution and heated with a heat gun 
(HL 1610 S, Steinel) until the spots appeared. The orcinol/H2SO4 solution was prepared 
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by dissolving 180 mg of orcinol  (BDH) in 5 ml of water. After adding 75 ml of ethanol, 
the solution was cooled on ice for at least 30 min before 10 ml of concentrated H2SO4 
(VWR) were carefully mixed in.  
 
3.7.4 Extraction of radiolabelled TbFT reaction products 
 Fractions corresponding to 50 % of the reaction products from the TbFT activity 
assays with lactose, lacto-N-biose and N-acetyllactosamine as acceptors were run twice 
on a HPTLC plate (20 cm high) in 1-propanol: acetone: H2O 9:6:4 (v:v:v). The position 
of the radiolabelled products on the TLC plate was determined using an AR-2000 
(BioScan) plate reader. The areas corresponding to the reaction products were wetted 
with mobile phase and the silica scraped and transferred to 1.5 ml eppendorf tubes. The 
radiolabelled materials were extracted from the solid phase by incubating 3 times with 
200 µl of mobile phase for 15 min. The supernatants from these extractions were 
combined and a 5% aliquot counted at the scintillation counter (LS 6500, Beckmann) to 
determine the percentage of recovered material. 
 
3.7.5 TFA acid hydrolysis 
 Aliquots corresponding to 15% of the extracted radiolabelled reaction products 
were dried in a speedvac concentrator (Savant SC110A, Thermo), redissolved in 200 µl 
4 M TFA (Pierce) and incubated at 100°C for 4 h. After cooling, the samples were dried 
on a speedvac concentrator, washed with water and dried again. The hydrolyzed 
samples were redissolved in 20% 1-propanol, run on a HPTLC plate and fluorographed 
as detailed in Section 3.7.2. Non-radioactive fucose and galactose standards were run in 
parallel and imaged by orcinol/ H2SO4 staining. 
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3.7.6 Exoglycosidase reaction 
 Aliquots corresponding to 15% of the extracted radiolabelled reaction products 
were treated or mock treated with 10 U Xanthomonas manihotis α-1,2-fucosidase (New 
Engand Biolabs) at 37°C for 16 h. The exoglycosidase was then inhibited by heating at 
100°C for 10 min and after cooling the reaction was desalted on mixed bed columns as 
described in Section 3.7.1. After freeze drying samples were washed with water, dried 
on a speedvac concentrator, redissolved in 20% 1-propanol and analysed by TLC. 
 When the galactosidase reactions were performed on blots, the nitrocellulose 
membranes were blocked in 50 mM TrisHCl, 0.25% BSA, 0.05% NP-40, 150 mM 
NaCl pH 7.4 (Blocking buffer) before incubation with pre-heated reaction buffer or 
buffer plus the exoglycosidase for 48 h at 37°C shaking (Infors HT incubator) in sealed 
plastic bags. The ricin purified cell lysate was digested with 75 mU/ml bovine testis β-
galactosidase (Glyko) in 0.1 M citric acid, 0.5% BSA, 0.06% NP-40 pH 4.5, while 
coffee bean α-galactosidase (Sigma) digestion was carried out with 0.3 U/ml of enzyme 
in 0.1 M citrate-phosphate, 0.5% BSA, 0.06% NP-40 pH 6. At the end of the digestions, 
the membranes were washed in Blocking buffer 3 times for 15 min, before proceeding 
with the lectin incubations (Section 3.5.3). 
  
3.7.7 Normal phase purification of TbFT reaction product 
 The TbFT activity assay was upscaled as follows: 5 mM Lacto-N-biose-β-O-
methyl as an acceptor, 2.5 mM GDP-Fuc (non-radioactive, Sigma), 8 µg affinity 
purified GST-TbFT were incubated in 20 mM TrisHCl, 25 mM KCl pH 7.2 at 37°C for 
24 h. The reaction was desalted on a mixed bed column as detailed in Section 3.7.1, 
before being freeze-dried on a Alpha 1-2 LD plus lyophilizer (Christ). The desalted 
sugars were redissolved in 95% acetonitrile (HPLC grade, Merck) and the trisaccharide 
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product separated by normal phase chromatography on a Supelco SUPELCOSYL™ LC 
NH2 HPLC column (7.5 cm x 3 mm, 3µm) using an Agilent 1120 Compact LC system. 
The purification was performed at 40°C with a 0.3 ml/min flow rate. The column was 
equilibrated in 100% Buffer A (95 % acetonitrile, 5% H2O) for 5 min, before applying a 
first gradient from 0-35 % Buffer B (95% H2O, 5 % acetonitrile, 15 mM ammonium 
acetate) over 25 min followed by a second gradient from 35-80 % Buffer B over 20 
min. The column was then re-equilibrated in 100% Buffer A for 10 min. Fractions were 
collected and 1.5% of each spotted on a HPTLC SI-60 plate and stained with orcinol/ 
H2SO4 to identify the sugar-containing fractions. About 2% of each of the orcinol 
positive fractions were evaporated under a nitrogen stream (Reacti-Vap™ evaporating 
unit, Pierce) and analyzed by TLC as described in Section 3.7.2. The fractions 
containing the trisaccharide products were pooled and freeze-dried (Alpha 1-2 LD plus 
lyophilizer, Christ) to eliminate the ammonium acetate. 
  
3.7.8 Neutral sugar composition analysis 
Aliquots of about 5 and 10 % of purified, salt-free reaction product and acceptor 
were mixed with 0.5 nmol of scyllo- inositol as an internal standard. This mixture was 
pipetted into a disposable microtube formed by heat-treated capillaries (Drummond 
Microdispenser 250 µl) sealed at one end on a Bunsen flame. A standard mix of 
monosaccharides and scyllo- inositol was also prepared in parallel. The samples and 
standard mix were dried in a speedvac concentrator (Savant SC110A, Thermo), washed 
with HPLC grade methanol and re-dried to ensure dehydration. Acid methanolysis was 
carried out in 50 µl 0.5 M HCl in methanol (Supelco) for 4 h at 80°C using tubes that 
had been flame sealed under slight vacuum. After cooling down, the tubes were opened 
and 5 µl of pyridine (Merck) added to destroy the HCl. Any free primary amine was re-
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N-acetylated with 5 µl acetic anhydride (Supelco) at room temperature for 20 min. The 
samples were dried in the speedvac concentrator, washed with methanol and dried 
again. One sample at a time was derivatised in 15 µl of TMS reagent (0.5 ml pyridine, 
50 µl chlorotrimethylsilane, 150 µl hexamethyldisilazane (Fluka)) for at least 20 min at 
room temperature, while the other samples were left drying. After derivatisation, 1 µl of 
the sample was injected in the GC-MS (HP6890 GC System, Hewlett Packard and 
5975C Agilent mass spectrometer) and analyzed on a HP-5 MS column (30 m long, 
0.25 mm ID, 0.25 µm film thickness, Agilent). The helium flow was kept at 5 psi with 
injector and GC/MS interface temperatures of 280°C. The injection time was 1-2 min 
and the temperature gradient as follows: 30°C/min up to 150°C and 5°C/min from 150 
to 280°C. The final temperature was held for 20 min. The peaks for the TMS 
derivatives of the standards were used to calculate the molar relative response factor 
(MRRF) for each monosaccharide compared to the scyllo-inositol internal standard: 
MRRFsugar = Sugar peak area/ scyllo-inositol peak area. The amounts of TMS-
derivatized neutral monosaccharide in the samples were then estimated as follows: 
nmolsugar = (Sugar peak area/ scyllo-inositol peak area) x (nmolscyllo-inositol/ MRRFsugar). 
Mutorotation of sugars causes each monosaccharide to produce up to 4 products 
detectable with this method. When more than one peak was present for a single 
monosaccharide (e.g. galactose and fucose), the bigger peak was used in the 
quantitation.  
 
3.7.9 Methylation linkage analysis 
This protocol is based on the method described in Ferguson, 1994. About 10 
nmol of purified reaction product were dried in a speedvac concentrator (Savant 
SC110A, Thermo) in an acid washed 3 ml Reacti-vial (Pierce). After drying, methanol 
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was added to the vial and the sample re-dried. As positive control, 5 nmol of Lacto-N-
tetraose (Sigma) were run in parallel with the samples. Each sample was incubated for 
20 min at room temperature with 50 µl DMSO (VWR) mixing occasionally. A 
suspension of approximately 120 mg/ml NaOH (Merck) in DMSO was prepared by 
grinding NaOH pellets in a clean glass pestle and mortar. Each vial was incubated with 
50 µl of this slurry for 20 min mixing occasionally. In a fume hood, 10 µl of 
iodomethane (Sigma) were added to each vial and the samples incubated for 10 min. 
This step was repeated a second time and a third incubation with 20 µl iodomethane for 
20 min was performed. To destroy the iodomethane, 250 µl chloroform and 1 ml of a 
100 mg/ml solution of sodium thiosulphate were added to each sample. The vials were 
vortexed for 1 min the phases allowed to separate. The aqueous phase was discarded 
and the lower phase was washed with water until it looked clear. At the end of the 
washing steps, the lower phase was removed from under the water, transferred to a glass 
screw top tube (Pyrex) and dried in a speedvac concentrator. After adding 100 µl 
methanol, 10% of each sample was saved to be analyzed by ESI mass spectrometry, 
while the remaining volume was re-dried. The permethylated sugars were hydrolysed at 
80°C for 4h in 0.25 M H2SO4 in 93% acetic acid. After cooling, 50% methanol was 
added to each vial and the acetic acid was neutralised with 1 M NaOH. The samples 
were dried in a speedvac concentrator, washed with 50% methanol and re-dried. The 
residual acetic acid was removed by adding 50 µl toluene. The samples were dried and 
the washing step repeated. The residues in the vials were dissolved in 100 µl 1 M 
NH4OH and 2 nmol scyllo-inositol (Sigma) as an internal standard. A 0.5 M NaB2H4 
(Isotec) solution was freshly prepared and 100 µl added to each vial. The samples were 
left to reduce for at least 3 h at room temperature. The excess reducing reagent was 
destroyed by adding 10 µl aliquots of 5 M acetic acid until it stopped effervescing. The 
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samples were dried in a speedvac concentrator and re-dried after washing twice with 5% 
acetic acid in methanol (v:v). The drying step was repeated twice more with methanol to 
remove any boric acid. The samples were then washed twice in toluene to remove acetic 
acid. The partially methylated alditols were acetylated at 100°C for 2.5 h in 250 µl 
acetic anhydride (Supelco). After cooling, the acetic anhydride was removed in a 
speedvac concentrator at low or medium heat. The residues were redissolved in 0.5 ml 
dichloromethane (VWR) and 2 ml water. The samples were vortexed and the phases 
allowed to settle, the water was then removed and the organic phase washed once more 
with water. The dichloromethane was recovered and transferred to a small glass vial. 
The sample was dried under a nitrogen stream and redissolved in 20 µl 
dichloromethane. A 1 µl aliquot of the partially methylated alditol acetates (PMAAs) 
was analyzed by GC-MS (HP6890 GC System, Hewlett Packard and 5975C Agilent 
mass spectrometer) on an Agilent HP5-MS column. The GC-MS programme used had a 
splitless injector held at 280°C, an initial time of 1 min and an initial oven temp of 80°C 
and a solvent delay of 7.5 min. The following oven temperature gradient was applied: 
30°C/min from 80 to 140°C, 5°C/min from 140 to 250°C and this final temperature was 
held for 20 min before returning to 80°C. The interface from the GC to the MS was held 
at 280°C throughout the programme. 
 
3.7.10 NMR 
 The TbFT reaction product purified by normal phase HPLC was exchanged in 
2H2O by freeze drying on a Alpha 1-2 LD plus lyophilizer (Christ) and analyzed by one-
dimensional 1H NMR and two-dimensional 1H ROESY (Rotating frame Overhouser 
Effect SpectroscopY). All spectra were acquired on a Bruker Avance spectrometer 
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operating at 500 MHz with a probe temperature of 293°K. The NMR analysis was 
performed by Gina McKay, Univeristy of Dundee. 
 
3.7.11 ESI-MS/MS of the permethylated glycans 
 Permethylated glycans in chloroform were dried under a nitrogen stream, 
redissolved in 80% acetonitrile containing 0.5 mM sodium acetate and loaded onto a 
nano flow probe tip (Waters) for direct infusion on a Q-Star XL electrospray mass 
spectrometer equipped with Analyst software (Applied Biosystems). The mass 
spectrometer was operated in positive ion mode using a ion spray voltage of 900 V for 
the MS-TOF and 1200 V for the ESI-MS/MS. In the ESI-MS/MS mode a collision 
voltage of 50-60 V was used. Alternatively, the samples were redissolved in 30 % 
acetonitrile, directly infused on an Agilent Q-TOF instrument and analyzed in positive 
ion mode using a ion spray voltage of 2100 V. 
  
3.7.12 Extraction and analysis of T. brucei procyclic form N-glycan fraction 
 Procyclic form dm cells were grown to mid log density and 109 cells were 
harvested by centrifugation (600xg, 10 min, 4°C in a 4K15 Sigma centrifuge). After 
washing with 1x PBS, the cells were resuspended in water, vortexed for 30 s and the 
lipids present in the cell lysate were extracted immediately in 
chloroform:methanol:water 10:10:3 (v:v:v). The precipitated material, recovered after 
lipid extraction, was resuspended in 100 µl 20 mM sodium phosphate pH 7.6 and 
incubated for 1 h in a bath sonicator (UW, Norm Tech) to help resolubilization. The 
material was digested with 100 µg of Pronase (from Merck, prepared in 5 mM calcium 
acetate) for 16 h at 37°C. This step was repeated twice for a total incubation time of 60 
h. After heating for 1 h at 100°C, the soluble material was recovered by centrifuging 30 
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min at 16000xg (Centrifuge 5415 R, Eppendorf) and digested with 5 U of peptide:N-
glycosidase F (PNGaseF, Roche) for 16 h at 37°C plus 2 h after addition of 2 more units 
of enzyme. The sample was then moved to 3 ml Reacti-vials (Pierce), the glycans 
permethylated as described in Section 3.7.9 and analyzed by ESI-MS/MS on a Agilent 
Q-TOF instrument as described in Section 3.7.11. Lacto-N-tetraose was used a positive 
control for the permethylation. 
 
3.7.13 Extraction and analysis of T. brucei procylcic form β-eliminated glycan fraction  
 A starting material of 8.5x109 freeze-dried procyclic form dm cell equivalents 
was resuspended in 500 µl of water and redissolved using a 3 ml homogenizer (Uniform 
Jencons). The lipid fraction was extracted in chloroform:methanol:water 10:10:3 (v:v:v) 
and the precipitated material was resuspended in 1x PBS, vortexed and incubated for 1 
h in a bath sonicator (UW, Norm Tech) to help solubilization. The nucleic acids present 
were digested with 250 µg of RNaseA and 250 µg of DNaseI (Roche) at 37°C for 1 h. 
The proteinaceous material was precipitated with absolute ethanol (HPLC grade, Fluka) 
for 16 h at -80°C. The supernatant was removed by centrifugation (30 min, 4°C, 
16500xg in a J2-21 Beckmann centrifuge) and the pellet resuspended in 0.5 M NaOH 
and 1 M NaB2H4 by vortexing and sonicating (using a UW bath sonicator, Norm Tech). 
The β-elimination was performed for 3 h at room temperature and for 16 h at 60°C. The 
NaB2H4 was neutralized by adding 10 µl aliquots of 5 M acetic acid and the sample 
centrifuged for 15 min at 16000xg (Centrifuge 5415 R, Eppendorf) to eliminate any 
insoluble material. The soluble fraction was desalted on AG50 resin (BioRad) and the 
flow through and elutions pooled and dried on a Büchi Syncore RotoVap system 
(vacuum: 72 mbar, heat: 60°C, 360 rpm). The sample was redissolved in water, moved 
to a 3 ml Reacti-vial and dried on a speedvac concentrator (Savant SC110A, Thermo). 
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The sample was washed twice with 5% acetic acid in methanol and twice with 
methanol. After two additional washes in toluene, the sample was permethylated as 
described in Section 3.7.9. Lacto-N-tetraose was used a positive control for the 
permethylation. Positive control and sample were redissolved in 100% methanol and 1 
µl aliquots were mixed with dihydroxybenzoic acid matrix and analyzed by positive ion 
mode MALDI-TOF on a ABI Voyager-DE STR instrument in reflectoron mode. The 
accelerating voltage was 25 kV and the grid voltage was set to 93% with an extraction 
time delay of 200 ns. Data were collected manually at 500 shots/spectrum with laser 
intensity set at 2200. The remainder of the sample was dried, redissolved in 80% 
acetonitrile, 0.5 mM sodium acetate and analyzed by ESI-MS on a Agilent Q-TOF 
instrument as described in Section 3.7.11. 
 
3.7.14 Activity assay for the conversion of Mannose-1-P to Mannose-6-P 
 To assay activity, 50 ng of recombinant untagged TbPMM (expressed and 
purified at the Structural Genomic Consurtium, SGC) were incubated in 100 µl reaction 
volume for 20 min at room temperature in buffer D (2 mM Bis-Tris propane pH 7.3, 5 
mM MgCl2, 1 µM glucose-1,6-biphosphate, 50 ng BSA and 250 µM Man-1-P). The 
reaction was then stopped by addition of an equal volume of 0.2 M NaOH, raising the 
pH above 12. The samples were analyzed by High Pressure Anion Exchange 
Chromatography coupled to a Pulse Amperometric Detector (HPAEC-PAD, Dionex) 
using a CarboPac PA1 column (Dionex) and conditions adapted from Zhou et al., 2002. 
Briefly, a linear gradient from 150 mM sodium acetate (Merck), 0.1 M NaOH to 400 
mM sodium acetate, 0.1 M NaOH was applied over 25 min, before lowering the 
concentration of sodium acetate back to the initial conditions over 5 min. The column 
was then re-equilibrated at 150 mM sodium acetate, 0.1 M NaOH for 5 min. The flow 
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rate was kept constant at 0.25 ml/min. The same set up was used for the kinetic analysis, 
but the amount of TbPMM in each reaction was reduced to 10 ng and the concentration 
of Man-1-P in the reaction was varied between 10-1000 µM. Each concentration was 
analyzed in triplicates. A high-substrate inhibition equation (1) based on a non-linear fit 
was used to calculate the kinetic parameters of the reaction. The equation was kindly 
provided by Prof. Alan H. Fairlamb, University of Dundee. 
(1)     
 
All kinetic data were fitted using GraFit5. 
 
3.7.15 Activity assays for the conversions of Glucose-6-P and Glucose-1-P 
The conversion of Glc-1-P to Glc-6-P by recombinant TbPMM was first 
followed by HPAEC-PAD. The conditions and reaction buffer are the same described 
above for the Man-1-P to Man-6-P conversion, except 75 ng of enzyme were used and 
the substrate was changed to Glc-1-P. 
The conversion of Glc-6-P to Glc-1-P by TbPMM was also analyzed using a 
coupled assay with TbUGP. The formation of the final product (UDP-glucose) was 
followed on a HPAEC system (Dionex) using a CarboPac PA1 column and a UV 
detector set at 260 nm. The conditions were adapted from Tomiya et al., 2001. Briefly, 
a linear gradient from 0.2 M sodium acetate, 1 mM NaOH to 0.4 M sodium acetate, 1 
mM NaOH was applied over 5 min, followed by a second gradient to 1 M sodium 
acetate (always in 1 mM NaOH) over 2.5 min. The column was then washed for 5 min 
in 1 M sodium acetate, 1 mM NaOH, before gradually lowering the concentration of 
sodium acetate to 0.2 M over 2.5 min. The column was then re-equilibrated at 0.2 M 
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sodium acetate, 1 mM NaOH for 5 min. The flow rate was kept constant at 0.25 ml/min. 
In this case 100 ng of recombinant TbPMM were incubated 15 min at room temperature 
in 100 µl reaction volume containing 2mM Bis-Tris propane pH 7.3, 10 mM MgCl2, 1 
µM glucose-1,6-biphosphate, 500 µM Glc-6-P, 1 mM DTT, 0.1 mg/ml BSA, 500 µM 
UTP (CalBiochem) and 1  µg/rx TbUGP (Buffer CA). The reaction was stopped by 
addition of an equal volume of 0.2 M NaOH. Kinetic parameters were determined using 
a colorimetric assay on a 96-well plate format (Cellstar) as described in (Stokes et al., 
2008). Briefly, 25 ng of recombinant TbPMM were incubated in 100 µl reaction volume 
for 15 min at room temperature in buffer CA, containing also 0.08 U/rx 
pyrophosphatase (Sigma).  The concentration of Glc-6-P was varied between 10-1000 
µM. After addition of 100  µl of Biomol Green (Biomol International) and 20 min 
incubation, the A620 was measured on a SpectraMax 340PC (Molecular Devices) plate 
reader. Triplicates were run for each point. 
 
3.7.16 Analytical centrifugation 
Recombinant, untagged TbPMM was analyzed by sedimentation velocity on a 
Beckman Optima XL-1 Analytical Ultracentrifuge with an AN50-Ti rotor at 4°C, 
32,000 rpm. The quaternary structure of the protein was studied at 0.25, 0.5 and 0.75 
mg/ml in two different buffers: (i) 10 mM HEPES pH 7.5, 150 mM NaCl, (ii) 10 mM 
TrisHCl pH 7.5, 1 mM DTT. Absorbance data were collected and analyzed using the 
SEDFIT software (Schuck, 2004). TbPMM was assumed to be a globular protein and its 
amino acid composition was used to determine its density. The analysis was performed 
by Mark Agacan, University of Dundee.  
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4.     TRYPANOSOMA BRUCEI FUCOSYLTRANSFERASE (TbFT) 
 
 
4.1 Identification and biochemical characterization of Trypanosoma brucei 
fucosyltransferase (TbFT) 
 
4.1.1 Identification of putative TbFT gene 
 The Carbohydrate Active Enzyme database (CAZy, http://www.cazy.org; 
Cantarel et al., 2009) lists 8 distinct fucosyltransferases families: GT10, 11, 23, 37, 56, 
65, 68 and 76. One or more members from each family were selected and their protein 
sequences used as templates for a BLASTp search of T. brucei, T. cruzi and L. major 
predicted proteins. The list of the protein templates can be found in Table 4.1, together 
with the results from the BLASTp search. Genes encoding for predicted proteins with 
homology to known fucosyltransferases families could be found in all three 
trypanosomatids. 
 Only one gene could be identified in the T. brucei genome. This putative 
fucosyltransferase (TbFT, GeneDB ID: Tb09.160.2220) shows homology to the GT11 
family which is comprised almost exclusively of α-1,2-fucosyltransferases (Coutinho et 
al, 2003; Zhang et al., 2010). 
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Table 4.1: Initial BLASTp search for putative fucosyltransferases in the trypanosomatids 
genomes 
 
Results given as GeneDB IDs (http://www.genedb.org) 
 
 
 In the T. cruzi and L. major genomes, sequences showing homology to the GT11 
family could also be identified (GeneDB ID: Tc00.1047053506893.90, 
Tc00.1047053508501.240 and LmjF01.0100), together with predicted proteins with 
homology to the GT10 family (GeneDB ID: Tc00.1047053509233.40, 
Tc00.104053509437.80 and LmjF02.0330). The GT10 family is made of α-1,3/α-1,4-
fucosyltransferases that transfer fucose to N-acetylglucosamine residues on 
carbohydrate chains (Ma et al., 2006). Two genes were identified in the T. cruzi genome 
for both GT families. In both cases, these two genes were very similar and probably 
accounted for the two haplotypes that are present in the T. cruzi strain that was 
sequenced (El-Sayed et al., 2005a). 
 The lack of any genes encoding for a putative fucosyltransferase belonging to 
the GT10 family in the T. brucei genome was verified by using the newly identified 
putative fucosyltransferases, in the two other trypanosomatids genomes, as templates 
for a new BLASTp search of T. brucei predicted proteins. No putative α-1,3/α-1,4-
fucosyltransferase could be identified even using what would presumably be the more 
closely related T. cruzi and L. major sequences as templates. 
 T. brucei GT11 family TbFT shows quite low similarity with the previously 
characterized H. pylori fucosyltransferase (26 %) and human FUT2 (21 %) (Wang et 
Sheet1
Page 1
BLASTp results
CAZy family Linkage Query input L. major
GT10 LmjF2.0330
GT11 Tb09.160.2220 LmjF01.0100
GT23
GT37
GT56
GT65
GT68
GT74
Table 3.1: BLASTp searches for putative fucosyltrasferases in the trypanosomatids genomes
Fucosyltransferases
T. brucei T. cruzi
!1,3/1,4
CAC38049.1 (A. thaliana), AAA92977.1 (HsFUT4), 
AAH36037.1 (HsFUT11)
Tc00.1047053509233.40, 
Tc00.1047053509437.80
!1,2(!1,3) AAC24453.1 (HsFUT2), AAA53639.1 (HsFUT1)
Tc00.1047053506893.90, 
Tc00.1047053508501.240
!1,6 BAA19764.1 (HsFUT8)
!1,2 AAD41092.1 (A. thaliana)
!1,4 AAK62972.1 (E.coli)
O-Fuc AAL09576.1 (HsPOFUT1)
O-Fuc AAK77300.1 (D. melanogaster)
!1,2/GalT AAF828378.1(D. discoideum) 
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al., 1999; Kelly et al., 1995). However, the conserved motifs characteristic of the GT11 
family can be clearly identified in TbFT (Figure 4.1) (Martinez-Dunker et al., 2003; Li 
et al., 2008). Motif I (aa 147-156) is shared with α-1,6-fucosyltransferases and in this 
family it has been implicated in the GDP-Fucose binding (Takahashi et al., 2000). No 
clear function as yet been assigned to motifs II, III and IV (aa 198-204, 268-274 and 13-
18 respectively). 
Eukaryotic fucosyltrasferases are almost always type II transmembrane proteins 
(Breton et al., 1998; van der Hel et al., 2001), however a clear consensus on the 
presence of a transmembrane domain at the N-terminus of TbFT cannot be obtained 
with secondary structure prediction analyses. Furthermore, when a transmembrane 
domain is predicted, for example using HMMTOP or TMpred, it is located around motif 
IV (aa 6-28) rather than with the conserved domains (Figure 4.1).  
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Figure 4.1: Multiple sequence alignment of TbFT and other GT11 family fucosyltransferases 
(putative or characterized). Sequences from protozoa (T. cruzi, L. major), bacteria (H. pylori) 
and mammals (HsFUT2 and MmFUT2) were used for the alignment. Identical or highly 
conserved amino acids are highlighted in blue, while residues with a lower degree of 
conservation are highlighted in lilac. The conserved motifs are marked by black boxes. The 
predicted N-terminal transmembrane domain for TbFT is marked by a green box, while the 
transmembrane domains for the mammalian enzymes are marked in red. 
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4.1.2. Genomic organization and transcription of TbFT  
 The expression of mRNA for TbFT in procyclic and bloodstream form T. brucei 
was analysed by semi-quantitative RT-PCR. Total RNA was extracted from T. brucei 
cells as described in the Materials and Methods and primers ORF-N and ORF-C were 
used to amplify the TbFT open reading frame (ORF) from the reverse transcribed RNA. 
As shown in Figure 4.2, mRNA for TbFT was expressed in both bloodstream form 
(panel A) and procyclic form (panel B) T. brucei. No amplification could be observed 
when the reverse transcriptase was removed from the reaction.  
 
 
Figure 4.2: TbFT mRNA was present in both procyclic and bloodstream form T. brucei. 
Increasing amounts (4-40ng) of total RNA were treated with reverse transcriptase and the 
resulting cDNA was amplified with primers specific for the TbFT ORF. Primers for dolichol-
phosphate-mannose synthase (DPMS) were used as positive control for a constitutive expressed 
gene, while the reverse transcriptase (RT) was removed from the reaction as a negative control. 
A. Bloodstream form. B. Procyclic form. 
 
Furthermore, mRNA for TbFT has been detected in both bloodstream and 
procyclic form in two different microarray experiments, analysing differentiation in T. 
brucei. No clear change in TbFT mRNA levels could be observed during the 
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differentiation from bloodstream form to procyclics (http://tritrypdb.org; Queiroz et al., 
2009; Kabani et al., 2009). 
T. brucei genome assembly indicated TbFT to be present as a single copy per 
haploid genome gene. Southern blot analysis was used to experimentally analyse the 
number of TbFT copies per haploid genome. Genomic DNA (gDNA) was extracted 
from bloodstream form T. brucei, strain 427, as described in Materials and Methods and 
digested with six specific endonucleases. The reactions were run on an agarose gel and 
blotted on nylon membrane. Primers ORF-N and ORF-C were used to generate a probe 
corresponding to the gene ORF and the detection was carried out using 32P-labelled 
probe. AccI, EcoRI, NcoI, SalI and XcmI should cut on both sides of the ORF, giving 
only one band. PstI instead should cleave inside the TbFT ORF as well, giving a two 
bands pattern in the case of a single copy gene (Figure 4.3, panel A). The Southern blot 
analysis was consistent with TbFT being present a single copy per haploid genome gene 
(Figure 4.3, panel B), making the generation of conditional null mutants for this gene 
possible. 
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   A 
 
   B 
 
Figure 4.3: TbFT was present as a single copy per haploid genome.  A. Schematic representation 
of the specific endonucleases digestions in the genomic area containing TbFT. B. Southern blot 
of bloodstream form gDNA (5 µg/ lane) digested with EcoRI, NcoI, XcmI, AccI, SalI or PstI. 
TbFT ORF was used as a probe. 
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4.1.3. Cloning of TbFT ORF for recombinant expression 
 TbFT ORF was amplified from T. brucei 427 gDNA using primers ORF-N and 
ORF-C. The EcoRI and XhoI restriction sites inserted by the primers were used to clone 
the gene in the pGEX6P1 vector. The resulting construct (pGEX6P1-GST-PP-TbFT) 
encoded for the TbFT ORF with a glutathione-S-transferase (GST) tag at its N-terminus 
and a PreScission™ Protease  (PP) cleavage site between the two protein encoding 
sequences. 
 The constructs obtained from four different PCR experiments were sequenced 
twice in both directions and the consensus TbFT ORF sequences compared to the one 
reported in the GeneDB database (T. brucei strain 927). Table 4.2 lists the nucleotide 
and amino acid differences identified between the 427 and 927 strains. Of the six single 
nucleotide polymorphisms, two resulted in amino acid changes: L186V and T232A. 
None of these residues were located within the CAZy GT11 family conserved motifs.  
 
Table 4.2: Differences in the nucleotide and amino acid sequences of TbFT between T. brucei 
strains 927 and 427 
 
 
T. brucei strain 427 genome has now been partially assembled and deposited in 
TriTrypDB.  The 427 TbFT gene sequence deposited presents all six single nucleotide 
polymorphisms described above.  
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4.1.4. Establishing a recombinant expression system for TbFT  
 The pGEX6P1-GST-PP-TbFT construct was transformed in E. coli BL21(DE3) 
and over-expressed at 16°C for 16 h, after induction with 0.1 mM IPTG. The 
recombinant protein was purified on Glutathione Sepharose beads (Figure 4.4) and the 
identities of the two higher molecular weight bands in lane 8 were verified by peptide 
mass fingerprinting (data not shown). The most abundant band (indicated by an arrow 
in the figure below) was identified as TbFT, while the second smaller band (marked by 
an asterisk) was identified as a subunit of the E. coli GroEL chaperonin complex 
(Martin et al., 1993). The apparent molecular weight of GST-TbFT chimeric protein (57 
kDa) was consistent with the predicted theoretical molecular weight (58.1 kDa). A low 
molecular weight band (25 kDa) was observed in both the material purified from the 
empty pGEX6P-1 vector and from the vector expression GST-TbFT and is consistent 
with free GST (lanes 2-4 and 7-9). 
 
Figure 4.4: Over-expression and purification of GST-TbFT. The material encoded by the 
pGEX6P-1 empty vector (lanes 1-4) and the GST-TbFT containing vector (lanes 5-9) were 
expressed and purified following the same protocol (as described in Material and Methods). 
Aliquots from the lysis and affinity purification steps were run on a SDS-PAGE and stained 
with Comassie. SF: soluble fraction. P: pellet (insoluble fraction). E1-E3: elutions.   
58
25
KDa
SF  E1  E2   E3  SF    P    E1  E2   E3
pGEX6P1                    pGEX6P1-TbFT
 1     2     3     4     5    6     7    8    9
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 As observed in Figure 4.4, lane 6, most of the recombinant GST-TbFT was 
found in the insoluble protein fraction. Low solubility might explain the presence of the 
chaperonin subunit co-eluting with the purified GST-TbFT (lanes 7-9). It might also 
explain the relative low yield of the recombinant protein expression and purification 
process (0.3 mg GST-TbFT/ liter of culture).  
 
4.1.5 TbFT Activity assay 
 The recombinantly expressed soluble GST-TbFT was tested for activity by 
incubating the purified material with GDP-[3H]Fuc as a donor and a small panel of 
disaccharides as acceptors. Nothing is known about the structure of the physiological 
substrate(s) of TbFT, therefore the acceptors for the assay were chosen by searching the 
literature for common, broad range α-1,2-fucosyltransferases substrates or sub-
structures thereof (Wang et al., 1999; Zhang et al., 2008; Li et al., 2008).  Lactose (Lac, 
Galβ1,4Glc), N-acetyllactosamine (LacNAc, Galβ1,4GlcNAc) and lacto-N-biose (LNB, 
Galβ1,3GlcNAc) met these criteria.  
 This first experiment showed that GST-TbFT was active and able to transfer 
fucose to all three disaccharides, although the best activity was observed with lacto-N-
biose. No formation of trisaccharide product could be observed when the acceptors were 
removed from the reaction (Figure 4.5A, lane 4 and Figure 4.5B, lane 2). To confirm 
the detected activity was specific to the recombinant GST-TbFT and not of some minor 
endogenous E. coli contaminant, the same assay was run using the material purified 
from E. coli containing the empty pGEX6P1 vector (as described in the previous 
section). No transfer of radiolabelled fucose could be observed in this case (Figure 
4.5B, lanes 3-5).  
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 A band with the same retention factor (Rf) of fucose and presumably due to the 
hydrolysis of GDP-Fuc to the sugar moiety was always present in the reactions (Figure 
4.5A lanes 1-4 and Figure 4.5B lanes 1-2).  As shown in panel B, GDP-Fuc hydrolysis 
was considerably higher in the presence of the enzyme preparation than when the sugar 
nucleotide was incubated in the presence of the reaction buffer alone (Figure 4.5B, lane 
6) or in the presence of the material purified from the E.coli cells containing the empty 
vector (lanes 3-5). This result suggests that TbFT has a sugar nucleotide hydrolase 
activity as well as a fucosyltransferase activity. Although less likely, there is a formal 
possibility that an endogenous E. coli hydrolase co-purifies with the GST-TbFT. 
 
Figure 4.5: TbFT activity assay. 2 µg of total protein from the second elution (Figure 4.4, lane 
8) were incubated with GDP-[3H]Fuc and different acceptors. The reaction was then desalted 
and run on a HPTLC plate and the radioactive products were detected by fluorography. A. GST-
TbFT activity using the initial three putative acceptors. B. No activity could be detected when 
the assay was performed using material purified from E. coli cells expressing the empty vector. 
–ctr: negative control; BG: hydrolysis background. 
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The inverting α-1,2 and α1,6-fucosyltransferases are independent of divalent 
metal cations for their activity (Bayer and Hill, 1980; Pettit et al., 2010; Li et al., 2008; 
Kaminska et al., 2003). To study the dependence of TbFT on these co-factors, the assay 
was repeated in buffer without divalent cations or containing EDTA. As shown in 
Figure 4.6, no change in activity could be observed when the divalent cations were 
removed from the reaction (lane 3) or when EDTA was added to it (lane 2). These 
results indicate that TbFT activity was independent of divalent metal cations. 
 
 
Figure 4.6: TbFT activity is independent of divalent metal cations. The activity assay using 
lacto-N-biose (LNB) as acceptor was performed, as described in the experimental procedures, 
with the normal reaction buffer (+, lanes 1 and 4), removing MgCl2 and MnCl2 from the buffer 
(none, lane 3) or adding EDTA to it (EDTA, lane 2). A negative control missing the LNB 
acceptor (- ctr, lane 4) was also run.  
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4.1.6 TbFT acceptor specificity 
 A wider panel of acceptors were tested to study TbFT substrate specificity. The 
oligo- and monosaccharides assayed are listed in Table 4.3, together with their 
structures and a qualitative estimation of their effectiveness as acceptors for T. brucei 
fucosyltransferase. The effectiveness of each acceptor was estimated based on the 
presence/absence and the intensity of the TLC band corresponding to the reaction 
product of the assayed acceptors (Figure 4.7).  
As observed in both Figure 4.7 and Table 4.3, TbFT showed its best activity 
with LNB (Galβ1,3GlcNAc, Figure 4.7 lane 2) and its β-O-Methyl glycoside as 
acceptor (lane 20). Larger oligosaccharides containing Galβ1,3GlcNAc as a terminal 
moiety (LNT, LNH and iLNO) were also good acceptors (lanes 8, 9 and 10). As 
mentioned in the previous section, lactose was also an acceptor (lane 1) and 
interestingly, TbFT was able to transfer fucose to 3’-fucosyllactose (lane 13), a 
trisaccharide that already contains a fucose linked to the glucose residue. A low level of 
transfer was observed with LacNAc (Galβ1,4GlcNAc) as an acceptor (lane 3), while no 
transfer could be seen with β1,6 galactosyl-N-acetyl glucosamine (Galβ1,6GlcNAc, lane 
12). No transfer could be observed with β-Gal or β-Gal-O-Methyl either (lanes 5 and 
18). 
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Table 4.3: Name, structure and effectiveness as TbFT acceptors of the tested oligosaccharides 
 
 
Figure 4.7: TLC of the TbFT activity assays with the tested oligosaccharides. The assay was 
performed as previously described (see Materials and Methods) with a final concentration of 1 
mM for each substrate. Table 4.3 lists the identity of the acceptors used in each lane. Lanes 2, 4, 
7, 17 and 19 show the lacto-N-biose control run in each experiment.  
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4.1.7 Characterization of reaction products by acid hydrolysis and α1,2-fucosidase 
reaction 
 Biochemical characterization of the reaction products was necessary to 
demonstrate the anomeric and stereochemical specificity of TbFT. An initial 
characterization was done by acid hydrolysis and exoglycosidase reaction. 
A preparative TLC of the reactions using LNB, Lac and LacNAc as acceptors 
was run and the material corresponding to the reaction products recovered. An aliquot 
(15%) of the isolated reaction products were treated with 4 M TFA (100°C, 4 h), before 
being run on a TLC plate. After acid hydrolysis, the tritium labelled material run as a 
band with an Rf similar to an authentic Fuc standard (Figure 4.8), indicating that 
[3H]Fuc had indeed being transferred from the tritiated donor to the acceptors.  
 
Figure 4.8: Acid hydrolysis of TbFT reaction products. Labelled products, recovered from the 
activity assays, were hydrolysed in TFA. Reaction products and monosaccharide standards were 
run on the same TLC plate. The radiolabelled products were visualized by fluorography and the 
standards with orcinol/sulphuric acid. 
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Aliquots (15%) of the products recovered from the Lac and LNB reactions, were 
treated or mock treated with α-1,2-fucosidase from Xanthomonas manihotis. As shown 
in Figure 4.9, when the reaction products were treated with this specific fucosidase 
(lanes 1 and 3) and analyzed by TLC, the labelled material run as a band with an Rf 
consistent with free fucose. 
The release of tritiated material consistent with the fucose Rf after treatment with 
α-1,2-fucosidase indicates that TbFT is indeed an α-1,2-fucosyltransferase. However, 
because there is always a possibility that other exoglycosidases might be present in the 
α-1,2-fucosidase preparation, such a result should, when possible, be confirmed using 
other non-enzymatic techniques, e.g mass spectrometry and NMR. 
 
Figure 4.9: X. manihotis α-1,2-fucosidase treatment of TbFT reaction products. Tritiated 
products, recovered from the TbFT activity assays, were treated (lanes 1 and 3) or mock treated 
(lanes 2 and 4) with α-1,2-fucosidase. The radiolabelled products were visualized by 
fluorography and the standards with orcinol/sulphuric acid. 
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4.1.8 Product purification from large-scale activity assay 
 To obtain enough pure reaction product to proceed with structural analyses, a 
large-scale activity assay using LNB-O-methyl as an acceptor was performed. A sample 
(8 µg) of GST-TbFT was incubated with unlabelled GDP-Fuc and a 5 mM final 
concentration of acceptor for 24 h at 37°C. After desalting, the reaction product was 
purified from the unmodified acceptor by normal phase HPLC using an amino-bonded 
phase column, as described in the Materials and Methods section. The sugar-containing 
fractions were identified by orcinol/sulphuric acid staining and analysed by TLC 
(Figure 4.10). The fractions containing the fucosylated trisaccharide product (33 and 34) 
were pooled. The analysis of the fractions by TLC showed also that not all the acceptor 
had been consumed in the reaction and this material appeared in fractions 26-29. 
  
Figure 4.10: Purification of the TbFT reaction product by normal phase HPLC. Aliquots (2%) of 
the fractions from the normal phase purification were run on a HPTLC plate in solvent A and 
developed with orcinol/sulphuric acid. Standards for the acceptor (LNB) and for Fuc were 
analysed as well.  
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 An aliquot corresponding to 5% of the purified product was analysed for its 
neutral monosaccharide content to confirm the presence of Fuc and to quantify the 
purified material. Monosaccharide standards in known quantities (Figure 4.11, panel A) 
and the purified product were converted to trimethylsilyl methyl-glycoside derivatives 
and analysed by GC-MS, as detailed in the experimental procedures. Fuc (retention 
times, RT, 13.46 and 13.92 min), Gal (RT 17.1, 17.88 and 18.51 min) and GlcNAc (RT 
23.2 min) were present in the purified material (Figure 4.11, panel C), suggesting it was 
indeed a fucosylated LNB-O-methyl product. None of the peaks corresponding to Fuc 
could be observed when the unmodified acceptor was analysed (panel B). The 
quantification of the three monosaccharides is shown in (Table 4.4). The amount of 
product was quantified based on the Fuc calculations, resulting in a total of about 20 
nmol of purified fucosylated LNB-O-methyl. 
 
Table 4.4: Quantification of neutral monosaccharides from the purified reaction product 
 
*when more that one peak was present for a monosaccharide, the main peak was used for the 
calculations: RT 12.46 min for Fuc and 17.87 min for Gal. 
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Figure 4.11: GC-MS chromatograms of neutral monosaccharide analysis. Enlargements of 
retention times 1-24 min. Three peaks are present for galactose and two for fucose. A. 
Monosaccharide standards. B. LNB-O-methyl acceptor. C. Purified reaction product. sI: scyllo-
inositol internal standard; Rha: rhamnose; Xyl: xylose 
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4.1.9 Structural characterization of the reaction product 
 
4.1.9.1 Methylation linkage analysis 
 An aliquot (10 nmol) of the purified reaction product was analysed by 
methylation linkage analysis as detailed in Materials and Methods. As shown in Figure 
4.12, in the first step of this analysis, the free hydroxyl groups on the sugar residues 
were permethylated. Secondly, the oligosaccharide was hydrolysed, freeing the 
hydroxyl groups that were involved in the glycosidic linkages, and reduced to its 
partially methylated alditols. The newly freed hydroxyl groups were acetylated, thus 
chemically labelling the positions that were originally involved in inter-sugar linkages. 
The derivatives resulting from these chemical modifications (partially methylated 
alditol acetates, PMAAs) were run on a GC-MS. 
 
 
Figure 4.12: Methylation linkage analysis. 
 
 Analysis of the reaction products identified derivatives consistent with the 
presence of the following monosaccharides in the starting material: non-reducing 
terminal Fuc, 3-O-substituted GlcNAc and 2-O-substituted Gal (Figure 4.13, panel A, 
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C-E and Table 4.5). These results were consistent with Fuc being linked to the position 
2 of Gal and therefore TbFT being a α-1,2-fucosyltransferase.  
Interestingly, a small peak consistent with a 2-O-substituted deoxyhexose (RT 
15.9 min) could be observed in the chromatogram as well. The MS spectrum for this 
peak confirmed the expected ions for this PMAA derivative (Figure 4.13, panel B): the 
doublets at 130/131 and 174/175 m/z in particular are characteristic of a 2-O-substituted 
deoxyhexose. Deoxyhexoses are not commonly found contaminants, suggesting that a 
very small part of the product was the tetrasaccharide Fuc1,2Fuc1,2Galβ1,3GlcNAc-O-
Methyl. No peak corresponding to a terminal or substituted deoxyhexose could be 
observed when the acceptor was analysed (data not shown).  
 
Table 4.5: PMAA derivatives identified by GC-MS methylation linkage analysis 
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Figure 4.13: GC-MS methylation linkage analysis of the purified reaction product. A. 
Chromatogram showing the PMAAs obtained from the methylation linkage analysis of the 
reaction product. The peaks are annotated according to their origin in the oligosaccharide: t-
Fuc= non-reducing terminal fucose, 2-Gal= 2-O-substituted galactose, 3-GlcNAc= 3-O-
substituted N-acetylglucosamine and 2-Fuc= 2-O-substituted fucose. B-E. Electron-impact MS 
spectra for the peaks at 15.9, 18.6, 24.7 and 14.1 min, respectively. The insets in each panel 
show the fragmentation pattern from the electron-impact ionization. 
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4.1.9.2 ESI-MS/MS 
A fraction of permethylated reaction product was analysed by electrospray 
ionization mass spectrometry (ESI-MS) and tandem mass spectrometry (ESI-MS/MS). 
The material was infused directly on a QStar-XL instrument via a nanoflow probe tip 
(see Materials and Methods). An ion at m/z 692.5, consistent with being the [M + Na]+ 
ion of the permethylated TbFT reaction product with the composition 
(dHex1Hex1HexNAc1) was observed (Figure 4.14, panel A). Fragmentation of this ion 
by collision-induced dissociation gave a pattern of product ions (at m/z 433, 260 and 
504) consistent with Fuc being linked to the Gal residue (Figure 4.14, panel B). 
Although, methylation linkage analysis indicated the presence of a 
tetrasaccharide of composition dHex2Hex1HexNAc1. No ions corresponding to the 
expected [M + Na]+ or [M + H]+ species (m/z 866 and 844, respectively) could be 
observed, possibly due to the extreme low abundance of this ion species (Figure 4.14, 
panel A).  
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Figure 4.14: ESI-MS and ESI-MS/MS of the trisaccharide reaction product. A. MS-TOF of the 
purified and permethylated product. The ion at m/z 692.5 is consistent with the [M + Na]+ 
species of the trisaccharide. Some of the unmodified acceptor could still be observed (m/z 
518.4). B. MS/MS spectrum for the product ions of m/z 692.5. The fragmentation pattern 
indicated that the Fuc residue was linked to Gal. 
 
A
B
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4.1.9.3 NMR 
 The remainder of the purified TbFT reaction product (about 10 nmol) was 
exchanged in deuterated water (2H2O) and analyzed by one-dimensional 1H NMR and 
two-dimensional 1H ROESY (Rotating frame Overhouse Effect SpectroscopY).  
 1H NMR showed a doublet at about 5.1 ppm, which is consistent with the signal 
from the proton on the anomeric carbon (H1) of a α-Fuc (Figure 4.15, panel A). The 
doublet for the proton on the anomeric carbon of a β-Gal residue was also observed (4.5 
ppm). It was not possible to observe the signal for the β-GlcNAc H1 as it was probably 
obscured with the water signal. 
 In the 1H ROESY spectrum, a cross-peak (labelled a) could be observed 
indicating a through-space connectivity between the H1 of a α-Fuc and the H2 of a β-
Gal, further indicating that the TbFT reaction product is Fucα1,2Galβ1,3GlcNAcβ-O-
Me (Figure 4.15, panel B). The chemical shifts that could be clearly assigned by either 
one-dimensional 1H NMR or two-dimensional 1H ROESY are listed in Table 4.6.  
 
Table 4.6: 1H NMR and 1H ROESY chemical shift assignments of the TbFT reaction product 
 
J: coupling constant 
ND: the chemical shift could not be clearly assigned 
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Figure 4.15: 1H NMR and 1H ROESY spectra of the TbFT reaction product. The purified 
reaction product was exchanged in 2H2O by freeze-drying A. One-dimensional 1H-NMR 
spectrum. The arrow points to the α-Fuc H1 doublet. B. Enlargement of the 3.2-5.1 ppm region 
of the two-dimensional 1H ROESY. a indicates the signal for a  between α-Fuc H1 and β-Gal H2.  
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4.1.10 Optimization of GST-TbFT recombinant expression and purification for animal 
immunization 
 The recombinant expression of GST-TbFT was optimized to obtain sufficient 
material for rabbit and mouse immunizations. A small-scale expression protocol, which 
allows rapid testing of different expression conditions, was employed. The detailed 
procedure is described in the Materials and Methods section, but an overview can be 
found in Figure 4.16.  
 
 
Figure 4.16: Small scale recombinant expression trial of GST-TbFT in BL21(DE3), Tuner™ 
(DE3) and BL21 CodonPlus (DE3) RiPL E. coli strains. t= incubation time after IPTG 
induction. 
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Briefly, pGEX6P1-GST-PP-TbFT was transformed in Tuner™ (DE3) and BL21 
CodonPlus (DE3) RiPL E. coli strains. The Tuner™ strain has been optimized for 
expression at lower temperatures (16°C), while the RiPL strain carries a plasmid 
encoding for rare codons tRNAs. In TbFT 10.3% of the amino acids are encoded by 
tRNAs characterized as rare in E. coli: GGA for glycine, CUA for leucine, AUA for 
isoleucine, CCC for proline and AGG, CGG, CGA or AGA for arginine. The RiPL 
strain additional tRNAs encode for AGA, AGG, CUA, CCC and AUA, covering half of 
the rare codons in TbFT. Cultures from these two cell lines and the previously used 
BL21 (DE3) cell line were grown to an optical density (OD600) of 0.6 and then aliquoted 
in 24-well plates. One of the plates containing BL21 (DE3) cell cultures was incubated 
at 16°C, together with the Tuner™ strain plate, while the RiPL plate and the remaining 
BL21 (DE3) containing plate were incubated at 20°C. A range of IPTG concentrations 
(50-1000 µM) and four incubation time points (2, 4, 16 and 24 h) were tested. At each 
time point the cells were harvested and enzymatically lysed. After lysis, the cell lysates 
were centrifuged in 96-well plates to separate the soluble and insoluble fractions. An 
aliquot of the soluble fraction was transferred to a PCR plate and heated for 15 min at 
70°C in the presence of sample buffer. The material was then run on a 96-well SDS-
PAGE gel.   
GST-TbFT recombinant expression in the BL21 (DE3) RiPL strain with 0.1 mM 
IPTG induction and 16 h incubation seemed higher than in the previous conditions. 
These new expression conditions were re-tested on a large-scale expression and 
purification experiment, which confirmed an increased expression of GST-TbFT to 1.6 
mg/ liter of culture (Figure 4.17, panel A). The GroEL chaperonin subunit was still 
present in the elutions (Figure 4.17, panel A, lanes 3-5) and could not be removed by 
size exclusion chromatography on a Superose 12 column (Figure 4.18). However, 
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separation of the chaperonin from the majority of GST-TbFT could be obtained by 
anion exchange chromatography using a HiTrap Q HP column (Figure 4.17, panel B).  
Two chromatographic peaks, corresponding to fractions 21-27, contained the 
chaperonin-free GST-TbFT. The majority of the recombinant protein was contained in 
first of the two peaks, consisting of fractions 21-23. These fractions were pooled and 
used for the subsequent experiments.  
Cleavage of the GST tag from the recombinantly expressed TbFT was attempted 
before and after the anion exchange purification step. The tagged recombinant protein 
was incubated with a GST-tagged version of PreScission™ protease and Sepharose 
Glutathione beads, in this way the untagged TbFT should be found in the supernatant 
while the cleaved GST and the GST-tagged protease should remain bound to the beads. 
Three time points (16, 24 and 40 h) were tested and complete cleavage could not be 
observed even after 40 h of incubation. Furthermore, the untagged TbFT seemed to have 
a reduced solubility and was mostly found with the beads after separation of the 
supernatant by centrifugation (data not shown). Alternatively, if GST-TbFT was a 
dimer, the recombinant protein would be bound to the beads by two GST tags and the 
probability of cleaving two tags is quite low, resulting in most of the protein still found 
in the beads after PreScission™ protease incubation. Due to the unsuccessful GST-tag 
cleavage, the still tagged GST-TbFT was sent for immunization in rabbit and mouse. 
The final purified material sent for immunization is shown in Figure 4.19, panel A.  
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Figure 4.17: Optimization of expression and purification of GST-TbFT. A. Recombinant 
expression in BL21CodonPlus (DE3) RiPL E.coli strain increased the yield to 1.6 mg/liter of 
culture. Lane 1: Molecular weights markers, Lane 2: flow-through from the affinity purification, 
Lane 3: washing step, Lanes 4-6: GST-TbFT elutions in 50 mM TrisHCl, 150 mM NaCl, 10 
mM GSH pH 8. B. Anion exchange (AEX) chromatography was used to separate the GST-
TbFT from the co-eluting GroEL chaperonin subunit. The top half of the panel shows the 
chromatogram for the anion exchange chromatography (AEX; A280) with the fractions marked 
in red. The bottom half shows the SDS-PAGE for fractions 18 and 20-30. 
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Recombinant GST-TbFT was also analyzed by size exclusion chromatography 
on a Superose 12 column to study the protein quaternary structure. Comparison of the 
chromatographic profiles of GST-TbFT (predicted molecular weight 58 kDa), BSA (67 
kDa) and aldolase (158 KDa) suggested the recombinant TbFT to be assembled in an 
oligomer (Figure 4.18, panel A). When fractions 7-15 (panel A) from the GST-TbFT 
size exclusion chromatography were analysed by SDS-PAGE, fractions 8 and 9 
presented two bands: a more abundant band consistent with the recombinant GST-TbFT 
and a slightly higher molecular weight band consistent with the GroEL chaperonin 
subunit (panel B), suggesting that the elution of the correctly folded GST-TbFT started 
at fraction 10. This shifted elution profile is still consistent with GST-TbFT being 
assembled in an oligomer.  
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Figure 4.18: Analysis by size exclusion chromatography of recombinant GST-TbFT.  The 
protein was expressed in BL21 CodonPlus (DE3) RiPL E.coli strain and purified by affinity 
chromatography before being loaded on a Superose 12 gel filtration column run in 20 mM 
HEPES, 0.15 M NaCl pH 7.2. A. Comparison of the chromatographic profiles of GST-TbFT 
and BSA. B. Fractions 7-15 were analyzed by SDS-PAGE to show the presence of recombinant 
GST-TbFT. Fractions 8-10 present also a band consistent with the GroEL chaperonin subunit. 
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4.1.11 Generation of antibodies against recombinant GST-TbFT  
 The sera obtained from one rabbit and two mice immunized with GST-TbFT 
were tested against the recombinant protein itself. A band of about 57 kDa, 
corresponding to GST-TbFT was recognized by both sera, however there was also 
recognition of the free GST band at 25 kDa (Figure 4.19, panel B). This result 
suggested that a fraction of the IgG in the sera were specifically recognizing GST. To 
remove this IgG portion, GST was covalently bound to CNBr-activated sepharose beads 
as described in the experimental procedures. Aliquots from both rabbit and mouse sera 
where then incubated with the GST-agarose beads to be depleted of their GST-specific 
IgG fractions. The depleted sera were tested against GST-TbFT and another GST-
tagged protein (GPI12-GST) as a positive control for GST recognition. As shown in 
Figure 4.19, panel B for the rabbit serum, the depleted sera have lost their recognition of 
free GST or GPI12-GST (lanes 7-8), while there is still some recognition, albeit low, of 
GST-TbFT (lane 5).  The low-level recognition of GST-TbFT suggests that the titer of 
these sera against TbFT is very low. 
 
4. RESULTS - CHAPTER I  
 
108 
 
Figure 4.19: Generation of antibodies against GST-TbFT. A. GST-TbFT was expressed in BL21 
CodonPlus (DE3) RiPL E. coli strain, purified by affinity chromatography followed by anion 
exchange chromatography on a HiTrap Q HP column. The recombinant still tagged protein was 
dialyzed in 1x PBS and concentrated to 1 mg/ml (lane 2), before being sent for rabbit and 
mouse immunization. Lane 1: molecular weight markers B-C. Anti-GST-TbFT rabbit serum 
(panel B) and mouse serum (panel C) were tested against 50 ng of GST-TbFT (lanes 1 and 5), 
50 ng of BSA (lanes 2 and 6) and 25 or 50 ng GPI12-GST (lanes 3 and 7, 4 and 8 respectively) 
before and after depletion of the GST-specific IgG fraction. The sera were used at a 1:500 
dilution. 
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4.2 Generation of TbFT conditional null mutants and analysis of their phenotype 
 
4.2.1 Constructs for the replacement of TbFT alleles 
 The bloodstream form T. brucei 427 strain has been genetically modified to 
express a T7 polymerase and a tetracycline repressor protein (TetR) under neomycin 
selection (single marker cell line, sm). The same modifications have been carried out in 
a procyclic form strain, generating the double marker (dm) cell line, so called because 
the selective pressure is maintained by two markers: neomycin and hygromycin (Wirtz 
et al., 1999). These two modified strains are amenable to the generation of null and 
conditional null mutants by gene replacement. Different antibiotic markers can be used 
to replace the alleles of the gene of interest by homologous recombination (Figure 4.20). 
Antibiotic resistance cassettes for puromycin (PAC) and hygromycin (HYG) are 
generally used to replace alleles in bloodstream form T. brucei. Because of the presence 
of the HYG marker in the procyclic form dm cell line, the gene conferring resistance to 
blastacidine (BSD) is used instead of HYG. To create a conditional null mutant, an 
ectopic copy of the gene of interest is inserted after replacement of the first allele. The 
pLew100 plasmid allows the insertion of a gene copy in the rDNA locus under the 
control of a tetracycline inducible promoter. The promoter used in this plasmid is the 
procyclin (or PARP) promoter (Wirtz et al., 1999). The phleomycin marker in the 
pLew100 plasmid allows for selection after electroporation.  
The strategy used to create the gene replacement constructs for TbFT is 
described in Figure 4.21. Briefly, about 500bp of the 5’ and 3’ untranslated regions 
(UTRs) of TbFT were amplified by PCR. Primers 5F and 5R were used to amplify the 
5’UTR and to insert NotI and HindIII restriction sites, respectively.  The 3’UTR was 
amplified using primers 3F and 3R to contain a BamHI site and a NotI site at its 5’ and 
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3’ respectively. The UTRs were joined together by PCR, using primers 5F and 3R, and 
cloned in the pGEM5Zf vector via the NotI restriction sites (pGEM5Zf-jUTRs). 
 
Figure 4.20: TbFT gene replacement strategy in bloodstream and procyclic forms T. brucei. The 
first allele is replaced by homologous recombination using a selection marker of choice (HYG 
or PAC). An ectopic copy of the gene of interest is inserted in the rDNA locus under the control 
of a tetracycline-inducible version of the procyclin promoter. After activation of the ectopic 
copy expression, the second allele is replaced by PAC, HYG or BSD. 
   
 Sequencing of the joined UTRs confirmed the presence of a BamHI restriction 
site in the 5’UTR. The site was mutated using a quick mutagenesis kit (see Materials 
and Methods) before proceeding to the next step. The antibiotic resistance cassettes 
were then ligated into the UTRs, following BamHI/HindIII digestion of the pGEM5Zf-
jUTRs. Lastly, the DNA fragments containing the UTRs and the resistance cassette 
were released from the vector by NotI digestion to be ready for electroporation. 
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Figure 4.21: Strategy for the generation of TbFT gene replacement constructs.  
 
4.2.2 Attempts to generate TbFT conditional null mutants in bloodstream form T. brucei 
 Despite many attempts, it was not possible to replace the first TbFT allele with 
either HYG or PAC as selection markers in bloodstream form T. brucei. In one 
experiment, cells survived the electroporation and initial selection, but it was not 
possible to establish a culture. The possibility of a mistake in the constructs seems 
unlikely, given that the same PAC construct was used to successfully generate the single 
knockout in procyclic form (see Section 4.2.3). Another possible explanation is haploid 
insufficiency; i.e. that the protein levels ensured by the remaining allele are not 
sufficient to sustain proper growth. If this is the case, it should be possible to replace the 
first allele after insertion of the TbFT ectopic copy in the sm cell line. Indeed, 
replacement of the first TbFT allele with HYG was possible after insertion and induction 
of the ectopic copy expression (data not shown).  
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Unfortunately, all attempts to replace the second allele failed. Cells were 
recovered from the electroporation, but genotypic analysis revealed that the resistance 
cassette was inserted in the wrong locus (data not shown). An alternative construct, 
based on a modified version of pLew82 and containing an ectopic T7 promoter driving 
PAC expression, was generated (Figure 4.22) in case the difficulty in replacing the 
second allele was due to low expression of the resistance cassette by the TbFT 
endogenous promoter (Wirtz et al., 1999). Such a problem had been previously 
observed with the generation of the bloodstream form GDP-fucose biosynthesis null 
mutants (Turnock et al., 2007). However, also in this case, replacement of the final 
allele was unsuccessful. As observed with the original PAC construct, puromycin 
resistant cells were obtained but the resistance cassette was inserted in the wrong locus.  
 
 
Figure 4.22: Alternative construct for the replacement of TbFT second allele in bloodstream 
form. This new PAC resistance cassette contained an ectopic T7 promoter and two T7 
terminators at the 5’ and 3’ of the PAC ORF, respectively. The TbFT 5’ and 3’ UTRs remained 
the same as in the previous constructs. 
 
4.2.3 Generation of TbFT conditional null mutants in procyclic form T. brucei 
 The first TbFT allele was replaced with the puromycin resistance cassette (single 
knockout), followed by insertion of the ectopic TbFT copy in the rDNA locus using the 
plew100 vector. After induction of ectopic TbFT expression, the second allele was 
replaced with BSD. The electroporation efficiency was quite low for procyclic form, 
with resistant cells growing in only one out of 168 wells obtained from two 
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transfections in which a total of 1.6x108 cells were used (Burkard et al., 2007). For this 
reason, we assumed that the recovered resistant cells were already clonal. Analysis of 
the genotype of the recovered cells by Southern blot showed the disappearance of the 
band corresponding to the genomic copies of TbFT and confirmed the presence of the 
ectopic copy and of the antibiotic resistance cassettes in the correct loci (Figure 4.23). 
The predicted restriction pattern shown in the figure below accounts only for the gDNA 
locus. Additional bands for the TbFT ectopic copy were present at about 5.8 kb and 6.5 
kb for NcoI and AccI digestions, respectively. 
 
 
Figure 4.23: (next page) Generation of the TbFT conditional null mutants in procyclic form. 
gDNA  (5 µg/lane) was extracted from dm (wt), single knockout (sKO), single knockout 
containing the ectopic copy (sKO + ectopic copy) and conditional null mutant (cKO) cells, 
digested with NcoI or AccI endonucleases and blotted. The blot was sequentially probed with 
TbFT (A), BSD (B) and PAC (C) ORFs. A. Bands corresponding to the ectopic copy of TbFT are 
marked by a green box. B. The two additional bands present in this blot, corresponding to the 
BSD ORF, are identified by a blue box.  C. The black boxes drawn in the sKO, sKO + ectopic 
copy and cKO lanes mark the bands representing the PAC ORF. 
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Figure 4.23 
 
 
 
 
 
 
cKO            
sKO + ectopic
copy sKO wt
AccI   NcoI AccI   NcoI AccI   NcoI AccI   NcoI
cKO            
sKO + ectopic
copy sKO wt
AccI   NcoI AccI   NcoI AccI   NcoI AccI   NcoI
cKO            
sKO + ectopic
copy sKO wt
AccI   NcoI AccI   NcoI AccI   NcoI AccI   NcoI
TbFT
NcoI NcoI
AccI AccI
3.5 kb
4.2 kb
PAC
NcoI NcoI
AccI AccI
3.2 kb
3.9 kb
BSD
NcoI NcoI
AccI AccI
3 kb
3.7 kb
3
4
2.5
6
kb
3
4
2.5
6
kb
3
4
2.5
6
kb
probe
ectopic TbFT
BSD
PAC
PAC
A
B
C
4. RESULTS - CHAPTER I  
 
115 
4.2.4 The phenotype of TbFT conditional null mutants 
 TbFT was found to be essential for the growth of procyclic form T. brucei in 
vitro (Figure 4.24, panel A). The TbFT conditional null mutant cell line (cKO) was 
grown in the presence or absence of tetracycline, together with the GMD conditional 
null mutant cell line (Turnock et al., 2007). TbFT cKO cells grown in non-permissive 
conditions showed a clear reduction in the rate of cell growth after 7 days in media 
without tetracycline, eventually dying after 15 days. This phenotype is similar to the 
growth defect observed in the GMD conditional null mutants (Figure 4.24, panel B).  
The highly comparable growth phenotype is consistent with the hypothesis that TbFT is 
the only downstream user of GDP-Fuc or at least the one that is transferring fucose to 
its essential acceptor(s). 
From a morphological point of view, TbFT and GMD conditional null mutant 
cells grown in non-permissive conditions showed an increase in the average cell volume 
concomitant with the start of the cell growth phenotype (Figure 4.25, panel A). More 
precisely, the cells were getting longer, not larger or rounder (panel B). Such an 
increase in cell volume could not be observed in the cells grown in the presence of 
tetracycline. 
 
 
Figure 4.24: (next page) TbFT is essential for procyclic form cell growth in vitro. TbFT and 
GMD conditional null mutants were grown in parallel. Cell numbers were counted in biological 
duplicates every 24 h and cells were split when required. A. Growth curve for TbFT cKO cells 
grown in permissive (green) or non-permissive (orange) conditions. B. Growth curve for GMD 
cKO cells grown in permissive (red) or non-permissive (blue) conditions. C. Comparison 
between the TbFT (orange) and GMD (blue) conditional null mutants grown in non-permissive 
conditions. 
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Figure 4.25: Comparison of the average cell volume and the morphology of TbFT and GMD 
conditional null mutants. A. The average cell volume was measured using a Casy cell counter 
from day 10 to 13 for both cell lines grown in permissive (plus) or non-permissive (minus) 
conditions. B. Still images from time lapse microscopy analysis of TbFT and GMD conditional 
null mutants grown in presence or absence of tetracycline for 11 days. The analysis was 
performed on a Nikon Eclipse Ti microscope in phase contrast mode. A 25x objective was used 
and the cells were recorded for 5 min at 4 frames/s.   
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(Figure 4.25, continued) 
 
 
 
4.2.5 Evaluation of flagellar attachment 
 Analysis of the procyclic form GMD conditional null mutant by scanning 
electron microscopy (SEM) had identified a phenotype of flagellar detachment 
(Turnock et al., 2007). To further analyse the similarity in the phenotypes of GMD and 
TbFT conditional null mutants, flagellar attachement was evaluated in these two cell 
lines using different techniques, i.e. motility analysis and immunofluorescence. No 
defect in flagellar attachment in the TbFT conditional null mutants could be observed, 
nor surprisingly in the GMD cKO cell line (Figures 4.26-4.28). 
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Figure 4.26: Estimation of cells with detached flagella or stuck during cytokenesis. Biological 
duplicates were counted for each cell line. For each replicate, 200 cells were counted using a 
haemocytometer at an inverted light microscope. Orange: dm; Purple: GMD cKO; Blue: TbFT 
cKO 
 
At first, the percentages of cells presenting flagellar detachment or stuck during 
cytokinesis were evaluated at the inverted light microscope. A fraction corresponding to 
0.5-2% of the observed cells presented flagellar detachment (Figure 4.26, panel A) in 
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both TbFT and GMD conditional null mutant cell lines grown in non-permissive 
conditions. However, this percentage is consistent with the expected fraction of cells 
presenting flagellar detachment in the wild type (LaCount et al., 2002). The percentage 
of cells stuck during cytokinesis was higher (up to 20%) and statistically significant 
when compared to the same mutant cell line grown in permissive conditions (panel B). 
However, it was not always significant when compared to the percentage of cells stuck 
during cytokinesis in a dm cell culture that showed signs of stress (orange columns).  
 
4.2.5.1 Motility analysis 
Another consequence of defects in flagellar attachment is a reduction in cell 
motility. The motility of a culture can be evaluated by sedimentation assay, as a 
reduction in motility will cause cells to sediment faster and therefore the optical density 
(OD600) of the culture to diminish over time (Bastin et al., 1999). 
As shown in Figure 4.27, a reduction in motility could indeed be observed in the 
TbFT and GMD conditional null mutants, grown in non-permissive conditions, from 
day 10 onwards (panel B). However, this diminished motility could be observed only 
after the start of the growth phenotype, not before. This suggests that the reduction in 
motility may be an effect of the growth defect and not its cause, as would be expected in 
a true flagellar attachment mutant (Bastin et al., 1999; Demonchy et al., 2009). 
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Figure 4.27: Sedimentation assay. The GMD cKO is marked in blue while TbFT cKO is marked 
in purple. Cultures grown in non-permissive conditions are marked with dashed lines. A. 
Growth curve from day 6 to 13 of the cultures used in the sedimentation assay. B. 
Sedimentation assays from day 8 to 13. 5x106 cells in media were incubated in polystyrene 
cuvettes in a spectrophotometer maintained at 28°C. OD600 was measured every 30 min.  
 
 
 
 
 
 
 
 
A
B
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4.2.5.2 Immunofluorescence 
 Antibodies against components of the T. brucei flagellum and the flagellar 
attachement zone (FAZ) are available (Kohl et al., 1999). Anti-paraflagellar rod (PFR) 
and anti-FAZ monoclonal antibodies were used to further confirm the absence of an 
overt flagellar phenotype in TbFT and GMD conditional null mutants.   
Cells were fixed on coverslips, permeabilized and stained as described in the 
experimental procedures. No sign of flagellar detachment could be observed in both 
TbFT (Figure 4.28) and GMD (data not shown) conditional null mutants: the PFR run 
parallel to the FAZ along the bodies of the cells analyzed, while the FAZ itself was well 
stained and did not present any interruptions (refer to Figure 1.2, panel B for a 
schematic representation of T. brucei flagellar components).  
From all these analyses we concluded that no clear defect in flagellar attachment 
is evident in either TbFT or GMD conditional null mutants. The previously described 
detachment phenotype in the GMD cKO cell line (Turnock et al., 2007) might be an 
artefact of the SEM or an indication that the flagellum attachment to the cell body is 
more fragile than normal in this mutant. A corrigendum to Turnock et al., 2007 will be 
sent to the journal. 
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Figure 4.28: The paraflagellar rod (PFR) and flagellar attachment zone (FAZ) appear normal in 
TbFT conditional null mutant. TbFT cKO cells were grown in permissive (+tet) or non-
permissive (-tet) conditions and harvested at days 10 and 13. They were fixed, permeabilized 
and stained as described in the Materials and Methods. The antibodies were used at the 
following dilutions: anti-FAZ 1:2, anti-PFR 1:10. 
  
 
 
 
4. RESULTS - CHAPTER I  
 
124 
4.2.6 Biochemical characterization of TbFT conditional null mutant 
 The fucose-containing high molecular weight glycoconjugate complex (Guther 
et al., 2009) was analysed in the TbFT conditional null mutant. Cells were grown in 
permissive and non-permissive conditions and at day 10 the galactose-containing 
glycoconjugates on the surface were labelled with galactose oxidase/NaB[3H]4. In the 
first step of this labelling procedure, galactose oxidase oxidises the hydroxyl groups on 
the C-6 position of non-reducing terminal galactose or internal 1,2-linked galactose 
residues to their corresponding aldehydes, with the reduction of molecular oxygen to 
hydrogen peroxide. This step is followed by the sodium borotritiide reduction of the 
aldehydes to the original galactose residues, now radiolabelled with [3H] at the C-6 
position (Gahmberg & Tolvanen, 1994; Goudsmit et al., 1984). Briefly, cells that had 
been pre-reduced with NaBH4 and pre-treated with Clostridium perfringens 
neuraminidase were incubated with or without galactose oxidase (from Dactylium 
dendroides) in media lacking fetal bovine serum at 37°C for 30 min. After washing, the 
cells were incubated with NaB[3H]4 for 30 min at 28°C. The labelled cells were then 
washed and extracted in buffer containing 2% SDS, 8 M urea and 0.1 M DTT. An 
aliquot (about 20 %) was analyzed directly by SDS-PAGE while the remaining material 
was analyzed by lectin purification using ricin (specific for non-reducing terminal 
galactose) or Aleuria aurentia (AAL, fucose-specific). 
 The first noticeable difference was a reduction in the total galactose 
oxidase/NaB[3H]4 labelled material in the TbFT conditional null mutant (Figure 4.29, 
lanes 3 and 4 and Table 4.7) when compared to the wild type (lane 1). This reduction in 
labelling was already present in the mutant grown in permissive conditions (lane 3), but 
it was slightly more marked when the cells were grown in the absence of tetracycline 
(lane 4). The labelled ricin-purified material was also reduced in the mutant cell lines 
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grown in either permissive or non-permissive conditions when compared to wild type 
procyclic form cells (Table 4.7). 
 The second observed difference was in the binding to the fucose-specific AAL. 
A slight increase in material purified with this lectin could be observed in the TbFT 
conditional null mutant grown in permissive conditions (Table 4.7). On the other hand, 
the binding to AAL was almost completely abolished in the mutant grown in non-
permissive conditions. This last result suggests that the transfer of fucose to the high-
molecular weight glycoconjugate complex has indeed been inhibited in the TbFT 
conditional null mutant. 
 
 
Table 4.7: Counts per minute of incorporated [3H] in the labelled material 
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Figure 4.29: Galactose oxidase/NaB[3H]4 labelling of the high molecular weight glycoconjugate 
complex. Procyclic form dm (wt, lanes 1 and 2) and TbFT conditional null mutant cells (TbFT 
cKO) grown in permissive (lanes 3 and 5) or non-permissive (lanes 4 and 6) conditions were 
labelled and processed as described in the Materials and Methods. Negative controls in which 
the cells were not treated with galactose oxidase prior reduction with NaB[3H]4 were run for 
each cell line (lanes 2, 5 and 6). The radiolabelled material was detected by fluorography. 
GalOx: galactose oxidase  
 
 
$PPNBTTJF
           
4. RESULTS - CHAPTER I  
 
127 
4.3 Searches for Trypanosoma brucei fucosylated glycoconjugates 
 
4.3.1 Fucose-specific lectins 
 Two fucose-specific lectins were tested against T. brucei cell lysates: Ulex 
europaeus agglutinin I (UEA I), which has been described as specific α1,2-linked 
fucose, and Aleuria aurantia lectin (AAL), which has higher specificity towards α1,6- 
and α1,3-linked fucose residues. The details of the experiments performed with these 
two lectins and the results obtained are described in the Appendix.  
Evidence of specific binding could be obtained with UEA I against the cell 
lysate of procyclic form T. brucei, as it was possible to inhibit binding almost 
completely by preincubating the lectin with methyl-α-L-fucopyranoside. However, there 
were difficulties in reproducing the binding pattern in different experiments (Figure A1) 
and some of the bands recognized by the UEA I suggested the presence of some 
unspecific binding as they corresponded to abundant cell lysate proteins (Figure A1).  
Using AAL in lectin purification experiments it was possible to bind and 
specifically elute a fraction of the high molecular weight glycoconjugate complex 
(Figure A2). 
 
4.3.2 Galectin-2 
 The information obtained from the biochemical characterization of TbFT as an 
α1,2-FT was used in the search for better reagents to identify the fucosylated 
component(s) of the high molecular weight glycoconjugate. Knowing from substrate 
specificity studies that Galβ1,3GlcNAc was a very likely substrate for this 
fucosyltransferase, we searched the glycan array database created by the Consortium for 
Functional Glycomics (www.functionalglycomics.org) for glycan binding proteins that 
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presented high affinity  to Fucα1,2Galβ1,3GlcNAc. The highest-ranking proteins were 
the already utilized Aleuria aurantia lectin and members of the human galectin family, 
galectin-2 in particular.  Galectins are a family of β-galactoside-binding proteins found 
in all metazoans examined so far. They have been localized intracellularly, in the 
plasma membrane and in the extracellular matrix. In addition, human galectins have 
been implicated in various roles in the regulation of immune and inflammatory 
responses (Varki et al., 2009).  
 Recombinant human Galectin-2 (hGal-2) and an antibody raised against it are 
commercially available and were used for Western blots and immunoprecipitation 
experiments with procyclic form and bloodstream form T. brucei cell lysates. Briefly, 
2x107 cells were washed and lysed in buffer containing 2% SDS and 0.1 M DTT. The 
cell lysate was then treated or mock treated with recombinant PNGaseF at 37°C for 16 
h, before the material was resolved by SDS-PAGE and blotted on nitrocellulose. The 
Ponceau staining in Figure 4.30, panel B, shows VSG and the reduction in its molecular 
weight (lanes 1 and 3) after successful treatment with PNGaseF. In the case of procyclic 
form (Figure 4.30, panel A), two bands at about 190 and 120 kDa could be observed 
with or without treatment with PNGaseF (lanes 1 and 2). Recognition seemed specific 
only for the 190 kDa band, as it was not possible to inhibit binding to the 120 kDa band 
when the galectin was pre-incubated with specific sugar inhibitors (lanes 3 and 4). In 
the case of bloodstream form cell lysate (panel B), only unspecific recognition of low 
molecular weight bands could be observed, as shown by the lack of inhibition when the 
blot was performed in the presence of the sugar inhibitors (lanes 3 and 4). Bloodstream 
form T. brucei contains endogenous low molecular weight biotinylated proteins and 
because blot detection was carried out by chemiluminescence, using horseradish 
peroxidase-labelled ExtraAvidin to recognize the biotinylated anti-galectin-2, it is 
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possible that these biotinylated proteins could be responsible for the unspecific binding 
observed with single marker cell lysate (panel B, all lanes). 
This lack of specific binding in Western blot analysis in bloodstream form might 
be due to low abundance of the fucosylated glycoconjugate(s). However, it was not 
possible to verify this hypothesis by immunoprecipitation experiments with hGal-2 or to 
further investigate the 190 kDa band present in procyclic form, as the anti-galectin-2 
antibody was not working in this application. 
 
 
Figure 4.30: Western blot analysis of procyclic form and bloodstream form T. brucei with 
human Galectin-2. A. Double marker procyclic form. B. Single marker bloodstream form. Cell 
lysate (2x107 cells/lane) was treated (lanes 1 and 3) or mock treated (lanes 2 and 4) with 
PNGaseF before being resolved by SDS-PAGE and blotted on nitrocellulose. The membranes 
were stained with Ponceau before blocking to verify equal loading. In panel B, the Ponceau 
staining shows the reduction in the molecular weight of VSG after PNGaseF treatment. Reagent 
dilutions: hGal-2: 1: 500, biotinylated anti-hGal-2: 1:500, ExtraAvidin-HRP:  1:100000. 
Lactose (Lac) and galatose (Gal) at 30 mg/ml were used to inhibit hGal-2 binding (lanes 3 and 4 
in both panels).  
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 More precisely, it was possible to bind and recover the antibody using 
StreptAvidin or protein G conjugated Dynabeads, but no hGal-2 was recovered in these 
experiments, even in the controls where no cell lysate was added to the reaction, 
indicating that the problem was in the immunoprecipitation of the human galectin-2 by 
the antibody. The experiment conditions were varied by changing the detergents used 
and by reducing detergent and salt concentrations in the search for more permissive 
immunoprecipitation conditions, however these trials were unsuccessful (data not 
shown). This problem could be solved by expressing and purifying our own hGal-2, 
coupled to a tag, so that the immunoprecipitation would be independent from the anti-
hGal-2 antibody (see Discussion). 
  
4.3.3 ESI-MS analysis of the total N-glycan fraction from procyclic form T. brucei 
  A more analytical approach was used to try to identify the fucose-containing 
glycan(s) looking at the whole N-glycan fraction recovered from double marker 
procyclic form cells.  Briefly, 109 cells were lysed in hypotonic conditions and the lipid 
fraction was extracted using chloroform:methanol:water (10:10:3 v:v:v). The extracted 
lipids were saved, while the insoluble material was resuspended in PBS and treated with 
Pronase for 64 h at 37°C. The soluble, Pronase-digested peptides were treated with 
PNGaseF for 20 h at 37°C and the released N-glycans were permethylated before being 
analysed by ESI-MS on an Agilent QTOF instrument.  
 Oligomannose N-glycans have been previously described in procyclic form T. 
brucei (Treumann et al., 1997; Hwa et al., 1999; Hwa and Khoo, 2000) and a series of 
ions consistent with permethylated oligosaccharides ranging from Hex5HexNAc2 to 
Hex9HexNAc2 could be identified in this analysis of the total N-glycan fraction (Figure 
4.31). An inclusion list for these permethylated glycans is presented in Table 4.8 with 
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the detected ions marked in red. These species were seen mostly as [M + 2Na]2+ ions, 
with Hex5HexNAc2 present also as a [M + Na]+ ion. Smaller secondary peaks were 
observed for all these ions and the Δ between each peak was 14 Da, suggesting they 
were probably due to undermethylation of the isolated N-glycan fraction (Figure 4.31). 
The identification of the ions with m/z consistent with the expected 
oligomannose N-glycans suggested that the protocol was successful in isolating these 
structures. However no other N-glycans, fucosylated or not, could be identified with this 
approach. 
 
Table 4.8: Inclusion list for the permethylated oligomannose series 
 
 
 
 
Figure 4.31: ESI-MS of the total N-glycan fraction from procyclic form T. brucei. MS-TOF of 
the m/z from 850 to 1700. A graphic representation of the corresponding putative oligomannose 
structures is given above each underlined m/z ion (= Man, = GlcNAc). 
 
 
4.3.4 ESI-MS and MALDI-TOF analysis of the total β-eliminated fraction from 
procyclic form T. brucei 
[M+2Na]2+
[M+2Na]2+
[M+2Na]2+
[M+Na]+
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  The total β-eliminated fraction from procyclic form T. brucei was also analyzed 
to look for the possibility of fucosylated O-glycans. Briefly, 8x109 cells equivalent from 
the dm cell line were extracted in chloroform:methanol:water (10:10:3 v:v:v) to remove 
the lipid fraction. The insoluble material was treated with RNaseA and DNaseI at 37°C 
for 1 h to remove the nucleic acids and the remaining proteinaceous material was 
ethanol precipitated. The pellet obtained from the precipitation was subjected to β-
elimination for 16 h at 60°C using 0.5 M NaOH and 1 M NaB[2H]4. After neutralization 
of the reducing agent, the material was desalted, permethylated and analyzed both by 
ESI-MS (QSTAR XL and Agilent QTOF) and MALDI-TOF (Voyager-DE STR). 
 No clear signal for ions consistent with the masses of permethylated glycans 
could be identified. The signal to noise ratio observed at the mass spectrometers was 
very low, suggesting that the sample preparations might have presented quite a few 
contaminants. This result does not clearly answer the question of the presence of 
glycans sensitive to β-elimination in T. brucei.  To further test this hypothesis, this 
protocol needs to be improved, e.g. spiking the preparation with mucins as a positive 
control or alternatively a different methodology should be applied (see Discussion). It is 
also worth noting that O-glycans have not yet been described in T. brucei.  
 
4.3.5 In vivo labelling of procyclic form surface glycans with recombinant TbFT and 
GDP-[3H]Fuc  
 The recombinant GST-TbFT and GDP-[3H]Fuc were used to investigate if it was 
possible to identify T. brucei fucosyltransferase physiological acceptors by labelling in 
vivo the surface of procyclic form cells. The GPI12 null mutant was used in this 
experiment. This cell line is deficient in GPI-anchor biosynthesis, so that its surface coat 
does not contain procyclin and free GPI glycolipids and presents only the high 
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molecular weight glycoconjugate complex (Guther et al., 2009). Briefly, 4x107 cells 
were washed in medium without fetal bovine serum to remove any source of sialic acid 
and then treated with X. manihotis α-1,2-fucosidase. After additional washes to remove 
the exoglycosidase, the cells were incubated for 30 min at 28°C in phosphate buffer 
saline containing GDP-[3H]Fuc with or without GST-TbFT (4 µg) and in the presence 
or absence of ATP to try to inhibit any unspecific sugar nucleotide/nucleotide hydrolase 
activity. The cells were then lysed in SDS-PAGE sample buffer containing also 8 M 
urea and 0.1 M DTT and resolved on a gradient gel. Detection by fluorography 
indicated that no tritiated material had been incorporated on the cell surface. It seems 
unlikely that this result is due to inactivity of the recombinant GST-TbFT, as the 
enzyme preparation used in the labelling was active when tested in the in vitro activity 
assay using LNB-O-methyl as acceptor, both in the normal activity buffer and in PBS 
(data not shown). 
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5. T. BRUCEI PHOSPHOMANNOMUTASE (TbPMM) 
 
5.1 Identification of putative T. brucei phosphomannomutase gene 
 In Turnock and Ferguson, Saccharomyces cerevisiae phosphomannomutase 
(NCBI accession no: NP116609) had been used as a template for a BLASTp search of 
T. brucei predicted proteins. Tb10.70.0370 was identified as a putative TbPMM and 
putative phosphomannomutase genes were also found in the L. major (Gene DB ID: 
LmjF36.1960) and T. cruzi (Gene DB ID: Tc00.1047053510187) genomes. 
Furthermore, L. mexicana PMM has been structurally characterized (Kedzierski et. al., 
2006). TbPMM belongs to the eukaryotic phosphomannomutase family and showed 
57% sequence identity to its S. cerevisiae homologue (Figure 5.1, panel A). 
Interestingly, eukaryotic PMMs do not belong to the α-D-phosphohexomutase 
superfamily, like their bacterial counterparts and the eukaryotic phospho-N-
acetylglucosamine mutases and phosphoglucomutases, but are members of the haloacid 
dehydrogenase (HAD) superfamily of phosphotransferases.  This superfamily is 
characterized by a conserved DVDGT motif (motif I, aa 9-13), localized at the protein 
N-terminus. The first Asp of this motif (D9) is generally phosphorylated during the 
catalytic cycle. TbPMM, like the other eukaryotic PMMs, belongs to the type II class of 
this superfamily (Silvaggi et al., 2006; Kedzierski et al., 2006). This could be 
determined by the location of the cap domain, which in this class is found between 
motif II and III. The position of the cap domain (aa 85-183) between these two motifs 
could be observed in the amino acid sequence of this protein (Figure 5.1, panel A). The 
cap domain contains the residues involved in substrate recognition, so that the active 
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site is located in the groove at the interface of the core and cap domains (Kedzierski et 
al., 2006; Silvaggi et al., 2006).  
 
Figure 5.1: Identification and recombinant expression of TbPMM. A. Sequences from 
protozoans (T. brucei, T. cruzi and L. major), yeasts (S. cerevisiae and Candida albicans) and 
mammals (Homo sapiens PMM1) were used for the alignment. Residues conserved between all 
proteins are highlighted in dark grey. The four conserved motifs are indicated by black boxes, 
while the arrow points to the Asp residue phosphorylated during the reaction. B. His6-tagged 
TbPMM was overexpressed in E.coli and purified by nickel column chromatography (lane A) 
followed by gel filtration (lane B). The tag was removed by incubation with TEV protease (lane 
C).  
"
#
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5.2 Recombinant TbPMM is active in vitro 
In previous work carried out by a summer student in our lab, Shamshad Afzal, 
the TbPMM ORF was amplified by PCR from gDNA obtained from T. brucei strain 
427, cloned in an expression vector containing an N-terminal His6-tag and sent to the 
Structural Genomic Consortium (SGC, Toronto, Canada). At the SGC, conditions were 
identified for expression and purification of recombinant TbPMM from E. coli. Briefly, 
TbPMM was expressed in E.coli BL21(DE3) strain and purified by nickel column 
chromatography. The recombinant protein was further purified by size exclusion 
chromatography, before removing the His6-tag by incubation with TEV protease. The 
resulting recombinant untagged TbPMM (Figure 5.1, panel B) was used for activity 
assays. 
 
Figure 5.2: TbPMM could convert Man-1-P to Man-6-P. Recombinant TbPMM (50 ng) was 
incubated with 700 µM Man-1-P and 1 µM Glc-1,6-biphosphate as co-factor. The product of the 
reaction was analyzed by HPAEC-PAD (retention time 5-19 min shown). A peak corresponding 
to Man-6-P was observed in the presence of the recombinant enzyme but not in its absence.  
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An HPAEC-PAD system was used to assay the activity of the recombinant 
TbPMM, as described in the Material and Methods. TbPMM was able to convert Man-
1-P to Man-6-P in the presence of glucose-1,6-biphosphate, as a co-factor.  No Man-6-P 
could be detected when the TbPMM was removed from the reaction (Figure 5.2). The 
co-factor is not observed in Figure 5.2 as it elutes with a retention time around 24 min. 
The pH dependency of the enzyme was also studied over the pH range 5.0 to 10.0. The 
enzyme showed activity between pH 6.0 and 8.0 with an optimum at about pH 6.5 
(Figure 5.3). 
   
Figure 5.3: pH dependency of recombinant TbPMM when assayed in vitro for the conversion of 
Man-1-P to Man-6-P. Recombinant TbPMM (50 ng) was incubated with 700 µM Man-1-P and 
1 µM Glc-1,6-biphosphate as co-factor for 20 min at room temperature. The Bis-Tris propane 
buffer was varied to obtain a pH range of 5-10. The product of the reaction was analyzed by 
HPAEC-PAD.  
 
Mannose-1,6-biphosphate is the natural co-factor for this class of enzymes, but it 
has been shown in different systems, that the more readily available Glc-1,6-biP can be 
used as a co-factor without apparent loss in efficiency (Oesterhelt et al., 1997; Pirard et 
"
#
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al., 1999; Qian et al., 2007). However, Oesterhelt et al. have also suggested that plants 
and yeast PMMs differ from animal PMMs in their reaction mechanism. They proposed 
that while animal enzymes require the hexose-biphosphate co-factor only for the 
activation of the enzyme, plants and S. cerevisiae PMMs, when incubated with Man-1-P 
and Glc-1,6-biP, convert the Glc-1,6-biP to Man-1,6-biP. This was indicated by an 
initial lag phase in the reaction time course (Figure 5.4, panel A), which is not observed 
when Glc-1-P is used as a substrate. No such lag phase could be observed with the 
recombinant TbPMM when the enzyme was incubated with Man-1-P and Glc-1,6-biP, 
suggesting the mechanism being similar to animal PMMs (Figure 5.4, panel B). 
The same HPAEC-PAD setup was used to determine the kinetic properties of 
the enzyme, but conditions were chosen so that a conversion of less of 30% of the 
substrate was observed (10 ng recombinant TbPMM, 20 min at room temperature). It 
was not possible to saturate the reaction, as the TbPMM activity showed inhibition at 
the highest Man-1-P concentrations (Figure 5.5). Consequently, an equation for high-
substrate inhibition was used to calculate the kinetic parameters of the reaction. The Km 
for Man-1-P was estimated at 327 ± 66 µM, with a maximum velocity of 2.6 ± 0.4 nmol 
• min-1 per mg of protein (Table 5.1).  
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Figure 5.4: Time course for the conversion of Man-1-P to Man-6-P in the presence of Glc-1,6-
biP. A. G. sulphuria PMM reaction using Man-1-P (black circles) or Glc-1-P (white circles) as 
substrates. A lag phase can be observed at the beginning of the PMM incubation with Man-1-P. 
Taken from Oesterhelt et al., 1997. B. Man-1-P conversion by TbPMM in the presence of Glc-
1,6-biP. For this time course, 10 ng of recombinant TbPMM were incubated in the presence of 
700 µM Man-1-P. Time points were collected between 30 s and 20 min. 
"
#
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Figure 5.5: TbPMM kinetics for the conversion of Man-1-P. As described in the Material and 
Methods section, 10 ng of TbPMM were incubated, as described in Material & Methods, with a 
concentration of Man-1-P between 10-1000 µM, before being analyzed by HPAEC-PAD. The 
recombinant TbPMM kinetic analysis showed high-substrate inhibition.  
 
5.3 Recombinant TbPMM can catalyze the conversion of Glc-6-P to Glc-1-P  
The ability of TbPMM to use glucose phosphates as substrates was assessed by 
incubating each recombinant enzyme in the presence of Glc-1-P. The formation of Glc-
6-P could be detected by HPAEC-PAD (Figure 5.6, panel A). Since Glc-1-P is the 
substrate for the UDP-glucose pyrophosphorylase (UGP), we were able to set up an 
assay for the conversion of Glc-6-P to Glc-1-P by coupling TbPMM with TbUGP to 
produce UDP-Glc in the presence of UTP (Mariño et al., 2010). Thus, a single peak that 
co-eluted with UDP-Glc could be detected on an HPAEC-UV system at A260. Removal 
of TbPMM from the reaction resulted in the loss of the UDP-Glc peak (Figure 5.6, panel 
B).   
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Figure 5.6: Recombinant TbPMM can convert Glc-1-P and Glc-6-P in vitro. A. Recombinant 
TbPMM (50 ng) was incubated with Glc-1-P and Glc-1,6-biP as co-factor. The product of the 
reaction was analyzed by HPAEC-PAD. A peak corresponding to Glc-6-P was observed in the 
presence of the recombinant enzyme, but not in its absence. B. TbPMM activity was analyzed in 
a coupled assay with TbUGP in the presence of Glc-6-P and UTP, as indicated. The products of 
the reactions were analyzed by HPAEC with UV detection. Formation of UDP-Glc was 
observed in the presence of TbPMM, but not when the mutase was removed from the reaction. 
 
The kinetic parameters for the conversion of Glc-6-P to Glc-1-P by TbPMM 
were determined in a discontinuous coupled assay with TbUGP with colorimetric 
detection. This assay measures the pyrophosphate (PPi) product of the Glc-1-P +UTP -> 
UDP-Glc + PPi coupling reaction via conversion of the PPi to inorganic phosphate and 
detection with a molybdate reagent (see Materials and Methods). To reach linearity for 
B
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the phosphomutase reaction, 1 µg of recombinant TbUGP and a concentration of UTP 5 
times higher than the Km (Mariño et al., 2010) were required. The amount of TbPMM 
(25 ng) used in the reaction and the incubation conditions (15 min at room temperature) 
were selected to have less than 30% substrate turnover. The conversion of Glc-6-P to 
Glc-1-P by the recombinant TbPMM followed classic Michaelis-Menten kinetics 
(Figure 5.7) and the enzyme displayed an apparent Km of 96 ± 8 µM for Glc-6-P and a 
specific activity of 0.331 ± 0.008 nmol  min-1 (Table 5.1).  
 
 
Figure 5.7: TbPMM kinetics for the conversion of Glc-6-P. The kinetic analysis of recombinant 
TbPMM was performed using a TbUGP-coupled assay with colorimetric detection (see Material 
and Methods). The concentration of Glc-6-P was varied between 10-1000 µM.  
 
 
Table 5.1: Comparison of TbPMM kinetic properties for Man-1-P and Glc-6-P 
 
a The kinetic constants were calculated using a high-substrate inhibition equation based on the 
best-fit non-linear lines.  
b The kinetic constants were calculated using the Michaelis-Menten equation. 
TbPMM
Substrate Km (µM) vmax (nmol min
-1
) Kcat/Km (M
-1 
s
-1
)
a
Man-1-P 327±66 2.6±0.4 3.7x10
5
b
Glc-6-P 96±8 0.331±0.008 5.7x10
4
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5.4 Studies on the oligomeric state of recombinant TbPMM 
The oligomeric state of TbPMM was studied by analytical ultracentrifugation 
(AUC) and size exclusion chromatography. All eukaryotic PMMs structurally described 
so far are homodimers (Kedzierski et al., 2006; Silvaggi et al., 2006; Kepes et al., 1988) 
and the predicted molecular weight of recombinant TbPMM in a dimeric state would be 
55.8 kDa. In the AUC experiments, performed by Mark Agacan (University of 
Dundee), the untagged recombinant TbPMM was analyzed in two different buffers 
(Figure 5.8): one containing sodium chloride at physiological concentrations (10 mM 
HEPES pH 7.5, 150 mM NaCl, panel A) and one without any salt (10 mM TrisHCl pH 
7.5, 1 mM DTT, panel B). This last buffer is the same used in the crystallization of L. 
mexicana PMM (Kedzierski et al., 2006). In both cases, TbPMM presented itself as a 
very pure monomer and no oligomers or degradation products could be observed. The 
calculated molecular weight was of 26.8 kDa in buffer A and 27.9 kDa in buffer B 
(Figure 5.8).  
However, when TbPMM was analyzed by size exclusion chromatography, 
during the purification process at the Structural Genomic Consurtium, the retention time 
was consistent with the apparent molecular weight of a homodimer. All the steps in the 
purification of recombinant TbPMM were carried out in high salt concentration (0.5 M 
NaCl) and it has been shown that high salt can drive dimerization in order to protect 
hydrophobic patches present on the surface of the molecule (Sakurai et al., 2008). 
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A 
 
MW S % 
26.8 2.513697 100 
 
B 
 
MW S % 
27.9 2.681 100 
Figure 5.8: Analysis of recombinant TbPMM by analytical ultracentrifugation. TbPMM at 0.5 
mg/ml was analysed by sedimentation velocity in A. 10 mM HEPES pH 7.5, 150 mM NaCl or 
B. 10 mM TrisHCl pH 7.5, 1 mM DTT. In both buffer conditions, TbPMM was a very pure 
monomer with no signs of aggregation, degradation products or oligomers.  
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In conclusion, recombinant TbPMM was consistent with a dimeric quaternary 
structure only at high concentrations of salt, while at physiological conditions the 
protein behaved as a monomer, suggesting that the monomeric state is the most 
probable natural state of this enzyme. As the previously described eukaryotic PMMs are 
all homodimers (Kedzierski et al., 2006; Silvaggi et al., 2006; Kepes et al., 1988), the 
atypical oligomeric state of TbPMM could be a possible explanation for the unusual 
kinetics displayed by this enzyme when compared to the other eukaryotic PMMs (see 
Section 6.4 in the Discussion). 
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6. DISCUSSION 
 
 
6.1 Putative fucosyltransferases in T. brucei, T. cruzi and L. major 
 Genes encoding for putative fucosyltransferases (FTs) were found in T. brucei, 
T. cruzi and L. major genomes. A putative FT with homology to the CAZy GT11 
family, which encodes almost exclusively for α-1,2-fucosyltransferases (Cantarel et al., 
2009; Coutinho et al., 2003; Zhang et al., 2010), could be identified in all three 
genomes. Instead, only T. cruzi and L. major presented a putative fucosyltransferase 
belonging to the GT10 family, which is characterized by enzymes that transfer fucose to 
N-acetylglucosamine in a α-1,3 or α-1,4 linkage (Ma et al., 2006). The predicted amino 
acid sequences for the putative T. cruzi (Tc00.1047053509233.40 and 
Tc00.104053509437.80) and L. major (LmjF02.0330) GT10 fucosyltransferases 
suggest quite different proteins, not only do they show very low sequence homology 
outside of the expected conserved motifs, but also the T. cruzi protein comprises 412 aa, 
while the L. major has 1539 residues (Figure 6.1, panel A). What is more, although the 
genomes of these trypanosomatids are highly syntenic (El-Sayed et al., 2005b), the 
genes encoding for these putative GT10 FTs do not show synteny. Notably, synteny is 
not found between the three sequenced Leishmania genomes either (Figure 6.1, panel 
B), as L. braziliensis has a homologue of LmjF02.0330, but located in a different 
genome locus. Peacock et al. have reported conservation of synteny between the three 
Leishmania genomes for 99% of the genes. These observations do not seem to be 
consistent with the hypothesis that T.brucei has deleted its GT10 fucosyltransferase at 
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some point after speciation. Additionally, the differences in the primary protein 
sequences of the putative L. major and T. cruzi α1,3/α1,4-FTs might suggest that these 
two parasites have acquired the two genes in separate events.  
 
 
 
Figure 6.1: Trypanosomatids putative fucosyltransferases. A. Multiple sequence alignment of 
the predicted amino acid sequences of the putative T. cruzi (Tc00.1047053509233.40/ 
Tc00.104053509437.80) and L. major (LmjF02.0330) GT10 fucosyltransferases. B. Analysis 
of synteny for LmjF02.0330 (top) and Tb09.160.2220, the gene encoding for TbFT (bottom).  
 
A
B
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(Figure 6.1, continued) 
 
 
It should be noted that, in contrast to the putative GT10 fucosyltransferases 
genes, synteny is conserved for the putative GT11 fucosyltransferase encoding genes 
between T. cruzi, T. brucei and Leishmania spp. (Figure 6.1, panel B).  
In the phosphodiester-linked glycans (P-glycans) of T.cruzi gp72, fucose is 
found linked to either xylose or GlcNAc in an α-1,4 linkage (Fig 1.8; Allen, 2001). The 
presence of two different linkages suggests the requirement for two distinct FTs, as the 
majority of glycosyltransferases catalyse one specific sugar linkage (Weigel and 
DeAngelis, 2007). The Fucα1,4GlcNAc linkage is consistent with the activity described 
for members of the GT10 family, suggesting that Tc00.1047053509233.40/ 
Tc00.104053509437.80 might encode for the protein responsible for this modification 
(Oriol et al., 1999). However, Fucα1,4Xyl or fucosyltransferases catalyzing this 
glycosidic linkage have not been described so far in the literature. A possible 
A
B
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explanation for the formation of this linkage is that the identified T.cruzi putative GT10 
enzyme has very loose specificity and it is able to recognize both GlcNAc and Xyl as 
acceptors. An alternative and more likely possibility, given our current knowledge of 
GTs, is that a member of a novel family of fucosyltransferases is responsible for this 
linkage. It should be noted that the NMR data for the highly unusual Fucα1,4Xyl 
linkage was difficult to interpret and as a consequence this result should be taken with 
caution (Allen, 2001).  
 
 
6.2 T. brucei encodes for an active α1,2-fucosyltransferase 
 Here we have described the biochemical characterization of the only T. brucei 
putative fucosyltransferase (TbFT). Structural analyses of the reaction product 
characterized TbFT as an α-1,2-fucosyltransferase and activity assays performed in vitro 
with the recombinant protein identified Galβ1,3GlcNAc (LNB) or Galβ1,3GlcNAc-β-
O-methyl (LNB-β-O-methyl) as the best acceptors tested. Transfer of Fuc was also 
observed to bigger oligosaccharides containing Galβ1,3GlcNAc as a terminal moiety at 
their non-reducing end (Figure 4.7 and Table 4.3). In T. brucei, this particular structure 
has been described so far only on the glycan chains of procyclin GPI anchors (Figure 
1.4). However, no fucose has been identified by neutral sugar composition analysis of 
the GPI anchors of wild type procyclin (Ferguson et al., 1993; Roper et al., 1995; 
Izquierdo et al., 2009b). Interestingly, in T. cruzi Galβ1,3GlcNAc has been described in 
the O-linked oligosaccharides of GPI-anchored epimastigote mucin-like glycoproteins 
(Previato et al., 1995; Almeida et al., 1994). 
Recombinant TbFT was also able to transfer Fuc to N-acetyllactosamine 
(Galβ1,4GlcNAc or LacNAc), albeit with lower efficiency. This is the repeating unit of 
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the poly-LacNAc containing structures found on N-glycans of bloodstream form T. 
brucei and in the procyclin GPI anchors (Figure 1.4). Given the prevalance of 
Galβ1,4GlcNAc repeats in the bloodstream form glycoproteins located in the flagellar 
pocket and through out the endosomal/lysosomal system, it is possible TbFT might 
transfer Fuc to these structures, but Fuc has not been identified on poly-LacNAc repeats 
(Atrih et al., 2005). In T. brucei the LacNAc repeats are mostly interconnected by a 
Galβ1,6GlcNAc glycosidic linkage, but in vitro activity assay indicated that TbFT could 
not transfer to this particular disaccharide acceptor (Figure 4.7 and Table 4.3). 
The activity of the recombinant TbFT was assayed in vitro using radiolabelled 
sugar nucleotide donor. In these experiments it was possible to observe high levels of 
hydrolysis of GDP-[3H]Fuc to [3H]Fuc in the presence of the purified recombinant 
protein preparation, but not when the material purified from E. coli transformed with the 
empty pGEX6P1 vector was used (Fig. 4.5, panel B). There is a formal possibility that 
an E. coli hydrolase/phosphodiesterase is specifically purified with the recombinant 
TbFT.  However, it seems more likely that the hydrolytic activity is due to the 
recombinant TbFT itself, as a sugar nucleotide hydrolysis reaction can be also seen as 
the transfer of the sugar moiety to water. High hydrolytic activity has been described for 
T. cruzi UDPGlcNAc:polypeptide α-N-acetylglucosaminyltransferase (Heise et al., 
2009) and recently in a α-1,3/α-1,4-FT belonging to the GT11 family (Zhang et al., 
2010). Furthermore, the hydrolysis of GDP-Fuc was reduced when the recombinant 
TbFT best acceptor (LNB-O-methyl) was used or when the acceptor concentration was 
increased, as in the activity assay upscale (Figure 4.10). The GDP-Fuc hydrolytic 
activity of T. brucei fucosyltransferase could be tested by generating a catalytically dead 
mutant of TbFT, as the disappearance of or the reduction in GDP-Fuc hydrolysis, in the 
TbFT mutant, would strongly associate the recombinant T. brucei FT with the 
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hydrolytic activity. Mutagenesis experiments in human α-1,6-fucosyltransferase showed 
that substitution of the first Arg, in Motif I (VG(L/V)H(I/V)RRDGY), to Ala or Lys 
abolished activity. As this motif is shared between α-1,2- and α-1,6-FTs, the 
corresponding Arg in TbFT, R152, would be a good candidate residue to mutate for the 
generation of a catalytically dead mutant (Takahashi et al., 2000). 
To obtain sufficient material for animal immunization, the recombinant 
expression of GST-TbFT was optimized, resulting in a 5-fold increase in protein yield 
(Figure 4.17). Additionally, with the newly available robotic technologies, the amount 
of GST-TbFT that can be purified, although not high, is sufficient for crystallization 
trials. This would be an interesting area of investigation as no structures have been 
described so far for proteins belonging to the CAZy GT11 family. What is more this GT 
family is one of the few (together with GT37, GT65, GT68 and GT74) where a fold 
could not be predicted based on iterative sequence searches, suggesting it might present 
a novel GT fold (Lairson et al., 2008). Unfortunately, removal of the GST-tag from the 
recombinant TbFT was not successful and crystallization of protein fused to bulky tags 
has been reported to present technical difficulties (Smyth et al., 2003). The inefficient 
cleavage of the GST tag might indicate that the PreScission protease site is hidden or 
sterically unavailable to the enzyme, which could be the result of the recombinant 
protein, or at least a fraction of it, being present as an oligomer. Such a possibility is 
consistent with the preliminary gel filtration data (Figure 4.18), but an additional 
technique, e.g analytical ultracentrifugation, should be used to test this hypothesis. 
The antibodies obtained by both mouse or rabbit immunization with GST-TbFT 
showed very low titers towards the recombinant protein itself (Figure 4.19). It is 
possible that TbFT is not a very immunogenic protein or at least not as immunogenic as 
GST. The low titer was probably the reason for our lack of success in trying to localize 
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the endogenous TbFT by immunofluorescence or even to isolate it by 
immunoprecipitation from procyclic form or bloodstream form cell lysates. An 
alternative approach could be to insert an ectopic copy of TbFT fused to a tag, e.g. GFP, 
HA or Ty or alternatively to tag the fucosyltransferase in situ. This would allow both 
localization and isolation of the endogenous TbFT protein. Considering that in procyclic 
form Fuc has been identified on a surface complex (Güther et al., 2009), our prediction 
is that TbFT should localize to the secretory pathway, at least in this life stage. 
Furthermore, given the current knowledge of eukaryotic α1,2-fucosyltransferases, TbFT 
should most likely localize to the Golgi apparatus (Ma et al., 2006).  
TbFT has been identified in a proteomic analysis in both procyclic and 
bloodstream form T. brucei (Urbaniak M., personal communication). In this chemical 
proteomic approach non-selective kinase inhibitors were bound to beads and used to 
enrich for kinases, resulting also in an enrichment of purine-binding proteins, e.g. TbFT 
(Bantscheff et al., 2007). 
 
 
6.3 TbFT conditional null mutants 
 The generation of conditional null mutants in T. brucei bloodstream form was 
unsuccessful. Attempts to replace the first TbFT allele were successful only after 
insertion and activation of the ectopic copy, which initially suggested haploid 
insufficiency. The subsequent attempts to replace the second allele all failed. Constructs 
containing an ectopic promoter, used also in the generation of the GDP-fucose 
biosynthesis null mutant (GMD cKO) cell line (Turnock et al., 2007), were tested here 
for replacement of the second allele. However this alternative construct did not help, 
indicating that low expression of the resistance cassette, due to the TbFT locus, was not 
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the cause of the difficulties encountered in replacing the alleles. It seems more likely 
that these results point to a problem with TbFT mRNA levels in the mutant cell lines. 
One possibility is that in both single knock-out cell line and conditional null mutants, 
mRNA levels are too low to allow normal cell growth. However, an alternative 
explanation could be that in bloodstream form T. brucei the range of permitted TbFT 
mRNA levels is quite restricted: while they are too low in the single knock-out for the 
cells to survive, they are too high when the ectopic copy is activated, so that the parasite 
has to use its RNA interference (RNAi) machinery (Militello et al., 2008) to reduce the 
TbFT mRNA levels. In this scenario, replacement of the second allele would remove the 
sequence template for the antisense RNA synthesis and the cells would be unable to 
reduce the high, possibly toxic levels of TbFT mRNA. Both these explanations account 
for the death of the parasites presenting the correct allele replacement and the observed 
recovery of cells where the resistance cassette has been inserted unspecifically. 
Northern blotting will be used to determine the TbFT mRNA levels in each of the cell 
lines involved (wild type, wild type plus ectopic copy induced or non induced and 
single knock-out). An advantage of this technique over quantitative RT-PCR is that it 
would also show, if present, any degradation of the TbFT mRNA upon ectopic copy 
induction.  
Given the high similarity between the GMD and TbFT conditional null mutants 
in procyclic form (see below), one might predict that the same correspondence should 
be observed for the TbFT and GMD cKO in bloodstream form. On the other hand, 
considering the difference in phenotype between the bloodstream form and procyclic 
form GMD cKO (Turnock et al., 2007), we cannot exclude the possibility of an 
additional essential role of Fuc in the mammalian stage. Knock-down of TbFT by RNAi 
could give some information on the role played by this fucosyltransferase in 
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bloodstream form T. brucei. However, recent published data obtained by RNA 
interference target sequencing (RIT-seq) has shown that, when TbFT has been knocked-
down, no effect could be observed on the growth phenotype of bloodstream form 
parasites or during differentiation (Alsford et al., 2011). It should also be noted that in 
the same screen, no effect could be observed on procyclic form proliferation upon TbFT 
knock-down, while the null mutants described here suggest the essentiality of TbFT for 
in vitro cell growth in this same life cycle stage. These contrasting results might be 
explained by the long time required before the appearance of the growth phenotype, as 
TbFT null mutants (TbFT cKO) show a reduction in cell growth rate after 7-8 days of 
culturing in non-permissive conditions and die around day 15 (Figure 4.24). It is 
possible that in Alsford et al. the cells were not maintained long enough to observe the 
occurrence of the growth phenotype.  
Interestingly, the cell growth phenotype observed in the procyclic form TbFT 
cKO is similar to the growth phenotype described for the GMD cKO mutants (Figure 
4.24; Turnock et al., 2007), suggesting that TbFT is either the only downstream user of 
GDP-Fuc in T. brucei or at least the enzyme responsible for the transfer of Fuc to its 
essential acceptor(s).  
A phenotype of flagellar detachment was observed by scanning electron 
microscopy (SEM) in GMD cKO procyclic form parasites, grown in the absence of 
tetracycline (Figure 1.7; Turnock et al., 2007). However, when flagellar detachment 
was studied in the GMD and TbFT cKO cell lines by motility analysis, 
immunofluorescence and by estimating the percentage of cells with detached flagella in 
culture, no clear phenotype could be observed (Figures 4.26-4.28). It is possible that the 
previously observed flagellar detachment was an SEM artefact. An alternative 
explanation for these contrasting results could be a more fragile attachment of the 
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flagellum to the cell surface in these mutants. This theory is supported by the 
observation that, although the percentage of flagellar detachment observed in culture in 
the TbFT and GMD cKO grown in non-permissive conditions was consistent with what 
has been previously reported for wild type (LaCount et al., 2002), it was still 
significantly higher than in the same mutant cell lines grown in the presence of 
tetracycline (Figure 4.26). A weakness in flagellar adhesion could be tested by briefly 
centrifuging the cells at high speed before estimating the percentage of flagellar 
detachment in culture; if the attachment of the flagellum to the cell surface is fragile, the 
centrifugation step might cause an increase in the fraction of cells presenting detached 
flagella. We tested this hypothesis on both the TbFT and GMD cKO cell lines, but no 
difference could be observed in the percentage of flagellar detachment between cells 
that had been centrifuged or not. 
Fla-1 had been proposed as the most likely candidate for a fucosylated 
glycoconjugate (Turnock et al., 2007). This protein has been shown to be required for 
flagellar attachment and cell growth in both procyclic and bloodstream form T. brucei 
and it is a homologue of T. cruzi gp72, the only characterized fucose-containing 
glycoconjugate in trypanosomatids (Haynes et al., 1996; Nozaki et al., 1996; Allen, 
2001). Although gp72 is not essential, it is required for flagellar adhesion and what is 
more, it has been suggested that its carbohydrate chains are required for this function 
(Nozaki and Cross, 1994). At this point we cannot completely exclude the presence of 
Fuc on Fla-1 glycan chains, however the clear flagellar detachment phenotype observed 
in the Fla-1 RNAi mutants (LaCount et al., 2002), compared to the phenotype of GMD 
and TbFT cKO lines, would suggest that Fuc, if present, is not required for flagellum 
adhesion and therefore this should not be the essential fucose-containing 
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glycoconjugate. This would make the characterization of Fla-1 glycans still interesting 
but not as important for this project as originally thought. 
 From a morphological point of view, TbFT and GMD cKO cells grown in non-
permissive conditions showed an increase in the average cell volume, with the cells 
looking longer and thinner when observed at the microscope in phase contrast mode 
(Figure 4.25). The meaning of this morphological change is not clear, but in our 
experience this is often a sign of stress, as wild type procyclic form T. brucei grown in 
less than ideal conditions, e.g. in old medium or in a highly diluted culture, shows a 
highly similar morphology. As this phenotype appears concomitantly with the reduction 
in growth rate, it is possible it is just another indication that some foundamental cell 
process is affected.  
 To biochemically characterize the TbFT conditional null mutant, the fucose-
containing high molecular weight glycoconjugate complexes (Güther et al., 2009) in the 
TbFT deficient cell line and in wild type cells were labelled by galactose 
oxidase/NaB[3H]4 treatment and compared. As shown in Table 4.7 and Figure 4.29, a 
reduction in the total labelled material with respect to wild type could be observed in the 
TbFT cKO mutants, even when the cells were grown in permissive conditions. TbFT 
cKO cells grown in the absence of tetracycline showed about 52 % of the labelled 
material of the same cell line grown in permissive conditions and 30 % of wild type. 
The reason for the reduction in the total galactose oxidase/NaB[3H]4 labelled material in 
the mutant cells expressing the ectopic TbFT is not clear, but the further reduction 
observed in the same cell line grown in the absence of tetracycline is quite striking. 
Even more so if we consider that these cells have a slightly larger volume and surface 
area. The labelled material that could be purified with ricin was also reduced in the 
TbFT deficient cell line, grown in either permissive or non-permissive conditions, to be 
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about half of wild type level. Interestingly, when the galactose oxidase/NaB[3H]4 
labelled material was purified with the fucose-specific AAL lectin, almost no counts 
could be observed in the TbFT cKO grown in the absence of tetracycline, suggesting 
that the transfer of fucose to the glycans on the high molecular weight glycoconjugate 
complex had been severely reduced. As a comparison, the percentage of material that 
could be purified with AAL was about 10 % of the total labelled material for wild type 
and 32 % for the TbFT cKO cell line grown in permissive condition (Table 4.7).  
 
 
Figure 6.2: A hypothetical model for the fucose-containing glycoconjugate(s) based on the 
results from the galactose oxidase/NaB[3H]4 labelling of wild type and TbFT cKO procyclic 
form. 
 
A hypothetical model to explain the results from this labelling experiment is shown in 
Figure 6.2. In this model, the Gal residues at the non-reducing end are all labelled by 
galactose oxidase/NaB[3H]4, while the internal ones cannot be labelled or, at best, can 
be labelled less efficiently (Gahmberg and Tolvanen, 1994). In the wild type (drawing 
on the left), a fraction of the galactose-containing glycans on the surface are also 
fucosylated and in this model the presence of fucose is required to add the next 
WILD TYPE TbFT cKO + tet TbFT cKO - tet
Gal
GlcNAc
Fuc
Ricin
AAL
x x
x
x
x
x labelled Gal
6. DISCUSSION  
 
158 
galactose residue on these glycan chains. In the TbFT cKO grown in the presence of 
tetracycline (middle drawing), an increase in the level of fucosylation on the surface 
glycans would result in a greater fraction of Gal residues being further modified and 
therefore not available for ricin binding, explaining the reduction of counts observed 
(Table 4.7). In the same mutant cell line, grown in the absence of tetracycline (drawing 
on the right), the lack of TbFT means there would be no fucose residues transferred to 
the glycan chains, as suggested by the background level of AAL binding, and according 
to this model the terminal Gal would not be added. This would cause a reduction of the 
amount of material bound by ricin, but also of the total material that can be labelled via 
galactose oxidase/NaB[3H]4 treatment. To test this model, the disappearance/reduction 
of Fuc should be confirmed by neutral sugar composition analysis by GC-MS.  
 
 
6.4 T. brucei fucose-containing glycoconjugates 
In T. brucei Fuc has been identified by neutral sugar composition analysis only 
in the high molecular weigh glycoconjugate complex on the surface of procyclic form 
parasites (Güther et al., 2009). It has not been possible so far to identify the fucose-
containing component(s) of this complex.  
Because of the lack of an apparent salvage pathway in T. brucei, it is not 
possible to metabolically label glycoconjugates with [3H]Fuc. For this reason, an 
attempt was made at labelling the surface of procyclic form parasites (where the high 
molecular weight glycoconjugate complex is found) using GDP-[3H]Fuc and the 
recombinant GST-TbFT, after treatment with α1,2-fucosidase. Unfortunately, no 
incorporation could be observed. A limitation of this experiment is that it is based on 
the assumption that all or most of the fucose is found as a terminal residue, although 
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there is not clear evidence for it. From an experimental point of view, the amount of 
recombinant TbFT used was chosen based on the in vitro activity assay: 4 µg should be 
able to catalyse the transfer of about 10 nmol of Fuc to LNB-β-O-methyl. However, 
considering the different conditions and probably substrate(s) present in the labelling 
experiment compared to the activity assay, testing different amounts of enzyme would 
have probably been more appropriate. For the same reason, although the activity of the 
GST-TbFT preparation used in the labelling was tested, it was done using the in vitro 
assay protocol, while a better positive control would have been to add LNB-β-O-methyl 
to the labelling mixture and verify the transfer of [3H]Fuc to the disaccharide under 
these conditions. Lastly, even though the medium was washed away and the cells were 
labelled in PBS, the presence of GDP-[3H]Fuc at the end of the incubation should have 
been checked to rule out degradation of the sugar nucleotide donor, e.g. by the action of 
phosphodiesterases. 
The recent identification of a bifunctional GDP-Fuc and GDP-Ara 
kinase/pyrophosphorylase (AFKP80) in Leishmania might provide a way to 
metabolically label T. brucei with [3H]Fuc (Guo et al., 2009). An interesting approach 
would be to transfect procyclic and bloodstream form T. brucei parasites with the 
afkp80 gene and use this cell line to attempt to label the fucose-containing 
glycoconjugates with [3H]Fuc. The ability of these two T. brucei life stages to uptake 
Fuc should be tested, as transport of Fuc by the T. brucei glucose transporters (THT1 
and THT2) has not been described in the literature (Barrett et al., 1995; Azema et al., 
2004). 
 Of the glycan-binding proteins that were tested, the fucose-specific lectins AAL 
and UEA I gave somewhat positive results. Purification experiments performed with 
AAL on procyclic form cell lysate isolated a fraction of the high molecular weight 
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glycoconjugate complex (Figure A2). Ulex europaeus agglutinin I, which should have 
higher specificity than AAL for α1,2-linked fucose, showed some level of specific 
recognition of procyclic form T. brucei cell lysate, but this result was not completely 
reproducible (Figure A1). Interestingly, glycan array data available from the CFG 
database suggest that UEA I might show a preference for α1,2Fuc linked to LacNAc 
repeats (http://www.functionalglycomics.org/glycomics/publicdata/selectedScreens.jsp) 
but not Galβ1,3GlcNAc, arguing that, although specific for α1,2linked Fuc, this lectin 
might not be the ideal for the study of this structure in T. brucei.  
Positive results were obtained also with hGalectin-2 (Figure 4.30). Western 
blotting identified a band at about 190 kDa, in T. brucei procyclic form cell lysate, that 
was specifically recognized by this glycan-binding protein. Unfortunately, further 
studies on this glycoprotein were not possible as trial experiments indicated that the 
biotinylated anti-hGal-2 antibody was not suitable for immunoprecipitation. A possible 
solution to this problem would be to express, purify and then biotinylate hGal-2 in 
house. All these steps have been described in the literature for this protein and 
biotinylation has been shown not to affect the stability of hGal-2 or its ability to bind 
glycans (Stowell et al., 2008; Dias-Baruffi et al., 2003) 
The possibility that in T. brucei Fuc residues might be further substituted, rather 
than terminal, had been suggested when the initial attempts to identify fucose-
containing glycoconjugate(s), by lectin blot or purification, failed (Turnock et al., 
2007). Although we have shown here that it is possible to partially isolate the high 
molecular weight glycoconjugate complex by AAL purification, given the apparent low 
abundance of this modification, we also investigated the possibility that at least a part of 
the fucose residues might be internal. One of the most common substitutions to Fuc 
described in the literature is by Gal, either in β or α configuration (Takahashi et al., 
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2003; Ercan et al., 2006; Takeuchi et al., 2008). Accordingly, ricin-purified material 
from procyclic form was treated with β-galactosidase (BTBG) or α-galactosidase 
(CBAG) on blot, before being probed with AAL to see if there was any increase in the 
binding of this fucose-specific lectin. Unfortunately, no specific change could be 
observed after treatment with either exoglycosidase (Figure A3). A few problems were 
associated with these experiments. First, after incubation with the exoglycosidases or 
even with the reaction buffers alone, the nitrocellulose membrane became very fragile 
and an increase in the level of background could also be observed. Possibly, 
polyvinylidene fluoride (PVDF) membranes, which are more resistant to chemical 
treatments, would have been more appropriate for this approach. Second, there might be 
an experimental design flaw as this method is based on the assumption that the 
exoglycosidases would be able to cleave whatever Gal linkage would be present. 
Although both BTBG and CBAG present quite broad specificities, they do not cleave 
all Gal linkages with the same efficiency; CBAG, for example, shows poor kinetics 
towards Galα1,3 terminating glycans (Liu et al., 2008).  
 Mass spectrometry is another technique that has been applied to the study of 
glycoconjugates. This methodology presents a few advantages over most of the 
experiments described here so far. First of all, it can work as a wider approach that is 
not limited to one particular set of molecules, e.g. the high molecular weight 
glycoconjugate complex. Secondly, MS/MS data can provide structural information on 
the analyzed glycans, something that very few other techniques, with the exception of 
NMR that requires large quantities of material, can do. However, there are also some 
disadvantages, the greatest limitation probably being that this approach would provide 
information only on the glycans and not on the identity of the protein carrying the 
modification. Also, protocols can be quite laborious, in our case especially for the 
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analysis of the putative β-eliminated glycans. Here we attempted to analyse the total N-
glycan and O-glycan fractions isolated from T. brucei procyclic form parasites.  When 
the N-glycan fraction was analyzed, no other glycans, beside the expected 
oligomannose series (Treumann et al., 1997; Hwa et al., 1999; Hwa and Khoo, 2000), 
could be identified (Figure 4.31 and Table 4.8). The observation of ions with m/z 
consistent with the Man5GlcNAc2 to Man9GlcNAc2 series suggested we were able to 
isolate the N-glycan fraction fom the total cell lysate. It is possible that our inability to 
detect other N-glycans might be due to their low abundance and in this case precursor-
ion scanning might be useful, for example we could look for species that upon collision 
induced fragmentation yield fragments with m/z consistent with a dHex (like Fuc) or 
dHex1Hex1 (like Fuc-Gal). In the case of the analysis of the β-eliminated fraction, no 
ions consistent with the m/z of permethylated glycans could be observed. As mentioned 
above, the protocol we followed for the isolation and analysis of the putative T. brucei 
O-glycans was laborious, presenting a lot of steps and therefore increasing the amount 
of material that is inevitably lost during these procedures. Because we do not have any 
idea on the abundance level of these types of structures, the amount of cells to be used 
as starting material was chosen arbitrarily. However, in our opinion, it was big enough 
to allow detection of even low abundance structures, especially given the sensitivity of 
mass spectrometry. A bigger problem is the lack of knowledge of a T. brucei molecule 
that could be used as an internal control for the isolation of O-glycans, as it was done 
with the high mannose N-glycan series. To overcome this problem, the cell lysate could 
be spiked with a known O-glycan structure, e.g. porcine mucin, which is commercially 
available. 
 In conclusion, the traditional approach for the isolation of glycans by lectin 
blotting or purification was only partially successful in this particular case. This was 
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probably due to the low abundance and/or the uncommon nature of the structures of T. 
brucei fucose-containing glycoconjugate(s). In situations like this one, labelling, 
especially metabolic radiolabelling, of the glycoconjugates offers the best chances; it is 
a sensitive method, thus helping with low abundance molecules, and it is independent of 
the actual glycan structure.  The generation of a T. brucei cell line carrying the AFKP80 
bifunctional enzyme and therefore a salvage pathway for the biosynthesis of GDP-Fuc 
seems the most advantageous approach. In a second time, after the identification of the 
fucose-containing glycoconjugates, mass spectrometry would become useful to 
characterize the structure of these molecules.  
 
 
6.5 Biochemical characterization of T. brucei phosophomannomutase 
Here we have also described the biochemical and kinetic characterization of T. 
brucei phosphomannomutase, an enzyme in the pathway to GDP-Man and GDP-Fuc. 
TbPMM showed some unusual features when compared to other eukaryotic PMMs. 
First, its apparent Km for Man-1-P was relatively high (327 ± 66 µM) in comparison to 
the values reported for A. thaliana (29.7 µM) (Qian et al., 2007), G. sulphuria (50 µM) 
(Oesterhelt et al., 1996), and human PMM1 (3.2 µM) and PMM2 (18 µM) (Pirard et al., 
1999; Pirard et al., 1997). Second, unlike the aforementioned enzymes, TbPMM was 
inhibited by high-levels of Man-1-P (Figure 5.5). Thirdly, whereas PMMs, including 
that of L. mexicana (Kedzierski et al., 2006) are typically homodimers, TbPMM 
appeared to be a monomer under physiological conditions by analytical 
ultracentrifugation (Figure 5.8).  
This last result is quite intriguing. The residues involved in the interface between 
the monomers have been determined both for the L. mexicana PMM and the human 
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PMM1 (PDB accession numbers 2i54 and 2fuc, respectively). All of these residues are 
located in the cap domain and are well conserved in the TbPMM amino acid sequence. 
Because the residues composing the interface are a mix of hydrophilic and hydrophobic 
amino acids, it is possible that the high salt conditions present in the purification process 
might be pushing towards dimerization of TbPMM, as it was observed. An intriguing 
possibility would be that the monomeric state of the enzyme is responsible for its unsual 
kinetics. In fact, it has been proposed that dimerization in the L. mexicana and human 
PMMs might be involved in catalysis (Kedzierski et al., 2006); firstly, it results in an 
extension of the solvent exposed face that brings the two active sites adjacent 
(Kedzierski et al., 2006).  Secondly, two point mutations in hPMM2 (F119L and 
P113L) that are clinically relevant to the congenital glycosylation disorder type a 
(CGD-1a) disrupt dimerization (Silvaggi et al., 2006).     
The properties of both T.brucei GDP-Man pyrophosphorylase, which shows 
significant product inhibition (Denton et al., 2010), and TbPMM, which shows product 
inhibition in the biosynthetic (Man-6-P to Man-1-P) direction, may also assist the 
coupling of GDP-sugar synthesis to glycoprotein synthesis. A reduction in glycoprotein 
precursor synthesis would reduce the demand for GDP-Man and lead to an 
accumulation of Man-6-P, which, via the reversible phosphomannose isomerase (PMI) 
reaction, would lead to Fru-6-P that would enter the glycolytic pathway. The product 
inhibition shown by these two enzymes might help trypanosomes manage 
differentiations between non-dividing and dividing trypomastigotes, i.e. from 
replicating slender-trypomastigotes to non-dividing stumpy-trypomastigotes, by swiftly 
diverting part of the carbon metabolism between GDP-sugars biosynthesis and 
glycolysis.  
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TbPMM was also able to convert Glc-6-P to Glc-1-P (Figure 5.7). No gene 
encoding a putative phosphoglucomutase (PGM), the enzyme responsible for the 
synthesis of Glc-1-P from Glc-6-P could be found in T. brucei (Berriman et al., 2005; 
Turnock and Ferguson, 2007). The absence of a T. brucei PGM gene is perplexing for 
many reasons. Firstly, T. cruzi and Leishmania have easily identifiable PGM genes and 
the T.cruzi PGM enzyme has been biochemically characterized (Penha et al., 2005; 
Penha et al., 2009). Secondly, the only known route to the identified T. brucei 
metabolites UDP-Glc and UDP-Gal (Turnock and Feguson, 2007) is via UDP-Glc 
pyrophosphorylase (TbUGP) and UDP-Glc 4’-epimerase (GalE) making UDP-Glc the 
obligate precursor to UDP-Gal, that, in turn, is used to synthesise many glycoproteins, 
including VSG and procyclins (Mariño et al., 2010; Roper et al., 2002; Roper et al., 
2005; Shaw et al., 2003; Urbaniak et al., 2006b). Since TbUGP uses Glc-1-P and UTP 
as substrates and the only known route to Glc-1-P is from Glc-6-P via PGM activity, it 
follows that T. brucei should possess PGM activity. The biochemical characterization of 
TbPMM described here partially resolve this metabolic paradox since this enzyme was 
capable of converting Glc-6-P to Glc-1-P, as well as inter-converting mannose-
phosphates. The gene for another phosphohexomutase could be identified in the T. 
brucei and it encoded for a phospho-N-acetylglucosamine mutase that catalyzes the 
conversion of GlcNAc-6-P to GlcNAc-1-P (Figure 1.5; Turnock and Ferguson, 2007). 
The activity of this gene as been confirmed in vitro and, furthermore, TbPAGM is also 
able to convert Glc-6-P to Glc-1-P (Bandini et al., manuscript in preparation). Other 
PMMs and PAGMs have been shown to be similarly promiscuous in other organisms 
(Qian et al., 2007; Pirard et al., 1999; Oesterhelt et al., 1996; Boles et al., 1994; 
Fernandez-Sorensen and Carlson, 1971; Kato et al., 2005; Hofmann et al., 1994), but 
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this would be the first example of PGM activity being completely functionally replaced 
by PMM and/or PAGM.  
In conclusion, the available biochemical data leads to three possible scenarios: 
(a) TbPMM is responsible for the glucose-phosphate conversion, (b) TbPAGM alone 
catalyzes this conversion, or (c) the biosynthesis of Glc-1-P is a concerted effort of both 
these enzymes. In vivo studies would be necessary to discern between these three 
alternatives; knock-down or knock-out cell lines for the genes encoding TbPMM and 
TbPAGM should be generated and the effect of these mutations on UDP-Glc 
biosynthesis analyzed, i.e. by determining sugar nucleotide levels by LC-MS/MS. 
 
 
There were three main aims to this thesis: characterise T. brucei 
fucosyltransferase(s), identify the fucosylated glycoconjugates in this parasite and 
further our understanding of the biosynthesis of GDP-Man and GDP-Fuc by 
characterizing T. brucei phosphomannomutase.  
The biochemical characterization of TbPMM was successful and, interestingly, 
it offered a possible solution to the perplexing lack of a PGM gene in T. brucei, as 
TbPMM was able to convert glucose-phosphates, as well as mannose-phosphates.  
A biochemical characterization of T. brucei only fucosyltransferase (TbFT) was 
also achieved. Furthermore, generation of conditional null mutants in procyclic form T. 
brucei indicated this enzyme to be essential for cell growth in this life stage. 
 The determination of TbFT anomeric and stereochemical specificity helped to 
single out a new reagent, human Galectin-2, which was used in the identification of a 
potential fucosylated glycoconjugate in procyclic form. Although in this thesis we were 
not able to identify T. brucei fucose-containing glycoconjugates, the preliminary 
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experiments carried out here have hopefully indicated the most likely experimental 
routes to the identification of these molecules, i.e. human Galectin-2 and the generation 
of a T. brucei mutant cell line expressing LmjAFKP80 and therefore amenable to 
metabolic labelling with [3H]Fuc. 
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Fucose-specific lectins 
 Fucose-specific lectins from various natural sources and with different 
specificities are commercially available. Ulex europaeus agglutinin I (UEA I) has been 
described as specific for glycoconjugates containing α1,2-linked fucose residues and 
was therefore the first choice of reagent (Pereira et al., 1978). Evidence of specific 
binding could be obtained when UEA I was used in lectin blotting experiments against 
procyclic form T. brucei cell lysate (Figure A1). It was possible to inhibit binding of 
this lectin by preincubating it with 0.2 M methyl-α-L-fucopyranoside (lanes 2 and 5). 
However, the binding pattern of UEA I was not completely reproducible in different 
experiments (lanes 1 and 4), e.g. when different blotting techniques were used (lane 1 
compared to lane 4). Furthermore, negative staining of tubulin (lane 4) suggested some 
level of unspecific binding. Lack of an available glycoprotein containing α1,2-linked 
fucose to be used as a positive control made the standardization of this reagent difficult.  
Aleuria aurantia lectin (AAL) was also tested. This lectin has been described to 
have higher specificity towards α1,6- and α1,3-linked fucose residues, but to recognize 
also α1,2-linked fucose (Kochibe and Furukawa, 1980; Matsumura et al., 2009). 
Biotinylated AAL was used in lectin purification experiments as described in the 
experimental procedures. Starting from 1010 procyclic form cell equivalents, it was 
possible to bind and specifically elute (with 0.2 M α-methyl-L-fucopyranoside) part of 
the high molecular weight glycoconjugate complex (Figure A2, lane 2). Some high 
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molecular weight material could still be found in the flow through from the purification 
experiment (lane 3).  
 
Figure A1: Ulex europaeus agglutinin I. Dm cells were lysed by hypotonic lysis and extracted 
in buffer containing 4 M urea, 2% SDS. The material separated by SDS-PAGE was transferred 
to nitrocellulose using either the semi-dry blotting (lanes 1-3) or the wet blotting (lanes 4-6). 
The cell lysate was probed with biotinylated UEA I (lanes 1 and 4) or lectin pre-incubated with 
methyl-α-L-fucopyranoside (lanes 2 and 5). ExtraAvidin-HRP was used as secondary reagent. 
About 107 cells equivalents were loaded in each lane. Lanes 3 and 6 (P): Ponceau staining of the 
cell lysate after blotting.  
 
 Further modification of fucose residues with other sugars, e.g, galactose, has 
been described in the literature (Takahashi et al., 2003; Ercan et al., 2006; Takeuchi et 
al., 2008). Furthermore, fucose is substituted by Gal, Rha or Xyl in the P-glycans of T. 
cruzi gp72, the only characterized trypanosmatid glycoprotein containing fucose (Allen, 
2001). To investigate the possible presence of Gal-Fuc in T.brucei, total cell lysate from 
dm cell line was purified with ricin, run on a 4-12% SDS-PAGE gel and blotted on 
nitrocellulose, before being treated or mock treated with bovine testis β-galactosidase 
-           +             P               -                 +             P
UEA I                      UEA I
1           2            3                4                5             6
semi dry blotting             wet blotting
kDa
51
97
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(BTBG) or coffee bean α-galactosidase (CBAG). After exoglycosidase treatment, the 
cell lysates were analysed by AAL and ricin blotting, this last as a control for the 
galactosidase reaction. As shown in Figure A3, treatment with CBAG (panel B) resulted 
in a complete inhibition of the ricin binding (lanes 1 and 2). Furthermore, no clear 
staining of the high molecular weight glycoconjugate complex could be observed even 
in the mock treated cell lysate (lane 4), suggesting that the incubations had some 
unspecific effect on lectin blotting. Treatment with BTBG (panel A) did not result in 
any change in the high-molecular weight glycoconjugate staining, which can be clearly 
observed in both treated and mock treated (lanes 3 and 4). It should be noted that the 
incubations with exoglycosidases or buffer alone made the membranes very fragile and 
increased the background signal, making reproducibility an issue.  
 
Figure A2: Partial isolation of the high molecular weight glycoconjugate complex by lectin 
AAL precipitation. Biotinylated AAL was incubated with cell lysate from 1010 procyclic form 
cells equivalents in the presence of Streptavidin-conjugated agarose beads. The material from 
the elution with methyl-α-L-fucopyranoside (lane 2), the purification flow through (lane 3) and 
a fraction of the beads (lane 4) were resolved by SDS-PAGE and visualized by silver staining. 
Lane 1: molecular weight markers. 
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Figure A3: AAL and ricin blots on ricin purified glycoconjugates from procyclic form T. brucei 
after bovine testis β-galactosidase or coffee bean α-galactosidase treatment. Biotinylated ricin 
was incubated with cell lysate from 8x109 procyclic form cells equivalents in the presence of 
Streptavidin-conjugated agarose beads. The material bound to the beads was resolved by SDS-
PAGE and transferred on nitrocellulose before being treated (lanes 1 and 3) of mock treated 
(lanes 2 and 4) with BTBG (panel A) or CBAG (panel B). After exoglycosidase digestion, 
membranes were incubated either with ricin (lanes 1 and 2) or AAL (lanes 3 and 4). Detection 
was performed by chemiluminescence after incubation with ExtraAvidin-HRP. 
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